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Abstract 
Proteins containing Myb domains are present in a wide variety of organisms, 
performing different tasks. A subset of them has been related to the telomere, as they 
are able to bind to the telomere repeats. In this work, while characterizing several of 
these Myb domain proteins it was found that they can be involved in regulating both 
the transcription and post transcriptional modification of genes implicated in essential 
processes, most notably the assembly of key chromatin structures including 
centromeres.  
More precisely, in this thesis it will be shown that the essential fission yeast Myb 
protein Laz1 binds to promoters throughout the genome and regulates the 
transcription of several groups of genes, like the histones. Moreover, the same protein 
is also in control of the post-transcriptional clipping of the histone H3 that occurs 
upon G1 arrest. In addition to these roles, it will be shown that Laz1 is involved in 
loading the histone variant CENP-A histone into the centromeres.  
In this work the function of another Myb protein, Tbf1, was also studied. This protein is 
essential for viability and localizes to the nucleus. Truncation of Tbf1 shows that its C-
terminal part, which includes the Myb domain, is fundamental for survival of the cell. It 
is also shown that this protein may have a telomere function, as its overexpression 
leads to telomere elongation.  
Finally, it is here described how a well characterized telomere protein containing Myb 
domains, Rap1, is crucial for the maintenance of the telomere chromatin structure.  
In summary, results from this thesis show how several proteins that share a similar 
domain can perform different essential tasks during the cell cycle, allowing the 
preservation of S. pombe chromosome integrity. 
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Resumo 
Proteínas que contêm domínios Myb estão presentes numa grande variedade de 
organismos, efectuando diferentes funções. Um subgrupo destas proteínas tem sido 
relacionado com os telómeros, pois os seus membros são capazes de se ligar às 
repetições teloméricas. Neste trabalho, ao caracterizar-se diversas proteínas contendo 
domínios Myb, descobriu-se que estas podem estar envolvidas em regular não só a 
transcrição, como também modificações pós-transcripcionais de genes associados a 
processos essenciais. Entre os processos abrangidos encontra-se a montagem de 
estruturas chave na cromatina, como os centrómeros. 
Mais precisamente, nesta tese vai ser demonstrado que a proteína Myb chamada Laz1 
se liga a promotores presentes no genoma e regula a transcrição de diferentes grupos 
de genes, como as histonas. Além disso, a mesma proteína também controla o corte 
pós-transcripcional da histona H3 que ocorre após paragem na fase G1. Para além de 
descrever essas funções, este trabalho demonstra que Laz1 está envolvida no 
carregamento da variante de histonas CENP-A para o centrómero. 
A função de Tbf1, outra proteína Myb, também é aqui estudada. Esta proteína é 
essencial e encontra-se no núcleo da célula. A supressão de partes de Tbf1 demonstra 
que a sua parte C-terminal, que inclui o domínio Myb, é fundamental para a 
sobrevivência da célula. É também demonstrado que esta proteína poderá ter uma 
função telomérica, pois a sua sobre-expressão leva a um elongamento dos telómeros. 
Por último, é aqui descrito como a já caracterizada proteína Myb Rap1 é fundamental 
para a manutenção da estrutura da cromatina dos telómeros. 
Em resumo, os resultados apresentados nesta tese demonstram como diversas 
proteínas que partilham um domínio semelhante podem efectuar diferentes tarefas 
essenciais durante o ciclo celular, permitindo a preservação da integridade 
cromossómica da levedura de fissão. 
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1.1 – Chromatin structure and organization 
 
The human genomic DNA, which is typically packaged into a nucleus of up to 10 
microns in diameter, is compacted more than 10 0000 fold inside the core of a cell. 
This remarkable fact can only be explained by multiple levels of DNA compaction, 
dependent on different factors (Fig. 1.1). The first level of organization is based on the 
nucleosome, which is the basic repeating unit of the chromatin and includes the DNA 
and an octamer of histones. More precisely, this complex is made of two copies of 
each one of the four histones (H2A, H2B, H3 and H4) (Luger, Mader et al. 1997) and of 
the 147 base pairs (bp) of DNA that are wrapped around the octamer. The length of 
DNA enclosing the complex of histones is always maintained. However, the spacer, or 
linker between different nucleosomes can vary. Importantly, the exact position of the 
nucleosomes with respect to the DNA and the open reading frames (ORF) is known to 
influence transcription (Li, Carey et al. 2007; Henikoff 2008).  
Nevertheless, the folding imparted by the nucleosomes is not sufficient to explain the 
total level of compaction. In fact, a higher-order chromatin structure is obtained by 
packing nucleosome arrays into tightly folded filamentous structures. Measurements 
made in HeLa metaphase cells showed thick fibres of a diameter of around 30 nm 
(Marsden and Laemmli 1979), that fold themselves in loops. Several different models 
have been proposed to explain the topology of this higher order chromatin structure 
but this subject remains controversial (Robinson and Rhodes 2006; Tremethick 2007). 
The extremely compacted structure of the chromatin is inherently repressive for 
factors that need access to the DNA sequence, and the role of chromatin folding in 
controlling transcription is well documented (Horn and Peterson 2002; Narlikar, Fan et 
al. 2002). However, the DNA is not distributed evenly inside the nucleus, as cytologists 
have found many years ago. They called the areas of more condensed DNA 
“heterochromatin”, and the less condensed areas “euchromatin” (Heitz 1928). 
Euchromatin is characterized by being decondensed in anaphase and for being easily 
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accessible to nucleases, a fact that suggested more accessibility to transcription 
factors. Heterochromatin, with its higher-order structures, is associated with silencing 
of genes, as observed by pioneering studies in Drosophila (Muller and Altenburg 1930; 
Schultz 1936). In these studies, it was observed that genes in close proximity with 
heterochromatin have more probability of being silenced. This process is called 
position effect variegation (PEV), and gives rise to heritable mosaic patterns of 
expression in a given tissue, and it has been described in other organisms from yeast 
to mammals. 
There are at least two different types of heterochromatin: a) the constitutive 
heterochromatin, which is silenced in every cell within a species and includes areas of 
the centromere (see section 1.3 ), telomere (see section 1.2) and other repetitive DNA 
elements; b) the facultative heterochromatin which is regulated and not conserved 
within a species (for review see (Arney and Fisher 2004). A widely used example of 
facultative heterochromatin is the inactivation of one of the X-chromosomes in female 
mammals (Chow and Heard 2009). 
Chromosome structure has to be highly dynamic in order to allow processes like 
replication, repair and transcription to occur. Almost paradoxically, chromatin 
structure also needs to be correctly and efficiently propagated generation through 
generation. One of the key moments of each cell cycle is the moment when the DNA 
has to be faithfully duplicated so it can be divided equally to each daughter cell. 
During this delicate process it is not enough to duplicate the DNA double helix, but 
also to reproduce all the information contained within the chromatin structure. The 
cell ability to perform this task is, in fact, the molecular source of hereditary traits. 
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Fig. 1.1 – Multiple levels of chromatin compaction. The DNA double-helix is 
wrapped around an octamer of histones, forming the nucleosome, which allows the first 
level of compaction. The nucleosomes are then packed in thicker fibers that also fold 
themselves into higher order structures (adapted from Sparmann and van Lohuizen 
2006). 
 
1.1.1 Histone proteins and the nucleosome 
 
The existence of histones was reported one hundred and twenty five years ago (Kossel 
1884). Histones were found at a mass level similar to the DNA and for many years they 
were considered as the genetic material itself (Kornberg and Lorch 1999). Upon acidic 
extraction, five histone types were identified (Phillips and Johns 1965). They are now 
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designated as H1, H2A, H2B, H3 and H4. Subsequently, histone H4 amino acid 
sequence was described. Sequencing data lead to the conclusion that histones are 
extremely conserved among species (DeLange, Fambrough et al. 1969). However, 
histone function was still unclear and scientists believed that these abundant proteins 
could be working as gene regulators, and that regulation would arise from diverse 
combinations of the five histones, which were thought to be present in different 
relative abundance in the cell. Histones also have a typical behaviour, forming all sorts 
of aggregates, individually or with other histones (Kornberg and Lorch 1999), making 
difficult to perform any kind of structural analysis. This led histones to be viewed by 
many as “an amorphous coating or passive polymeric counterion of the DNA” 
(Kornberg and Lorch 1999). It was only with the introduction of strong protease 
inhibitors that histones could be extracted with less damaging methods (the acidic 
extraction was denaturing histones, impeding further studies). With these less 
aggressive methods the H3-H4 tetramer and H2A-H2B dimers were discovered (Kelley 
1973; Kornberg and Thomas 1974; Roark, Geoghegan et al. 1974). It was then found 
that these oligomers, but not H1, were needed to produce the typical chromatin X-ray 
diffraction pattern, when recombined with the DNA. Histone H1 is now known to bind 
the DNA between nucleosomes (linker DNA) and is thought to help to regulate the 
compactness of the 30nm fiber (Robinson and Rhodes 2006). 
The properties of the tetramer allowed the designation of the organizing principle of 
the nucleosome (the octamer) and of the manner how the octamer interacts with the 
DNA (Kornberg 1974). Consequently, this discovery of the nucleosome led to the 
abandonment of the ideas that histones were the genetic material itself or merely 
DNA coating molecules, and allowed histones to be viewed as packaging material and, 
later, as chromatin regulatory elements.  
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1.1.2 - Histone roles in chromatin regulation and transcription 
 
Numerous regulatory pathways have been described as being involved in controlling 
gene expression. Among them, many are based on the regulation of chromatin and 
the histone epigenetic status. Remodelling of the chromatin allows the necessary 
rearrangements of the nucleosomes and more or less accessibility to the DNA 
sequence (Saha, Wittmeyer et al. 2006) (Fig. 1.2). Also, histones can have a dynamic 
turn-over and establish which promoters are active or to define boundary regions 
(Dion, Kaplan et al. 2007; Jamai, Imoberdorf et al. 2007; Rufiange, Jacques et al. 2007). 
Histones can even be replaced by histone variants or be post-translationally modified 
as a way of controlling transcription.  
 
1.1.2.1 - Histone variants 
 
In the majority of the organisms, the four types of core histones (H2A, H2B, H3 and 
H4) are encoded by various copies of histone genes, very similar in their sequence. 
These histones, which are expressed mainly during S-phase of the cell-cycle (Osley 
1991), were once thought to be the unique common elements of a nucleosome. 
However, studies revealed the existence of many variant forms of histones, present in 
different organisms (Kamakaka and Biggins 2005). These variants can show significant 
differences in their primary sequence when compared to the canonical histones. Some 
of these variants have different biochemical properties that are thought to modify 
characteristics of the nucleosomes, and some can localize into specific places of the 
chromosome. Unlike the typical histones, variants are normally coded by single genes 
that can be expressed outside S-phase and can contain introns (Kamakaka and Biggins 
2005). Histone variants can differ from major histone subtypes from few to many 
amino acid alterations. Variants like H3.3, which has only four or five different amino 
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acids compared to H3, have been implicated in chromatin dynamics. These two 
histones differ significantly in terms of characteristics. H3 is only synthesised in 
dividing cells, is integrated into chromatin upon DNA replication and is targeted by 
the CAF1 nucleosome assembly complex. In contrast, H3.3 is always expressed, can be 
loaded into the chromatin in different stages of the cell cycle, and is targeted by the 
HirA nucleosome regulatory complex. Notably, it has been shown that H3.3 deposition 
takes place mainly in regions of active transcription and gene regulatory sites 
(Henikoff 2008). 
Other variants have been described, among them the vertebrate MacroH2A. 
MacroH2A is an unusual histone variant that consists of a domain similar to that of the 
conventional H2A fused to a large nonhistone region that has been linked to gene 
silencing and condensed chromatin (Thambirajah, Li et al. 2009). In female mammals, 
MacroH2A is preferentially concentrated on the inactive X chromosome. During early 
female mammalian development, one of the two X-chromosomes is inactivated to 
attain gene dosage parity between XX females and XY males (Chow and Heard, 2009). 
This is achieved by the production of the non-coding Xist transcript that will coat the 
entire X-chromosome and trigger the recruitment of repressive complexes and 
MacroH2A to ensure the chromatin condensation and gene silencing along the X-
chromosome (Costanzi et al., 1998; Mietton et al., 2009). The specific role of 
MacroH2A in heterochromatinisation and/or gene silencing during X-inactivation 
remains still to be explored. H2A.Z is also a histone variant, and in yeast is involved in 
suppression of silencing but localizes to heterochromatin in mammalian cells (Fan, 
Rangasamy et al. 2004). Another key variant called CenH3 or CENP-A shows specific 
binding to the centromere and will be described with more detail in section 1.3.  
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1.1.2.2 - Histone modifications 
 
Histones can be subjected to a huge number of post-translational modifications (Fig. 
1.2). Indeed, more than 100 different modification sites have been described to date 
(Rando and Chang 2009). These include acetylation (lysine residues), phosphorylation 
(serine and threonine), methylation (lysine and arginine) and ubiquitylation (lysine), 
sumoylation (lysine) and ADP-ribosylation. These modifications can be present 
individually or in the context of several modifications that can allow or prevent 
processes like transcription (Berger 2007).  
Histones are made of a globular domain and a more flexible and charged NH2- 
terminus, which is called the histone tail. The histone tail extends beyond the 
nucleosome and is the target for enzymes responsible for the post-translational 
modifications. Histone modifications are thought to work as an efficient coding 
system, allowing heritable information to be read by different proteins. Because this 
histone code is regulating access to the DNA (Fig 1.2), histone modifications and the 
proteins that interact with them may profoundly impact the specificity of gene 
expression within each cell type (Jenuwein and Allis 2001). An enormous number of 
different combinations of modifications are possible. However, it has been described 
that several of these specific combinations are associated with a specific effect. One 
example is the tri-methylation of H3K9 and the absence of acetylation in histone H3 
and H4. In higher eukaryotes, these modifications correlate with areas of 
transcriptional repression (Peterson and Laniel 2004). In fact, it has been shown that 
acetylation of histone lysines “loosens” DNA-histone interactions by neutralizing 
lysine positive charges facilitating the accessibility of the transcription machinery 
(Marmorstein 2001; Hansen 2002). 
 Other combinations have also been correlated with active transcription. There is also 
increasing evidence that histone modifications can influence each other - a particular 
modification can lead to the recruitment or activation of chromatin-modifying 
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complexes that create further modifications. Basically this shows the existence of a 
crosstalk among histone modifications, allowing reinforcement of the activation or the 
repression of gene expression (Suganuma and Workman 2008). 
 
 
 
Fig. 1.2 – Histone modifications and chromatin remodelling control the access 
to the DNA. Changes in chromatin structure can be directed by histone post-
transcriptional modifications. Some of the marks can be associated with open 
chromatin and active transcription, whereas others are present in areas of repressed 
chromatin and are linked to inactive transcription (adapted from Sparmann and van 
Lohuizen 2006). 
  
1.1.2.3 – Organization of histone genes 
 
The canonical histones that exist in eukaryotes (H2A, H2B, H3 and H4) are all members 
of a multigene family and in higher eukaryotes the linker histone H1 genes are also 
repeated. Moreover, while fungi have families containing one or two members for 
each core histone, invertebrates can have as many as several hundred per histone, 
organized in tandem repeats that include all five main histone genes. Vertebrates 
display a different histone gene organization, with the genes more dispersed, but 
some clustering can occur, as it is the case for the human H4 gene (Osley 1991). In the 
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budding yeast Saccharomyces cerevisiae, histone genes are arranged in pairs, and 
there are two copies of each one of the four canonical histones.  
In fission yeast there are nine core histone genes. Three of them (hht1, hht2 and hht3) 
are H3 copies and three (hhf1, hhf2 and hhf3) are H4 copies. There are also two H2A 
genes (hta1 and hta2) and a single H2B (htb1). Similarly to the situation in S. cerevisiae, 
S. pombe histone genes tend to occur in pairs. Therefore, H3 and H4 genes are paired 
with each other, while one of the H2A genes is paired with the H2B gene. These pairs 
of histone genes are transcribed divergently and share the same promoter. The only 
histone gene that is isolated is one of the genes encoding H2A (hta2) (Fig. 1.3). 
Histones can be grouped in three main categories: replication-dependent, replication 
and cell cycle phase-independent, or tissue-specific (Hake and Allis 2006). In higher 
eukaryotes there are three H3 histone variants: H3.1, H3.2 and H3.3. The first two only 
differ in one amino acid and are replication-dependent, while human H3.3 differs in 
five amino acids from H3.2 and its transcription levels are stable throughout the cell 
cycle (Hake and Allis 2006; Hake, Garcia et al. 2006). As mentioned, H3.3 has been 
related with transcriptionally active sites, whereas H3.2 is mainly enriched with 
silencing markers (Ahmad and Henikoff 2002; Hake and Allis 2006). Yeasts, however, 
only have one type of histone H3. S. cerevisiae has a H3.3-type of histone and S. 
pombe has a histone H3 which exhibits features of both H3.2 and H3.3 (Hake and Allis 
2006).  
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Fig. 1.3 – Histone genes in fission yeast. In S. pombe histone transcription is 
divergent, with each pair of histone genes sharing the same promoter. Histone H4 
coding genes are associated with histone H3 coding genes, and the same happens for 
H2A alpha and H2B alpha. The only of the nine histone genes who does not share the 
same promoter with another histone is hta2, which codes for H2A beta. The two lines 
represent the two DNA strands, the boxes represent the histone genes and the 
promoter and the arrows the direction of transcription. 
 
1.1.2.4 - Histone transcriptional regulation 
 
Histones are fundamental proteins for the maintenance of the genome integrity. 
During DNA replication, the duplicated nucleic acid molecule needs to be compacted 
and organized, and a correct amount and stoichiometry of free histones needs to be in 
place for novel nucleosomes to form. In human cells each cell division requires the 
production and assembly of around 30 million nucleosomes (Gunjan, Paik et al. 2005). 
This is a tremendous task that also involves assembly of the newly synthesised 
histones into nucleosomes and their incorporation almost immediately after the DNA 
Introduction 
13 
 
is duplicated (Sogo, Stahl et al. 1986). Thus, histones need to be produced in large 
scale during S-phase and to be directed towards the formation of the nucleosome, a 
process mediated by histone chaperones (Park and Luger 2008), escort factors that 
associate with histones and facilitate their transfer (Corpet and Almouzni 2009).  
Therefore, restricting histone expression to S-phase provides a useful mode of 
coupling replication and histone availability. Histone levels tight control takes place in 
multiple ways, and there are different pathways that direct histone transcription, 
modifications and degradation.  
The importance of the histone transcription during a specific stage of the cell cycle 
was investigated in yeast, where passage through S-phase without histone production 
led to a serious drop in viability (Han, Chang et al. 1987; Kim, Han et al. 1988). S-phase 
is known to be the main time window for histone transcription (Osley 1991). However, 
not all histone genes are subjected to differential cell cycle regulation. For instance, 
histone variants can be exceptions to this rule, and can be expressed outside S-phase 
(Frank, Doenecke et al. 2003). The tight regulation of histone gene expression is not 
solely explained by transcriptional activation when entering S-phase. Transcriptional 
repression throughout G1 and G2 phases also has a crucial role for the maintenance of 
histone periodicity. In addition to this cell cycle regulation, histone gene transcription 
rate is negatively influenced by the presence of genotoxic agents that affect 
replication (Gunjan, Paik et al. 2005). In S. cerevisiae, genetic screens identified several 
proteins involved in the repression of histone genes outside S-phase or in response to 
hydroxyurea (HU), inhibitor of ribonucleotide reductase that leads to the reduction of 
the available deoxyribonucleotides, blocking DNA replication. These proteins are Hir1, 
Hir2, Hir3 and Hpc2 (Lycan, Osley et al. 1987; Xu, Kim et al. 1992; Sherwood, Tsang et 
al. 1993). Histones are the only genes described as being repressed by Hir proteins. 
When one of the Hir proteins is absent, budding yeast cells can no longer repress 
three of the four histone promoters outside S-phase (Osley and Lycan 1987).  
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Histone promoters in S. cerevisiae are divergent. HHT1-HHF1 and HHT2-HHF2 encode 
the two copies of histone H3 (HHT1, HHT2) and H4 (HHF1, HHF2), and are both 
dependent on Hir proteins for gene repression outside S-phase. Also dependent on 
Hir is one of the gene pairs, HTA1-HTB1, that express H2A and H2B. However, 
repression of the other gene pair, HTA2-HTB2, is independent of Hir proteins (Mitra, 
Vaughan et al. 2001). It is not know how these proteins regulate histone transcription, 
but it is thought that they work via a negative cis-acting sequence called NEG that is 
present in all the referred histone gene pair promoters, except the HTA2-HTB2 pair 
(Osley, Gould et al. 1986; Osley and Lycan 1987).  
Hir proteins are evolutionarily conserved, and homologues have been found in many 
organisms, from other yeasts to worms and mammals. In humans, the Hir homologue 
HIRA was firstly identified as being possibly linked with the development disorder 
DiGeorge syndrome (Halford, Wadey et al. 1993). However, it is now known that many 
of the DiGeorge syndrome associated phenotypes are not caused by HIRA mutations, 
but by defects in a neighbour gene (Baldini 2003). HIRA ectopic expression blocks S-
phase progression (Hall, Nelson et al. 2001) and its overexpression lead to repression 
of histone transcription in cultured cells (Nelson, Ye et al. 2002). In higher eukaryotes 
HIRA is also a fundamental component of the replication-dependent mechanism of 
nucleosome deposition, working as the histone chaperone in charge of the octamers 
that include H3.3 (Tagami, Ray-Gallet et al. 2004). 
Other proteins have been identified that control histone gene transcription. In S. 
cerevisiae, Yta7 binds to histone gene loci and works as a repressor of transcription, 
probably by establishing regions of transcriptional silencing (Gradolatto, Rogers et al. 
2008). In mammals, histone transcription is believed to be regulated by proteins that 
bind to regulatory elements that are specific to the promoters of each subtype of 
replication-dependent histone genes (Heintz 1991; Osley 1991). Examples of such 
regulation were described for H4 expression, which is induced by HiNF-P, a protein 
that binds a H4 subtype specific regulatory element, and for H2B expression, where 
Oct1 and the OCA-S complex activate transcription upon binding to the H2B specific 
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regulatory element (Miele, Braastad et al. 2005; Fletcher, Heintz et al. 1987; Zheng, 
Roeder et al. 2003). Other proteins, like YY1, NPAT, FLASH,BZAP45 and the TRRAP-
Tip60 complex have also been related to the regulation of histone transcription in 
mammals (Barcaroli, Bongiorno-Borbone et al. 2006; Eliassen, Baldwin et al. 1998; Last, 
van Wijnen et al. 1999; Mitra, Vaughan et al. 2001; Wu and Lee 2001; Zhao, Kennedy et 
al. 2000; DeRan, Pulvino et al. 2008).  
 
1.1.2.5 - Histone transcriptional regulation in fission yeast 
 
Hir homologues have also been identified in S. pombe. Hip1 shares homology with 
Hir1 and Hir2, while Slm9 has homology with Hir2. Slm9 and Hip1 can be found in a 
complex, but they are functionally distinct. While Slm9 does not affect the periodicity 
of histone H2A expression (Kanoh and Russell 2000), Hip1 loss leads to derepression 
of histone expression outside S-phase (Blackwell, Martin et al. 2004). However, both 
seem to have a function in repressing expression of histone H3 and H4 (Takayama and 
Takahashi 2007). One other protein, Hip3, is also part of the fission yeast HIRA 
complex (Greenall, Williams et al. 2006). However, no information about its specific 
impact in terms of histone transcription is available. While histone gene repression is a 
task for HIRA homologues, the periodic expression of the canonical histone genes is 
controlled by another protein, Ams2 (CENP-A multicopy supressor 2) (Takayama and 
Takahashi 2007). Ams2 is a GATA-type transcription factor first identified in a screen 
for multicopy suppressors of cnp1-1, a temperature-sensitive (ts) conditional allele of 
the fission yeast gene encoding CENP-A protein (Chen, Saitoh et al. 2003) (see section 
1.3.2). Ams2 has been reported to have DNA binding activity to GATA sequences in 
vitro and is cell cycle regulated, being more abundant in nuclear chromatin during S-
phase (Chen, Saitoh et al. 2003; Takayama and Takahashi 2007). Ams2-deficient cells 
are able to maintain basal levels of histone transcription, but its peak during S-phase is 
greatly impaired. Ams2 depletion also extends the time needed for division, a fact that 
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seems unrelated to the timing of replication, which is similar to wild type (wt) in Ams2 
deleted cells (Takayama and Takahashi 2007). ChIP assays have revealed Ams2 binding 
upstream of all the canonical histone genes, but not at the cnp1 (fission yeast gene 
encoding for CENP-A homologue) promoter. Furthermore, the binding occurs at the 
so-called AACCCT-box, a conserved 17 base pair sequence that occurs in the histone 
genes promoters. In addition to binding to the histone promoters, Takayama and 
colleagues showed that Ams2 could bind the promoter of SPAC631.02, a gene that 
encodes for a bromodomain containing protein (Takayama and Takahashi 2007). The 
same authors also found that different copies of the genes encoding histone H3 and 
histone H4 are differentially regulated. In fact, hht1, hhf1, hht3 and hhf3 have peaks of 
expression during S-phase, while hht2 and hhf2 do not. Moreover, Ams2 deletion 
leads to downregulation of all histone H3 and H4 copies except those encoded by 
hht2 and hhf2, which become upregulated, suggesting the existence of an Ams2-
independent feedback compensation mechanism. Ams2 overexpression, however, 
leads to upregulation of all copies. Therefore, the exact pathways that affect histone 
transcription are yet to be fully understood and other factors that also control histone 
gene transcription are yet to be described.  
 
1.2 – Telomeres 
 
Seen under the microscope, mitotic chromosomes look very homogeneous. 
Therefore, cytologists could only distinguish two different regions, the centromeres 
(see section 1.3) and the ends of the chromosomes. Then, in 1938, Muller observed 
that unlike chromosome breaks elsewhere in the genome, these end regions were not 
subjected to rearrangements upon X-ray treatment (Muller 1938). He and others 
named these ends telomeres. To him, a telomere was not just the end but a “terminal 
gene with a special function, that of sealing the ends of the chromosome”. His 
observations, together with the awareness that broken chromosomes would fuse with 
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one another (McClintock 1939) led to the conclusion that telomeres are protective 
structures, protecting the chromosomes from end-to-end fusions. In fact, these 
fusions do not normally occur as they would generate unstable dicentric 
chromosomes that would frequently break, when centromeres are pulled to opposite 
poles during cell division. Fusions would then lead to unequal distribution of the 
genetic material to the daughter cells and the formation of new unprotected ends. 
Hence, the experiments of Muller and McClintock provided the first evidence of the 
fundamental telomeric function: its ability to protect chromosome ends from DNA 
damage responses.  
Many years later it was found that telomeric sequences share a common theme, as 
divergent species of ciliates have a GT rich strand running 5’ to 3’from the center 
towards the end of the DNA (Blackburn and Gall 1978; Oka, Shiota et al. 1980; 
Klobutcher, Swanton et al. 1981). In many eukaryotes, telomeres are made of short 
repetitive G-rich sequences that recruit proteins that bind the dsDNA and in turn also 
recruit additional components. The total length of double strand repeats can vary 
from 20 bp in Oxytricha (Klobutcher, Swanton et al. 1981) to more than 100 kb in 
vertebrates, as observed in mouse cells (Kipling and Cooke 1990). Tipically, telomeres 
end with a DNA G-rich single-stranded overhang and proteins that bind to it.  
 
1.2.1 – The end-replication problem  
 
For cell division to occur, the replication machinery has to faithfully replicate the entire 
chromosome. However, telomeres present a big challenge for semi conservative 
replication, which starts from the centromere proximal side and moves towards the 
ends. In fact, the replication machinery is unable to completely replicate linear 
molecules. When the lagging strand is polymerized, it does it discontinuously, starting 
from RNA primers and forming Okazaki DNA fragments. Then the RNA primers are 
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removed and the gaps are filled. However, the removal of the last primer cannot be 
compensated by fill-in synthesis, as the polymerase acts only in the 5’ to 3’ 
direction and requires a 3’-hydroxyl group provided by a primer. This dilemma is 
called the “end-replication problem” (Watson 1972; Olovnikov 1973). However, 
telomeres do not end in a blunt DNA molecule, but possess a 3’G-rich single strand 
overhang (and proteins that bind to it). This fact changes the way the end replication 
problem affects the telomere. In fact, lagging strand synthesis and RNA primer 
removal can coexist with total telomere replication as long as the RNA primer 
corresponds to the 3’overhang. Yet, replication of the leading strand would now be 
problematic, as this strand would lose its 3’overhang, fact that would lead to 
subsequent loss of the telomere in the lagging strand, in the following cell divisions 
(Lingner, Cooper et al. 1995). 
Therefore, the end-replication problem suggests that telomeres would get 
continuously shorter after each round of replication, unless they are extended by other 
mechanisms. The mechanisms that provide this extension are telomerase or 
recombination (see section 1.2.2 and 1.2.3).   
 
1.2.2 – Telomerase 
 
Telomerase-mediated telomere synthesis is the most widely used method of 
maintaining chromosome length. Telomerase is a specialized reverse transcriptase 
that can add new telomeric repeats, copying its own RNA template, to the 3’ssDNA 
overhang (Greider and Blackburn 1985; Greider and Blackburn 1987). The telomerase 
catalytic subunit is known as TERT (telomerase reverse transcriptase), whereas the 
associated RNA template is called TERC (telomerase RNA component), TR or TER 
(reviewed in Smogorzewska and de Lange 2004). TERT homologues have been 
identified in many organisms, and the majority of them share similar domain structure 
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(reviewed in (Osterhage and Friedman 2009). The RNA components have also been 
shown to exist in a variety of organisms and present a great variability in structure, 
length and sequence. However they all have a short template sequence that is 
complementary to the telomeric repeat that characterizes the organism (Osterhage 
and Friedman 2009). Experiments in vitro showed that telomerase activity only 
depends on the presence of the telomerase catalytic subunit, the telomerase RNA 
template and a telomeric substrate including a telomeric 3’ssDNA (Weinrich, Pruzan 
et al. 1997), but the in vivo addition of telomere repeats depends on other factors.  
In S. cerevisiae, the RNA subunit is called TLC1 (telomerase component 1). In this 
organism several proteins were identified as having a role in telomere maintenance, as 
mutations of their coding sequences cause a gradual telomere shortening phenotype, 
known as Est (ever shorter telomeres). Est2 was identified as the TERT component of 
telomerase and Est1 and Est3 are examples of regulatory factors (Lundblad and 
Szostak 1989; Lendvay, Morris et al. 1996). Est1 binds telomerase RNA and directly 
associates with the ssDNA 3’overhang binding protein called Cdc13 (Pennock, 
Buckley et al. 2001; Seto, Livengood et al. 2002). Interaction between Est1 and Cdc13 is 
thought to promote the recruitment of telomerase to the chromosome ends, as fusing 
of Est2 with Cdc13 bypasses the need for Est1 presence to maintain telomeres 
(reviewed in Bianchi and Shore 2008). There are two human EST homologues, called 
EST1A and EST1B, that also bind to the telomeres (Reichenbach, Hoss et al. 2003; 
Snow, Erdmann et al. 2003), but their exact role is still poorly understood.    
In S. pombe the two telomerase subunits have also been identified: the catalytic 
subunit is called Trt1, whereas the RNA subunit is ter1. Several other gene deletions 
have been described to cause EST phenotype in the fission yeast: est1 (Beernink, Miller 
et al. 2003), ccq1 (Tomita and Cooper 2008), and the combination of tel1 (ATM 
homologue) and rad3 (ATR homologue) deletion (Naito, Matsuura et al. 1998).  
In fission yeast the presence of telomerase is not essential for viability. In its absence, 
telomeres shorten gradually after each round of cell division, until they get critically 
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short, and cells cease to divide. Then, a small percentage of survivors arise, belonging 
to three main groups: a) linear survivors that maintain their telomeres through 
recombination (Nakamura, Cooper et al. 1998); b) circular survivors that do not have 
any telomere sequence and circularize their three chromosomes by intra-molecular 
fusions (Nakamura, Cooper et al. 1998) and c) linear survivors that do not have 
telomere sequences but have amplified heterochromatin regions like the subtelomere 
or the rDNA (Jain, D. et al., manuscript in preparation).  
 
1.2.3 – Recombination-based mechanisms of telomere maintenance 
  
The telomerase dependent mechanism is the main mode of telomere maintenance. 
However there are other ways of maintaining the telomeres that do not need 
telomerase intervention and are based on recombination. Homologous 
recombination (HR) events would not allow telomere elongation. However, other 
recombination-based mechanisms, also known in human cells as ALT (alternative 
lengthening of the telomeres) can act in order to maintain and elongate the telomere 
by: a) unequal recombination, based on unequal crossing-over events, allows the 
lengthening of a telomere, but the other will shorten, b) break-induced replication, in 
which a 3’ end of a telomere invades another telomere and the end is extended by 
replication until the last part of the template telomere, c) rolling circle replication, in 
which an extra-chromosomal circle of telomeric DNA is invaded and leads to break-
induced replication, allowing a theoretically infinite extension, as circles do not have 
an end, d) subtelomeric amplification, based on the recombination events described 
above but the sequences amplified are subtelomeric. 
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1.2.4 – Mammalian telomeres and shelterin complex 
 
Mammalian telomeres are made of TTAGGG repeats. The length of the telomere 
repeat tracts vary. Typically, human telomeres are 10 to 15 kb long at birth, while mice 
and rats have from 20 to more than 100 kb of telomeric repeats (de Lange, Shiue et al. 
1990; Kipling and Cooke 1990; Lejnine, Makarov et al. 1995). Mammalian telomere 
3’overhangs are longer than those in other eukaryotes and vary between 50 to 500 
nucleotides. Control of overhang formation is still not fully understood, but 
telomerase is known not to be directly involved (Hemann and Greider 1999; Yuan, 
Ishibashi et al. 1999), and it is believed that the overhang depends on resection of the 
C-strand, as hypothesized by Makarov and colleagues (Makarov, Hirose et al. 1997).  
Evidence from electron microscopy showed human and mouse telomeres can form t-
loops (Griffith, Comeau et al. 1999). A t-loop is a structure that is thought to be formed 
by the invasion of the 3’overhang into a more internal section of the same telomere. 
Since its description, t-loops have been observed in a variety of organisms, from 
trypanosomes to plants (Murti and Prescott 1999; Munoz-Jordan, Cross et al. 2001; 
Cesare, Quinney et al. 2003; Cesare, Groff-Vindman et al. 2008; Raices, Verdun et al. 
2008). It has been proposed that t-loops confer protection to the chromosome ends, 
preventing the exposure of the telomere ends to DNA damage repair agents (Griffith, 
Comeau et al. 1999). However, it is still unclear whether this structure is indeed 
protecting the chromosome, and its presence throughout the cell cycle remains to be 
confirmed.  
Mammalian telomeric repeats associate with a complex of proteins, called shelterin 
(de Lange 2005). Six proteins have been identified as components of the complex: 
TRF1, TRF2, RAP1, POT1, TPP1 and TIN2. Together they allow cells to distinguish 
normal chromosome ends from DNA damage, they repress DNA repair and regulate 
telomere maintenance (reviewed in Palm and de Lange 2008). TRF1 and TRF2 
(Telomeric Repeat binding Factor 1 and 2) share a TRFH (TRF homology) domain and a 
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C-terminal Myb-type DNA-binding domain (Zhong, Shiue et al. 1992; Chong, van 
Steensel et al. 1995; Bianchi, Smith et al. 1997; Broccoli, Smogorzewska et al. 1997; 
Konig, Fairall et al. 1998; Fairall, Chapman et al. 2001). These two proteins bind DNA as 
homodimers, (Broccoli, Smogorzewska et al. 1997; Fairall, Chapman et al. 2001) and 
are in charge of recruiting other proteins to the telomeres (Chen, Yang et al. 2008). 
One of the proteins that bind to TRF2 is RAP1. RAP1 also has a Myb-domain but, 
unlike its yeast homologue, mammalian RAP1 does not show DNA binding activity, 
and requires interaction with TRF2 to bind the telomere (reviewed in Palm and de 
Lange 2008). TIN2 is also able to bind TRF2 and is essential for the shelterin complex. It 
also binds to TRF1 and recruits TPP1, a protein that in turn recruits POT1. It is not clear 
whether all POT1 is recruited by TPP1 (Colgin, Baran et al. 2003; Yang, Zheng et al. 
2005; He, Multani et al. 2006; O'Connor, Safari et al. 2006). However, TPP1 depletion or 
the expression of mutants that fails to bind POT1 cause POT1 to become undetectable 
at the telomeres (Liu, Safari et al. 2004; Ye, Hockemeyer et al. 2004; Hockemeyer, Palm 
et al. 2007; Xin, Liu et al. 2007). POT1 was identified based on homology to proteins 
that bind telomeric ssDNA in ciliates (Baumann and Cech 2001) and contains two OB-
fold (ologonucleotide/oligosaccharide binding motif) domains. OB-fold is a five-
stranded mixed beta barrel domain (Arcus 2002) and it is common in proteins that 
bind single strand nucleic acids, like RPA and budding yeast Cdc13 (Lin and Zakian 
1996; Nugent, Hughes et al. 1996; Hughes, Weilbaecher et al. 2000; Mitton-Fry, 
Anderson et al. 2002; Theobald, Cervantes et al. 2003). 
 
1.2.5 – Fission yeast telomeres 
 
S. pombe telomeres can be considered small, when compared to their mammalian 
counterparts, as they are made of only around 300 bp of the degenerate sequence 
TTAC(A)(C)G2-8. Taz1, a TRF ortholog, is the only telomeric double strand binding 
protein identified so far in this organism (Cooper, Nimmo et al. 1997). Taz1, like the 
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mammalian TRF proteins, has a Myb-like DNA binding domain which the protein uses 
for binding the telomere double strand repeats (Spink, Evans et al. 2000). Taz1 recruits 
Rap1 and Rif1 to the telomeres and together these proteins are crucial for several 
telomeric processes, like protection from DNA repair and telomerase regulation. 
Deleting either taz1 or rap1 does not impair survival under optimal growth conditions, 
despite the fact that telomeres are no longer protected from DNA repair mechanisms 
as NHEJ (NonHomologous End-Joining) and HR (Cooper, Nimmo et al. 1997). In the 
absence of these two genes, normal cell growth is due to the fact that growing fission 
yeast spends most of the time in G2 and does not have a proper G1 phase. It was 
shown that deleterious NHEJ only happens during G1. Therefore, taz1Δ and rap1Δ 
cycling cells do not undergo NHEJ, a fact that allows them to grow normally. Upon G1 
arrest, however, lack of Taz1 or Rap1, but not of Rif1, leads to NHEJ at the telomeres, 
which in turn causes end to end fusions and segregation problems (Ferreira and 
Cooper 2001; Ferreira and Cooper 2004). Taz1 or Rap1 absence also leads to 
elongation of both telomeric dsDNA (by up to 10-fold) and the telomeric single strand 
overhang (Cooper, Nimmo et al. 1997; Tomita, Matsuura et al. 2003; Miller, Ferreira et 
al. 2005). Like the other two proteins, Rif1 also has a role in telomere length control, as 
its deletion leads to slight elongation of the telomere dsDNA (around two fold). 
However, changes in the single strand overhang were not observed (Miller, Ferreira et 
al. 2005).    
Deletion of taz1 also leads to problems in telomere replication (Miller, Rog et al. 2006). 
In fact, fission yeast telomeres lacking Taz1 accumulate paused replication forks. 
Interestingly it is the telomere sequences themselves that cause the problem, and 
replication occurs normally when Taz1 is present. Despite many similarities in taz1Δ 
and rap1Δ phenotypes, the loss of Rap1 does not seem to interfere with telomere 
replication (Miller, Rog et al. 2006).  
Normal telomeres also have the ability to repress expression of genes in their vicinity, 
a conserved process called Telomere Position Effect (TPE). Alleviation of the silencing 
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can be observed in the absence of Taz1 or Rap1, but not Rif1 (Kanoh and Ishikawa 
2001).  
Another crucial protein complex for the physiology of the fission yeast telomere 
includes Pot1, Ccq1, Tpz1 and Poz1 proteins (Miyoshi, Kanoh et al. 2008). Pot1 is a 
telomere ssDNA-binding protein. Its deletion cause deprotection of the ends, and the 
surviving pot1Δ cells lose their telomere sequence, leading to chromosome 
circularization (see section 1.2.2) (Baumann and Cech 2001) Tpz1, a TPP1 homologue, 
is also essential for end-protection and is the core molecule that interacts with the 
other three members of the complex. Its physical interaction with Pot1 seems to be 
required for protection of the telomeres (Miyoshi, Kanoh et al. 2008), similarly to what 
was reported in mammals for POT1 and TPP1 (Hockemeyer, Palm et al. 2007; Xin, Liu 
et al. 2007). Cells can grow normally in the absence of either Ccq1 or Poz1, but not in 
the absence of the two proteins simultaneously, as this leads to rapid loss of the 
telomeres. Therefore, while the Pot1-Tpz1 complex is crucial for telomere protection, 
Ccq1 and Poz1 seem to have redundant functions in the pathway (Miyoshi, Kanoh et 
al. 2008). Both proteins also regulate telomere size, but while Poz1-deficient cells have 
elongated ends, Ccq1-deficient cells possess shortened telomeres and fail to utilize 
telomerase-dependent telomere maintenance (Tomita and Cooper 2008). Poz1 also 
has an important architectural role, as it interacts with Rap1, serving has a bridge 
between Pot1-Tpz1 and Taz1-Rap1 complexes (Miyoshi, Kanoh et al. 2008). Two 
budding yeast homologues, Stn1 and Ten1, also seem to act together with Pot1. 
Corresponding single deletion of each of these proteins prompts loss of telomeric 
DNA. Together, the information cited above implies that the telomere ssDNA-binding 
complex is crucial for the identity of the telomeres.  
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Fig. 1.4 – Diagram indicating central components of the mammalian and fission 
yeast telomeres. Proteins with the same colours reflect function similarity. The Myb-
domain dsDNA binding proteins are coloured in red, accessory factors in green and the 
ssDNA binding complex is coloured in blue. Telomerase and accessory factors are 
coloured in yellow (adapted from Rog 2008). This diagram allows to observe the 
similarities between the mammalian shelterin complex and fission yeast telomere 
components.   
 
Introduction 
26 
 
 
1.2.6 – Telomere chromatin structure 
 
The first level of organization of the chromosomes is the nucleosome (see section 1.1). 
Nucleosome positions can be inferred using an enzyme, Micrococcal Nuclease 
(MNase), which is able to cut the linker region between two successive nucleosomes. 
In budding yeast, nuclease mapping experiments showed that the subtelomeres are 
organized in nucleosomes, but the telomere is protected from digestion, forming a 
structure named the telosome that covers the 250-400 bp of the terminal repeat 
region (Wright, Gottschling et al. 1992; Gilson, Laroche et al. 1993). MNase digestion 
of mammalian nuclei cleaves telomeres with a periodicity of around 160 bp. In 1994, 
Tommerup and colleagues found that short telomeres (from 2 to 7 kb) from HeLa-S 
cells had altered chromatin structure (Tommerup, Dousmanis et al. 1994). In fact, these 
cells presented a normal nucleosome ladder when the bulk chromatin was digested 
with MNase. However, when telomeric chromatin digestion was observed, the 
nucleosome pattern was more diffuse, and mononucleosomes showed increased 
sensitivity to MNase digestion (Tommerup, Dousmanis et al. 1994). When cell lines 
with longer telomeres were tested, their telomere chromatin structure was identical to 
the bulk chromatin. This led the authors to suggest that only terminal parts of the 
telomeres, which could not be individually analysed, had altered chromatin structure. 
This hypothesis was dismissed recently, when a novel technique that allows the 
isolation of the terminal part of telomeres was used. In fact, MNase digestion of the 
terminal part of long telomeres from mouse embryonic fibroblasts (MEFs) seems to 
show that the terminal telomere is organized in nucleosomes identical in periodicity to 
the ones from the bulk chromatin (Wu and de Lange 2008). Furthermore, the absence 
of TRF2 or POT1 did not change the observed telomere chromatin structure, and the 
terminal nucleosome appeared to be unchanged following deprotection of the 
Introduction 
27 
 
telomeres. Mouse has two POT1 proteins and they were shown to have a role in 
protecting the 3’overhang from MNase digestion (Wu and de Lange 2008).  
Another interesting aspect of the telomere chromatin is its reaction to damage. When 
double strand breaks (DSBs) occur in the genome, they lead to extensive chromatin 
remodelling that is thought to contribute for the recognition and repair of the breaks. 
However, NHEJ and HR (activated by the deletion of TRF2 and POT1) at damaged 
telomeres does not appear to require nucleosome eviction, suggesting that their 
repair processes are different from the ones happening in response to DSBs in other 
places of the genome (Wu and de Lange 2008). 
Very little is published about the fission yeast telomere chromatin structure. 
Unpublished data shows evidence that this chromatin is protected from MNase 
digestion in a Taz1-dependent manner (Cooper et al, unpublished data). Therefore, S. 
pombe telomere structure will be addressed with more detail later in this thesis (see 
section 5). 
 
1.2.7 – The telobox 
 
The Myb domain was described first in the retroviral oncogene v-myb (Klempnauer 
and Sippel 1987), and belongs to the helix-turn-helix (HTH) family of DNA-recognition 
motifs that are present in many transcription factors. 
Many telomeric proteins are characterized for having a particular Myb-like domain 
that seems specialized in binding to telomere dsDNA. When present in telomere 
proteins, the Myb-like domain is also often called the “telobox” (Bilaud, Koering et 
al. 1996). The conservation of Myb-like domains in some telomere dsDNA binding 
proteins was only recognized using structural data, as sequence homology is poor 
(Blue, Marcand et al. 1997; Rhodes, Fairall et al. 2002). However, in other cases 
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homology was obvious from sequence (Cooper, Nimmo et al. 1997). Proteins like the 
human TRF1 and TRF2, the budding yeast RAP1 and fission yeast Taz1, have these 
Myb-like domains. Two poorly characterized S. pombe proteins, Tbf1 and Teb1, also 
have such teloboxes, and both have been indirectly implicated in telomere functions. 
The impact of these two proteins in the fission yeast cell will be addressed in sections 3 
and 4.  
 
1.2.8 – Telomeres and Cancer 
 
There are several telomere-related mechanisms thought to be involved in tumour 
formation. One example is that problems in the telomere physiology can lead to end-
to-end fusions. These fusions lead to the formation of dicentric chromosomes that in 
turn can become genomic instability factors that can lead to cancer (Bailey and 
Murnane 2006). Moreover, somatic cells do not express telomerase. Therefore, 
telomeres get shorter until their size limits the cell replicative capacity. However it is 
precisely from somatic cells that the majority of cancers are formed and cancer cells 
need to undergo extensive number of cell division cycles for tumours to progress. 
Hence, cancer cells need to maintain their telomeres in order to proliferate. In fact, 
they do it mainly by expressing telomerase (Kim, Piatyszek et al. 1994; Cao, Bryan et al. 
2008) (90% of known cancers), but also by ALT (reviewed in Royle, Foxon et al. 2008).      
 
1.3 – Centromeres 
 
The centromere, initially described by cytologists as the primary constriction region on 
chromosomes (Fillingham, Kainth et al. 2009), is an essential structure that allows 
chromosomes to associate with spindle microtubules and to segregate to the 
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daughter cells upon cell division. The spindle microtubules attach to a specific 
complex of centromeric DNA and proteins, the kinetochore, which must be 
established at a single site on each chromosome. When this process is disturbed, 
either by failure of correct kinetochore assembly, incorrect microtubule attachment or 
faulty sister-chromatid cohesion, it can lead to improper cell division. Such problems 
can cause serious health problems, such as tumour formation (Williams and Amon 
2009), or be at the base of serious birth defects (Dierssen, Herault et al. 2009). 
Centromeres are therefore both essential and conserved structures throughout 
eukaryotes, with specific proteins that localize at the centromeric chromatin helping to 
establish the kinetochore. One of them is CENP-A, a histone H3 variant that defines 
the kinetochore assembly site (reviewed in Torras-Llort, Moreno-Moreno et al. 2009).  
Despite many centromeric proteins being conserved, centromere DNA itself is very 
diverse among species and in many species, does not exhibit sequence specificity. 
The simplest centromeres described belong to S. cerevisiae, in which a 125 bp of 
centromeric sequence is sufficient for centromere function (Cottarel, Shero et al. 
1989). In budding yeast, all 16 centromeres have 3 conserved regions named CDE I, II 
and III. CDE I is a short 8 bp sequence and is used as a binding site for Cbf1 
(centromere binding factor 1) (Mellor, Jiang et al. 1990). CDE II is an AT-rich 78 to 86 
bp spacer sequences between CDE I and CDE III, whereas CDE III comprises 25 bp 
(Fitzgerald-Hayes, Clarke et al. 1982; Ishii 2009). These regions define the kinetochore 
attachment site, a 200 bp region protected from nuclease digestion, surrounded by 
regularly spaced nucleosomes on either side (Bloom and Carbon 1982; Clarke 1998).  
In budding yeast the DNA sequence is sufficient for the establishment of a 
centromere. The centromeric DNA is specifically wrapped around a single Cse4 (CENP-
A homologue) nucleosome (Meluh, Yang et al. 1998; Furuyama and Biggins 2007) and 
each kinetochore can only generate one microtubule attachment (Winey, Mamay et al. 
1995; Cheeseman, Drubin et al. 2002). Accordingly, the S. cerevisiae centromere is 
referred as being a “point centromere”.  
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Despite its unusual DNA sequence dependence, the budding yeast kinetochore 
machinery is very similar to the one present in other eukaryotes. The inner kinetochore 
is partially formed by the CBF3 (centromere binding factor 3) complex, which includes 
Ndc10, Cep3, Ctf13, Skp1 and Stg1 proteins (Kaplan, Hyman et al. 1997; Bouck and 
Bloom 2005). Three other proteins, Ctf19, Mcm21 and Okp1, act as linkers between the 
CBF3 complex and another set of centromeric components that includes Cbf1, the 
CENP-C distant homologue Mif2, and Cse4 (Ortiz, Stemmann et al. 1999). Many other 
proteins, like chromosomal passenger proteins (Yoon and Carbon 1999), or spindle 
pole body proteins (Wigge and Kilmartin 2001) have also been described to bind the 
budding yeast centromeres. 
Contrary to what is observed in S. cerevisiae, in most eukaryotes the kinetochore 
forms on a subset of long arrays of repetitive DNA associated with the centromeres. 
Therefore, they are called “regional” centromeres and they are not specified by the 
DNA sequence, but seem to arise from epigenetic regulation. Hence, mammalian 
centromeres cover big DNA regions, being much longer than the ones from S. 
cerevisiae. The core region of human centromeres is composed of repeat arrays of 171 
bp-long sequences called α-satellite, that can span several megabases (Carroll and 
Straight 2006). Occasionally interrupting such repeats, or on surrounding 
pericentromeric regions, L1 and Alu elements can be found, together with inversions 
and other types of satellite repeats (Willard 1998). CENP-A based nucleosomes are not 
the only ones present in the human centromeres. In fact, they only reside in domains 
that occupy around half to two thirds of the entire centromere, and are interspersed 
with H3 nucleosomes (Warburton, Cooke et al. 1997; Blower, Sullivan et al. 2002). α-
satellite repeats can only be found in primates, and they contain a conserved 17 bp 
long binding site for the sequence specific DNA binding protein CENP-B (centromere 
protein B) (Masumoto, Masukata et al. 1989), suggesting that the DNA repeats 
influence the centromere localization by recruiting specific DNA-binding proteins. In 
fact, mutation of the CENP-B binding site (CENP-B boxes) leads to less efficient 
formation of mammalian artificial chromosomes on synthetic alphoid arrays (Ohzeki, 
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Nakano et al. 2002). However, CENP-B deficient mice are viable and can perform 
chromosome segregation without major defects (Hudson, Fowler et al. 1998; Kapoor, 
Montes de Oca Luna et al. 1998), and stable human neocentromeres have been 
described that formed in regions without CENP-B binding (Voullaire, Slater et al. 1993; 
Barry, Howman et al. 1999) (see section 1.3.3).   
 
1.3.1 – Fission yeast centromere  
 
Fission yeast centromeres are very well characterized and the DNA sequence of the 
centromeric DNA from the three chromosomes is known (Wood, Gwilliam et al. 2002). 
S. pombe centromeres are simple, ranging from 40-100 kb, but are also quite similar 
to the multicellular organisms larger centromeres. They consist of an unconserved 
non-repetitive central core sequence (cnt) of around 4 to 7 kb long, flanked by the 
“inner-most repeats” (imr) which in turn are surrounded by the “outer repeats” 
(otr). Together, the cnt and imr regions act as the kinetochore assembly site and are 
also called the central domain. Despite all three chromosomes sharing a similar 
structure, they are different in size. The centromere from chromosome 3 (cen3) is the 
biggest, having a length of 110 kb, while cen2 spans 65 Kb and cen1 only 45 kb. 
Central cores from chromosome 1 and 3 share a 99% identical 3.3 kb long sequence, 
called “TM”, whereas central core 2 only has a 1.5 kb long region 48% identical to 
TM (Wood, Gwilliam et al. 2002). The two imr in each chromosome are similar to each 
other, but they are different when compared with those from other chromosomes. The 
otr are also more similar in the same chromosome but they also share some degree of 
similarity between the different chromosomes (Ishii 2009) and are made of dg and dh 
repeats and a small spacer sequence.  
The S. pombe CENP-A homologue, encoded by cnp1, binds to the central domain 
(Takahashi, Chen et al. 2000) and allows the kinetochore assembly. However, the otr 
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have been shown to be fundamental for the identity of the centromere, as revealed by 
experiments using artificial mini-chromosomes (Chikashige, Kinoshita et al. 1989; 
Niwa, Matsumoto et al. 1989; Hahnenberger, Carbon et al. 1991). 
A diagram showing the centromere composition in S. cerevisiae, S. pombe and in 
humans can be found in Fig. 1.5. 
 
 
 
Fig. 1.5 – Diagram representing the centromere composition in S. cerevisiae, S. 
pombe and in humans. Budding yeast (on top) has a 125 bp centromere composed 
of CDE I, CDE II and CDE III boxes. Human centromere (middle) is made of multiple 
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arrays (green arrow) of 171 bp-long alpha satellite repeats (green triangles), and it is 
surrounded by pericentromeric heterochromatic repeats (red). Fission yeast centromere 
(bottom) is made of the central domain, and the otr. The central domain is where the 
kinetochore is formed, and includes the central core and the imr. The otr surround the 
central domain and are formed of heterochromatin (adapted from Almeida 2008). 
 
1.3.1.1 – The central domain 
 
The fission yeast central domain holds a peculiar chromatin organization. In fact, S. 
pombe centromeres, when digested with MNase, do not produce a ladder pattern 
that indicates the canonical deposition of nucleosome arrays. Instead, the central 
domain produces a smear (Polizzi and Clarke 1991; Takahashi, Murakami et al. 1992). 
This chromatin organization is dependent on CENP-A deposition, since the loss of the 
functional protein conferred by the cnp1-1 ts allele at the restrictive temperature leads 
to the transformation of the central domain chromatin smear into a regular 
nucleosome ladder (Takahashi, Chen et al. 2000). Consequently, mutations in proteins 
that are needed for proper CENP-A deposition, like Mis6, Sim4 or Scm3 also induce 
the alteration of the smear (Saitoh, Takahashi et al. 1997; Pidoux, Richardson et al. 
2003; Pidoux, Choi et al. 2009). The central domain unusual MNase pattern might be 
caused by changes in chromatin structures derived from the formation of CENP-A 
nucleosomes, or might be a consequence of the presence of the kinetochore complex 
that binds to the central domain (Allshire and Karpen 2008). The kinetochore assembly 
on the central domain impedes transcription, as genes inserted inside its boundaries 
are transcriptional repressed. However, when the kinetochore is not being properly 
built, transcriptional repression of the inserted genes is alleviated. This led to the 
development of genetic screens for alleviated transcriptional repression that allowed 
the identification of genes involved in the kinetochore formation, like the Sim 
(silencing in the middle) group of genes.   
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1.3.1.2 – Outer repeats 
 
Similarly to what happens in the central domain, genes inserted in the otr are 
subjected to negative transcriptional regulation (Allshire, Javerzat et al. 1994), in a 
process that resembles the Position Effect Variegation (PEV), suggesting that 
heterochromatin assembles in the otr. Screens revealed that otr silencing depends on 
proteins as Clr4 (cryptic loci regulator 4), Rik1 and Swi6 (trans-acting switch locus 6, 
HP1 homologue) (Allshire, Nimmo et al. 1995). Mutations in one of these genes also 
lead to chromosome segregation defects, and to a higher rate of mini-chromosome 
loss (Allshire, Nimmo et al. 1995). Any of the mutants also affect the two other 
constitutive heterochromatin loci in S. pombe, the mating type loci mat2 - mat3 and 
the telomeres (Ekwall and Ruusala 1994; Lorentz, Ostermann et al. 1994; Allshire, 
Nimmo et al. 1995). Subsequent studies found other factors important for the 
maintenance of centromeric heterochromatin otr and identified some of the 
mechanisms involved.  
In centromeric heterochromatin, histones are underacetylated and are methylated on 
lysine 9 of histone 3 (H3K9me) by Clr4, which is a lysine methyltransferase (Rea, 
Eisenhaber et al. 2000). This process depends on Rik1 and on the H3-specific 
deacetylase Clr3 (Neuwald and Poleksic 2000; Nakayama, Rice et al. 2001). This allows 
Swi6 to bind (Ekwall, Javerzat et al. 1995; Bannister, Zegerman et al. 2001; Lachner, 
O'Carroll et al. 2001; Nakayama, Rice et al. 2001) and mediate cohesin binding, 
contributing to proper chromosome segregation (Bernard, Maure et al. 2001). Besides 
being required for cohesion, otr heterochromatin seems to be required for the CENP-
A de novo assembly in the central domain (Folco, Pidoux et al. 2008; Kagansky, Folco 
et al. 2009), suggesting that despite being independent domains, otr and the central 
domain collaborate in defining the centromere identity.  
The identification of transcripts corresponding to centromeric otr and of homologues 
of RNA interference (RNAi) machinery components (Reinhart and Bartel 2002) 
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provided the first observations that led to the discovery of the RNAi involvement in 
the otr silencing. In fission yeast, disruption of one of the three main RNAi 
components, Argonaute, Dicer and RdRP, leads to problems in chromosome 
segregation and elevated chromosome loss due to defective sister chromatid 
cohesion (Volpe, Kidner et al. 2002; Hall, Noma et al. 2003; Volpe, Schramke et al. 
2003). Mutations on one of these three proteins leads to an accumulation of otr 
transcripts, derepression of transcription in the centromere, loss of H3K9 methylation 
and impairment of centromere function, suggesting that double-strand RNA arising 
from otr targets heterochromatin formation through RNAi (Volpe, Kidner et al. 2002).  
Therefore, RNAi activity in centromeres is believed to be triggered by transcription of 
the outer repeats. In fact, RNA polymerase II generates centromeric transcripts from 
dg and dh repeats. These transcripts form dsRNAs which are then processed by Dicer 
(Djupedal, Portoso et al. 2005; Kato, Goto et al. 2005). Subsequently, RITS (RNA-
induced initiation of transcriptional silencing), the fission yeast main RNAi effector 
directs Clr4-mediated methylation of H3K9, allowing Swi6 binding. This, in turn, directs 
heterochromatin formation, transcriptional silencing and establishment of cohesion 
(Bernard, Maure et al. 2001; Nonaka, Kitajima et al. 2002; Noma, Sugiyama et al. 2004; 
Verdel, Jia et al. 2004).      
Importantly, it was shown that RNAi mutants do not affect central core silencing, 
providing evidence that RNAi activity at the centromeres occurs in the otr domains 
only. However, in newly introduced centromeric plasmids, RNAi is involved in de novo 
heterochromatin formation in otr and in CENP-A chromatin establishment in the 
adjacent central domain (Folco, Pidoux et al. 2008). Interestingly, tethering Clr4 at 
euchromatic loci in the minichromosomes induces the formation of heterochromatin, 
bypassing the need for the otr and RNAi activation. This indicates that the only 
function of the otr is to provide RNAi substrates for heterochromatin formation 
(Kagansky, Folco et al. 2009). 
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1.3.2 – CENP-A loading 
 
As previously mentioned, in the majority of eukaryotes (but not in budding yeast), 
centromere formation is not based on a specific DNA sequence, and seems to be 
epigenetically regulated. There are several lines of evidence that support that idea. In 
the last decade, experiments were done in fission yeast in which the behaviour of gene 
insertions in the centromere was analysed in the presence of Trichostatin A (TSA), an 
inhibitor of histone deacetylases (Ekwall, Olsson et al. 1997). Upon the addition of TSA, 
levels of histone acetylation are elevated, leading to alleviation of centromere 
silencing and impaired centromere function. Furthermore, this chromatin state of the 
centromere, but not of the chromosome arms, is heritable through cell divisions, even 
in the absence of TSA. This suggests that assembly of functional centromeres is at 
least partly imprinted in the underacetylated and silent state of the centromeric 
chromatin (Ekwall, Olsson et al. 1997). The existence of stable neocentromeres in 
human cells, which can arise at euchromatic sites (Amor, Bentley et al. 2004) (see 
section 1.3.3), also favour the epigenetic hypothesis. Evidence for the epigenetic 
regulation of the centromeres are also originated from the observation that CENP-A 
localizes at active centromeres but not at the inactive ones (Earnshaw and Migeon 
1985), suggesting that CENP-A determines centromere identity.   
In fact, all eukaryotes seem to have a unique histone variant that replaces canonical 
histone H3 in centromeric nucleosomes. As mentioned, this protein is called as CENP-
A in humans but is also known as Cse4 in budding yeast and as Cnp1 or CENP-A in 
fission yeast.    
In fission yeast, several different classes of CENP-A loading factors have been 
identified: the Mis6-Sim4 complex, The Mis16-Mis18 complex, Sim3, Scm3 and the 
Ams2 GATA factor (Takahashi, Takayama et al. 2005). 
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Mis6 was identified in a screen for minichromosome instability (mis). The mis6 ts 
mutation leads to frequent minichromosome loss at the permissive temperature and 
fatal missegregation at the restrictive temperature (Takahashi, Yamada et al. 1994). 
Mis6 binds to the centromere central core (Saitoh, Takahashi et al. 1997) and forms a 
complex with Mis15, Mis17 and Sim4 (Pidoux, Richardson et al. 2003; Hayashi, Fujita et 
al. 2004). Loss of any of the complex members leads to a reduction of centromere 
CENP-A localization and disruption of centromeric chromatin (Takahashi, Chen et al. 
2000; Pidoux, Richardson et al. 2003; Hayashi, Fujita et al. 2004). Importantly, the 
members of this complex are conserved as they all have orthologues in humans 
(reviewed in Silva and Jansen 2009). The Mis6-Sim4 complex was also shown to be 
necessary for the Mad2 related spindle checkpoint response (Saitoh, Ishii et al. 2005).  
Mis16 is other factor involved in CENP-A loading. The Mis16 homologue RbAp48 is a 
known histone chaperone and copurifies with Drosophila CENP-A, promoting 
chromatin assembly in vitro (Furuyama, Dalal et al. 2006). In fission yeast, Mis16 and 
Mis18 physically interact and bind to the centromeres in an interdependent manner. 
They also dissociate in early mitosis, reappearing in anaphase (Hayashi, Fujita et al. 
2004). In humans, the Mis18 complex comprises three proteins, Mis18a, Mis18b and 
Mis18BP1 (also known as KNL2, this protein has a Myb domain) (Maddox, Hyndman et 
al. 2007). The components of this complex are all required for CENP-A deposition and 
accumulate at the centromeres between telophase and G1. Recently, it has been 
proposed that the Mis18 complex primes the centromere to allow the incorporation of 
CENP-A (Fujita, Hayashi et al. 2007; Jansen, Black et al. 2007; Maddox, Hyndman et al. 
2007). However, with the referred exception in Drosophila, no other association 
between Mis18 and Mis16 has been reported in other organisms. 
Sim3 is a homologue of NASP/N1-N2, a histone binding protein. It was observed that 
Sim3 associates with CENP-A and is necessary for its centromeric loading (Dunleavy, 
Pidoux et al. 2007). Sim3 is distributed throughout the nucleoplasm and therefore has 
been proposed to work as a CENP-A chaperone, delivering it to CENP-A assembly 
factors (Dunleavy, Pidoux et al. 2007).  
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The fission yeast Scm3 is a recently found homologue of the budding yeast protein 
with the same name (Pidoux, Choi et al. 2009; Williams, Hayashi et al. 2009). In S. 
cerevisiae, Scm3 has been proposed to be part of a unique hexameric nucleosome of 
the centromere (Mizuguchi, Xiao et al. 2007). This nucleosome includes Smc3, 
together with CENP-A (Cse4) and histone H4. In this conformation H2A-H2B are 
thought to be absent. Budding yeast CENP-A nucleosomes seem to be wrapped in 
positive supercoils (rather than the negative supercoils that wrap the bulk 
nucleosomes). This makes it unlikely that these nucleosomes exist as octamers, 
supporting the idea of the hexameric Scm3 centromeric nucleosomes in S. cerevisiae. 
In S. pombe, Smc3 seems to have a different role. The fission yeast protein associates 
with the centromere and directly interacts with CENP-A (Pidoux, Choi et al. 2009; 
Williams, Hayashi et al. 2009). This interactions depends on Sim3, fact that led to the 
suggestion that Sim3 histone chaperone delivers CENP-A to Scm3 or complexes with 
the two proteins. Furthermore, and similarly to what was observed with Mis16 and 
Mis18, Scm3 also dissociates from the centromere between early mitosis and 
anaphase, suggesting a direct role in CENP-A loading (Pidoux, Choi et al. 2009). 
Ams2 was first identified as a multicopy suppressor of the CENP-A ts mutant cnp1-1 
(Chen, Saitoh et al. 2003; Chen, Yanagida et al. 2003) and is also a known histone 
transcriptional regulator (see section 1.1.3.5). As previously mentioned, Ams2 is a cell 
cycle regulated GATA-binding factor, that binds the GATA sequences present at the 
centromere central domain (Chen, Saitoh et al. 2003). Ams2 has been proposed to 
have a dual role in CENP-A loading. The first role is related with its ability to control 
histone transcription. It has been shown that overproduction of histone H4, but not of 
histone H3, promotes CENP-A incorporation in the absence of Ams2 and that relative 
levels of free histone H3/H4 affect CENP-A loading (Chen, Saitoh et al. 2003; Castillo, 
Mellone et al. 2007). As Ams2 is a transcriptional regulator of histones (Takayama and 
Takahashi 2007) (see section 1.1.3.5), it is possible that lack of free histone H4 is 
responsible for the mislocalization of CENP-A in Ams2-deficient cells (Takahashi, 
Takayama et al. 2005). The second proposed Ams2 role for influencing CENP-A 
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loading is based on the ability of Ams2 to bind to the centromeres. It has been shown 
that other GATA factors have nucleosome remodelling activity when binding to the 
promoters of target genes (Boyes, Omichinski et al. 1998; Cirillo, Lin et al. 2002; Chen, 
Saitoh et al. 2003). Therefore, it is believed that Ams2 keeps the nucleosomes in the 
centromere central domain in a state that is appropriate for CENP-A loading 
(Takahashi, Takayama et al. 2005).  
Despite having important roles in both histone regulation and in CENP-A loading, 
Ams2 is not essential for viability, unlike other CENP-A loading factors. In fact, it has 
been shown that in Ams2-deficient cells, there is another mechanism that allows 
CENP-A loading. Therefore, two different phases of CENP-A incorporation have been 
described (Takayama, Sato et al. 2008). One is the mentioned Ams2 dependent 
mechanism, which occurs during S phase. The other one occurs during G2, and seems 
to be responsible for some CENP-A incorporation, when S phase loading is impaired. 
The G2 loading does not seem to be essential in normal cells, as alterations in CENP-A 
loading were not detected in wee1 mutants, which have a shorter G2 phase, but 
appears to be crucial in the absence of Ams2 (Takayama, Sato et al. 2008). Both 
pathways seem to have the participation of Mis6 and Mis18 complexes, as CENP-A 
centromere localization disappears in the mutants (Takahashi, Chen et al. 2000; 
Hayashi, Fujita et al. 2004; Fujita, Hayashi et al. 2007; Takayama, Sato et al. 2008).  
In humans, contrary to what was described in fission yeast cells, CENP-A loading 
occurs in G1. In fact, pulse labelling experiments using SNAP-tagging showed that 
newly synthesized CENP-A is incorporated into the centromeres only after mitotic exit 
and the initial hours of G1 phase (Jansen, Black et al. 2007). Early G1 CENP-A loading 
seems to occur generally across animals (Silva and Jansen 2009), as data from 
Drosophila embryos suggest (Schuh, Lehner et al. 2007; Hemmerich, Weidtkamp-
Peters et al. 2008). It is possible that the timing of CENP-A incorporation is different in 
S. pombe because growing fission yeast does not spend time in G1 phase. Therefore, 
in this organism S phase occurs immediately after mitotic exit, which is also the main 
time window of CENP-A loading in S. pombe, suggestion a conservation of the 
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temporal control of CENP-A assembly into the centromeric chromatin (Silva and 
Jansen 2009). 
 
1.3.3 – Neocentromere formation 
 
Almost all centromeres are characterized by repetitive DNA. As mentioned, in 
primates the alpha satellite is the usual repetitive motif. Therefore, there was the idea 
that the DNA sequence was essential for the centromere formation. However, in 1993 
an ectopic centromere or neocentromere was found that was not associated with 
alpha-satellite DNA (Voullaire, Slater et al. 1993; Marshall, Chueh et al. 2008). Basically, 
the new centromere spontaneously formed in a euchromatic region of the 
chromosome arm that did not suffer any rearrangement or changes in its sequence 
(Marshall, Chueh et al. 2008). The ability to form a centromere at a random genomic 
locus provided one of the first observations of the epigenetic control of the 
centromere formation. By 2008, more than ninety neocentromere cases were 
identified. These described human neocentromeres seem to be fully functional both in 
mitosis and meiosis and they contain all known centromere essential proteins 
(Marshall, Chueh et al. 2008). Human neocentromeres often appear in cells with major 
chromosome rearrangements, rescuing acentric chromosome.  
Neocentromere formation has been recently described in other organisms. In Candida 
albicans, the centromere of chromosome 5 was replaced with a marker gene (Ketel, 
Wang et al. 2009). The transformants’ growth was normal and they were able to 
maintain the chromosome 5 by forming neocentromeres. Two different types of 
neocentromeres have been described: “proximal neoCEN” and “distal neoCEN”. 
Distal neocentromeres formed at loci around 200 to 450 kb away from where the 
marker was inserted, whereas proximal neoCEN were formed adjacently to the marker 
and moved into its DNA sequence, leading to repression of its transcription (Ketel, 
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Wang et al. 2009). All the neocentromeres described in this organism were formed in 
gene poor regions and the majority originated close to repeated DNA sequences, 
suggesting an incompatibility between CENP-A nucleosomes and transcription and 
also that repeated sequences might assist the kinetochore assembly (Ketel, Wang et 
al. 2009). 
S. pombe neocentromeres have also been identified. In 2008, Ishii and colleagues 
excised the centromere from chromosome I (cen I) (Ishii, Ogiyama et al. 2008). They 
found two types of survivors: In type I the size of the three chromosomes were 
maintained, and cells survived because of neocentromere formation in chromosome 
1, whereas in type II, cells survived because chromosome 1 and one of the other 
chromosomes underwent telomere-telomere fusion. ChIP-chip analysis of Mis6 and 
CENP-A localization on the 18 type I survivors showed that neocentromeres were 
invariably formed either in the proximal area of the left or right telomere (Ishii, 
Ogiyama et al. 2008). Furthermore, the neocentromere is formed very close to, but not 
in contact with, the subtelomeric heterochromatin where a peak of H3K9 methylation 
can then be detected, suggesting a role of heterochromatin in neocentromere 
formation. In fact, cen1 excision in the absence of Swi6, Dicer, or Clr4 led to a 
substantial decrease in the number of survivors that form neocentromeres in favour of 
survivors that perform telomere-telomere fusions (Ishii, Ogiyama et al. 2008). These 
findings suggest that heterochromatin is important but not essential for 
neocentromere formation in the fission yeast. 
 
1.4 – Objectives and aims 
 
Telomeres provide essential protection to the chromosomes, by capping them and 
not allowing DNA damage response pathways to perform end to end fusions. They 
also play a fundamental role in processes like aging and cancer. In fact, the 
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relationship between shortening of telomeres and cellular senescence is well 
established (Harley, Futcher et al. 1990). It is also well known that cancer cells need to 
stabilize their telomere size in order to proliferate, either by expressing telomerase 
(Kim, Piatyszek et al. 1994) (which is not expressed normally in somatic cells) or by 
using alternative recombination lengthening methods (reviewed in Royle, Foxon et al. 
2008). Therefore, understanding how telomeres are formed and maintained is crucial 
for the improvement of therapeutical intervention in human cancer therapy.  
Telomeres are quite conserved throughout eukaryotes, and proteins containing Myb-
like domains are often present at the telomeres of different organisms. This Myb 
domain is a DNA binding domain that has also been referred as the telosome, due to 
its function of binding to dsDNA telomere repeats (Bilaud, Koering et al. 1996).  
This thesis aims to achieve novel insights into the importance of the Myb domain 
proteins on essential chromosome tasks. Accordingly, the two main objectives are: 
- To study in detail the essential functions of two poorly characterized Myb 
domain proteins, Laz1 (previously known as Teb1) (see section 3) and Tbf1 (see 
section 4). These two proteins have been previously indirectly related with the S. 
pombe telomeres, but no direct evidence exists until now that reveals such 
function. As the project evolved, my observations about Laz1 led me to focus 
most of my energy in its role in centromere specification. 
- To investigate the importance of different known telomere Myb domain 
proteins in the maintenance of the typical chromatin structure of the telomeres 
(see section 5). 
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2.1 – Strains and Media 
 
Several strains were utilized for conducting the studies shown in this document. While the majority of them were created purposely for 
this research, some were provided by others. Generated strains were developed by mating, selecting on appropriate media, or the one-
step gene replacement method using a kanMX6 cassette (Bahler, Wu et al. 1998). The strains used are listed in Table I. 
 
Table I – List of strains used in this thesis. 
JCF 
Number 
Genotype 
Mating 
Type 
1 Wt h+ 
2 Wt h- 
24 ade6-M210 leu1-32 ura4-D18 h- 
1901 ade6-M216/ade6-M210 h- Mc::LEU2 leu1-32/leu1-32 tbf1CtermMyb::Kan/tbf1+ h+/h- 
1907 ade6? leu? ura? his? tbf1-LGS-GFP-KanMX6 h? 
1909 ade6-M216/ade6-M210 h- Mc::LEU2 leu1-32/leu1-32 tbf1Cterm22aa::Kan/tbf1+ h+/h- 
1917 ade6-M216/ade6-M210 h- Mc::LEU2 leu1-32/leu1-32 tbf1::Kan/tbf1+ 2N 
Material and Methods 
 
46 
 
1942 ade6-M210 leu1-32 ura4-D18 laz1-1-3HA-KanMX6 h- 
1944 ade6-M210 leu1-32 ura4-D18 laz1-2-3HA-KanMX6 h- 
1969 ade6-M? leu1-32 ura4-D18 hht1-CFP-KanMX6 sid4-YFP-KanMx6 laz1-1-3HA-KanMX6 mis6-mcherry-natMX6 h+ 
7401 
cnt (Nco1):arg3 cnt3 (Nco1):ade6 otr2 (HindIII): ura4 tel1L:his3 ade6-210 arg3-D4 his3-D1 leu1-32 ura4-D18 laz1-3HA-
KanMX6 h- 
7404 
cnt (Nco1):arg3 cnt3 (Nco1):ade6 otr2 (HindIII): ura4 tel1L:his3 ade6-210 arg3-D4 his3-D1 leu1-32 ura4-D18 laz1-1-3HA-
KanMX6 h- 
7419 laz1-1-3HA-KanMX6 h+ 
7429 laz1-3HA-KanMX6 h+ 
7433 cnt (Nco1):arg3 cnt3 (Nco1):ade6 otr2 (HindIII): ura4 tel1L:his3 ade6-210 arg3-D4 his3-D1 leu1-32 ura4-D18 teb1-3HA-Kan h+ 
7450 ade6-M210 leu1-32 ura4-D18 laz1-3HA-KanMX6 h- 
7452 cnt1 (Nco1):arg3 cnt3 (Nco1):ade6 otr2 (HindIII): ura4 tel1L:his3 ade6-210 arg3-D3 his3-D1 leu1-32 ura4-D18 rik1::LEU2+ h? 
7453 cnt1 (Nco1):arg3 cnt3 (Nco1):ade6 otr2 (HindIII): ura4 tel1L:his3 ade6-210 arg3-D3 his3-D1 leu1-32 ura4-D18 mis6-302 h? 
VKS 201 ade6? leu? ura? his? laz1-GFP-KanMX6 h? 
209 taz1::kan h+ 
409 rap1::kan h- 
955  ura4::telo trt1::his3 his3-D1 leu1-32 h+ 
909 trt1::his3 leu1-32 his3-D1 ura4-D18 ade6-M210 h- 
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2.1.1 – Media and growth conditions 
 
Media and growth conditions were as described previously (Moreno, Klar et al 1991). 
Cultures were grown at 32oC in rich media (YE4S) or in minimal media (EMM), unless 
otherwise indicated. Plasmid containing strains were grown under conditions selecting 
for the appropriate marker. laz1 ts strains were grown at 25oC for the permissive 
temperature and 36oC for the restrictive temperature. Dilution assays were carried out 
with five-fold sequential dilutions with starting concentration of 1x107 cells/ml. Plates 
were scanned after 3 to 5 days after. 
 
YE4S – 0.5% (w/v) Oxoid yeast extract, 3.0% (w/v) glucose, plus 225 mg/l adenine, 
histidine, leucine, uracil and lysine hydrochloride. For silencing assays, the nitrogen 
source NH4Cl was replaced with NaGlutamate (1 g/l) and arginine (225 mg/l).  
Edinburgh Minimal Medium (EMM) – 3 g/l potassium hydrogen phthallate (14.7mM), 
2.2 g/l Na2HPO4 (15.5 mM), 5 g/l NH4Cl (93.5 mM), 2% (w/v) glucose (111 mM), 20 
ml/l salts (stock x 50), 1 ml/l vitamins (stock x 1000), 0.1 ml/l minerals (stock x 10,000).  
Salts x 50 - 52.5 g/l MgCl2.6H20 (0.26 M), 0.735 mg/l CaCl2.2H20 (4.99 mM), 50 g/l KCl 
(0.67 M), 2 g/l Na2SO4 (14.l mM).  
Vitamins x 1000 - 1 g/l pantothenic acid (4.20 mM), 10 g/l nicotinic acid (8l.2 mM), 10 
g/l inositol (55.5 mM),10 mg/l biotin (40.8 μM).  
Minerals x 10,000 - 5 g/l boric acid (80.9 mM), 4 g/l MnSO4 (23.7 mM), 4 g/l 
ZnSO4.7H2O (13.9 mM), 2 g/l FeCl2.6H2O (7.40 mM), 0.4 g/l molybdic acid (2.47 mM), 
1 g/l KI (6.02 mM), 0.4 g/l CuSO4.5H2O (1.60 mM), 10 g/l citric acid (47.6 mM).  
After autoclaving, a few drops of preservative is added. (1:1: 2, chlorobenzene : 
dichloroethane :chlorobutane). As in YE4S, supplements can be added when 
necessary. 
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2.2 – Yeast transformation 
 
A volume of 50ml of liquid YE4S media was inoculated with the strain of interest. The 
culture was grown until log phase and then cells were pelleted and washed in 50ml 
ddH2O. Cells were pelleted and washed again first in 1mL ddH2O, and then in 1ml 
LiOAc solution (0.1M LiOAc, 10mM Tris-HCl (pH8), 1mM EDTA). A volume of 200 l of 
LiOAc solution was used to resuspend the cells. Then, 100l were used for each 
transformation. Salmon sperm DNA (10g/ml, Stratagene) was boiled for 5 mins then 
placed on ice. 2l of it was added to cell mix along with transforming DNA (~5mg PCR 
product or ~1mg supercoiled plasmid DNA). Cells were incubated with the DNA at 
room temperature for 10 mins. 260l of PEG4000 (40% in LiOAc solution) was added 
and mixed gently. The mixture was then incubated for 30mins at 30oC (25oC for ts 
strains). 43l of DMSO was added and the cells heat-shocked at 42oC for 5 mins. Cells 
were pelleted, washed in 1ml ddH2O then resuspended in 500l ddH2O. 250l (200l 
for plasmid transformations) was plated on the appropriate media and incubated 
either at 32oC or at 25oC, depending whether the strains are ts. For Kanr selection, cells 
were first plated onto YE4S and incubated overnight before replica plating onto YE4S 
+ G418. The same principle was applied for other selections based on antibiotic 
resistance cassettes. Transformants were picked, restreaked onto selective media and 
their genotype verified by PCR or southern analysis. 
 
2.3 - Construction of laz1 conditional mutants 
 
The laz1-3HA ORF and G418 resistance cassette from JCF7450 were PCR amplified 
(primers: 5’- AAG TTG AGT CTG TCA AGT GAT GAT TCC and 5’- CAC CCA ATA TTT 
CTG AGT TCT AAG AAC-3’) using Vent polymerase (New England Biolabs), in the 
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presence of 10 fold excess of dGTP, when comparing with the other dNTPs. PCR 
product in these mutagenic conditions was isolated and used to transform a wt strain. 
Cells were left growing overnight at 25°C without any selection and were then replica 
plated to a selective medium (with G418). When colonies started to arise, cells were 
replica plated to selective media with Phloxin B (helps visualization of death cells), at 
either 25°C or 36°C. After 3 to 5 days, cells that were growing more at 25°C than at 
36°C were isolated and tested to confirm their temperature sensitivity.   
 
2.4 – Cytological observations 
 
Cell morphology analysis was performed using live or fixed cells that were growing in 
log phase at 32° for non-ts strains, or at 25° and 36° for ts strains. Cells were washed in 
PBS and resuspended in 100l of PBS and 1l of Hoescht solution was added. Cells 
were again washed with PBS and were then ready for nucleus visualization. Cells 
stained with DAPI (4’, 6-diamidino-2-phenylindole, Vectashield, Vector Laboratories) 
were fixed first by resuspension in 70% ethanol for 5s followed by PBS washing. DAPI 
was then added in a 2X dilution (2.5l DAPI + 2.5l cells in PBS). Cells were visualised 
on a Zeiss Axioplan 2 Microscope (Carl Zeiss Microimaging, Inc.). All images were 
taken and analyzed using Volocity software (Improvision). 
 
2.5 – Chromatin Immunoprecipitation (ChIP) 
 
Cell pellet preparation 
100 ml of cells were grown until OD at 600 nm reached 0.5 to 0.7 (all cultures for each 
set of experiments were using having the same OD). DNA was crosslinked with 
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formaldehyde (final concentration of 1% (v/v)), and tubes were incubated for 15 min at 
RT. Cells were spin down (3000 rpm, 2 min) and washed twice with ice-cold PBS. Cells 
were frost in liquid nitrogen. 
Beads preparation 
Depending on the Antibody, anti-rabbit (for HA IP) or protein G (CENP-A IP) magnetic 
beads (Dynabeads, Invitrogen) were used. 50 µl of beads per sample were taken and 
washed 3 times with PBS and tubes were left rotating 3 min during each wash. Beads 
were resuspended in 50 µl of lysis buffer (50 mM HEPES pH 7.5, 140 mM NaCl, 1 mM 
EDTA, 1% IGEPAL CA-630, 0.1% Sodium deoxycholate, 1mM PMSF) per sample. 
Antibody was added until reaching the appropriate concentrations, and left 
incubating overnight rotating at 4°C. 
Immunoprecipitation (IP) 
Cells were resuspended in 500 µl of lysis buffer plus inhibitors (MG132 from SIGMA 
C2211 and Inhibitor cocktail, CALBIOCHEM, 539134). 500 µl of glass beads were added 
and cells were broken in a FastPrep machine (Q-Biogene) with the following settings: 3 
X 30 sec, speed 6.5, 1 min on ice in between each vortexing. Cells were then spin down 
at 20000 g, at 4° C for 30 min and the liquid above the transparent but slightly yellow 
layer was discarded. Pellet and the crosslinked chromatin were resuspended in 900 µl 
of lysis buffer with inhibitors and the liquid transfered to 15 ml, on ice. Lysate was 
sonicated using a Bioruptor (Diagenode) with the following settings: 7.5 min, 30 sec 
ON, 30 sec OFF, medium strength. Lysate was centrifuged at 10000 g at 4°C for 5 
minutes. 900 µl of supernatant were transferred to a new tube and centrifuged at 
10000 g, 4° C, for 10 min. 800 µl of supernatant were transferred to a new tube. 10 µl 
were used as “input” sample. Beads coupled with the antibody were washed 3 
times, resuspended in 50 µl of lysis buffer and added to each lysate sample (790 µl). 
Tubes were incubated at 4° C, for two h, in a rotating wheel. Samples were washed as 
follows, at RT, leaving the tubes rotating for 4 min between each step: a) wash with 1 
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ml of SDS buffer (50mM M HEPES, 140 mM NaCl, 1 mM EDTA, 0,025% SDS) b) repeat 
previous step c) wash with 1 ml of high salt buffer (50mM M HEPES, 1 M NaCl, 1 mM 
EDTA) d) wash with 1 ml of T/L buffer (20 mM TrisCl pH 7.5, 250 mM LiCl, 1 mM EDTA) 
e) wash 2 times with 1 ml of T/E buffer (20 mM TrisCl pH 7.5, 0.1 mM EDTA), only 
inverting tubes gently after each wash (do not rotate). 145 µl TE (pH=7.5) buffer with 
1% SDS was added to the beads. Samples were vortexed and heat at 65° C for 15 
minutes, with vortexing each 5 minutes. Beads were pulled down and 120 µl of the 
supernatant were taken as the “IP” sample. 110 µl of TE with 1% SDS were added to 
the “input”. Crosslink was reversed by incubating both “IP” and “input” samples 
at 36° C, for 12 to 16 h.  
Purification of IP and input samples 
Samples were spin down and 600 µl of PB buffer (Qiagen) was added. Samples were 
purified using a commercial kit (QIAquick PCR Purification Kit, Qiagen), using 2X 30 µl 
of the elution buffer supplied diluted 2X in water to elute each sample.  
Real-time quantitative PCR analysis (qPCR)  
qPCR was carried out on a MJ Research Chromo 4 machine. The PCR conditions were 
the following 95°C for 30s, 60°C for 1 min, 40 cycles. PCR reactions were done using 2X 
Sybr-Green PCR Mastermix (INVITROGEN), 0.05 µl of 100mM primers and 2 µl of a 
template in a 20 µl reaction. Each measurement was done in triplicate. The analysis of 
the qPCR data was performed with Opticon Monitor software and enrichment was 
normalized against the input. Primers used for qPCR were the following:  
ade6  5’- AGG TAT AAC GAC AAC AAA CGT TGC – 3’and 5’- CAA GGC ATC AGT 
GTT AAT ATG CTC – 3’ 
 
hsp90  5’- CCC TCT AGC ATC TTC TAG ATA CAC T -3’and 5’-GGG TTT TCT TCT 
CAG CTA TAA CGT G-3’ 
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hht2  5’- GCA CCA CCC TTT CCC AAT CC-3’and 5’- GGT TCT TTC CAC GTC GGG 
TG- 3’ 
 
act1 5’- GGA GGA AGA TTG AGC AGC AGT and 5’- GGA TTC CTA CGT TGG TGA 
TGA- 3’ 
 
centromere central core – 5’AAC AAT AAA CAC GAA TGC CTC- 3’ and 5’ ATA GTA 
CCA TGC GAT TGT CTG- 3’ 
 
The standard curve was done using successive dilutions (10 fold) of one of the 
“input”samples for each PCR. A melting curve programme was added to ensure the 
specificity of the amplification. 
 
2.6 – Southern blot 
 
Agarose gels (0.8%-1.2%, dependent on the separation of bands required) containing 
ethidium bromide (1µl per 100 ml) were made. Genomic DNA samples digested with 
ApaI were resolved in the agarose gels. The degree of separation can be visualised 
under an UV lamp. The gel is then incubated with freshly diluted 0.25 N HCl and is left 
in a shaker for 15min at RT. This step is necessary to create nicks in the DNA that allow 
a more efficient transfer to the membrane. The solution is replaced with Blot I (0.5 M 
NaOH, 1.5 M NaCl) to denature DNA, and the gel is left to shake for 30 min, followed 
by a neutralisation step in Blot II (1 M NH4 Acetate, 20 mM NaOH) for 30 to 60 min 
and then washed for 5 min in 6X SSC. During the last incubation times the membrane 
Duralon-UV (Stratagene) was cut to the appropriate size and soaked in Blot II for 10 
min. In order to set up the dry transfer, a stack of 10-15 cm of paper towels was 
placed. On top, 3 pieces of 3 mm Whatmann paper the membrane and then the gel 
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with wells up were left. The all stack was covered with cling film. On top of that, a glass 
plate holding 4 full bottles of 500 ml (to act as weight) was placed, and the transfer 
was done overnight. In the following day, the membrane was crosslinked with a 
Stratalinker (Stratagene) using 1200 microjoules. Membrane was pre-hybridised in 
Church Gilbert buffer (1% BSA, 1mM EDTA, 7%SDS, 0.5M NaHPO4 (pH 7.2) in a bottle 
for 2 hours at 65°C. Random primed probe preparation was performed using PCR 
products or plasmid restriction fragments. This DNA was gel purified and prepared 
using a random prime labelling kit (Stratagene). 25ng DNA in 24 µl ddH2O was mixed 
with 10 µl random oligonucleotide primers and heated at 100°C for 5 mins. 10 µl 5 x 
dCTP buffer, 5 µl α-32P dCTP and 1 µl Exo(-) klenow polymerase (5u/µl) were added 
and mixed thoroughly, and the tubes were incubated at 37oC for 7 mins and then 
placed over a pre-equilibrated Sepharose G-25 spin column. After short 
centrifugation, 50 µl TE was added and the solution was boiled for 2 mins. 50 µl were 
added to hybridisation mix and hybridisation was allowed overnight at 65oC. 
Following hybridisation, probe was poured off and membrane rinsed three times in 50 
ml wash solution (2 x SSC, 0.1% SDS), followed by incubation in 25 ml wash solution 
for 30 mins at hybridisation temperature. Membrane was wrapped in cling film and 
put down on a phosphorimager screen for 4-72 hours. Signal was detected on a 
Molecular Dynamics Storm 860 phosphorimager system. In order to remove the 
probes so membranes could be reused, the following protocol was followed: 
Membrane was incubated in 0.4M NaOH at 42oC for 30 min, followed by 30 mins in 
0.1x SSC, 0.1% SDS, 0.2M Tris (pH 7.5) at 42oC. Membrane was then preincubated in 
Church Gilbert solution before re-probing (as above). Telomeres were detected using 
a synthetic telomeric fragment (Miller, Rog et al. 2006), and PCR amplification of cdc2 
gene was used as control locus for the MNase experiments  
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2.7 – ChIP-chip 
 
Chromatin immunoprecipitation (ChIP) 
Our protocol was adapted from (Robyr and Grunstein 2003). For each IP, 50 ml of 
exponentially growing cells (titer: 6 x106 cells/ml) were fixed with 1% formaldehyde for 
30 min, and the reaction was stopped by adding 2.5 ml of 2.5M glycine. Cells were 
mechanically broken with glass beads (BioSpec) in lysis buffer containing protease 
inhibitors by vortexing 2 x 13 sec. Subsequently, the lysates were sonicated in a 
Bioruptor (Diagenode) for 3 x 5 min, with 30 sec ON and 30 sec OFF. A 50 μl aliquot 
per sample was immediately withdrawn and saved as input. Protein DNA-complexes 
were immunoprecipitated with 5 μg of antibody by incubating overnight at 4ºC with 
50 µl protein A Sepharose beads (Amersham). It was used anti-HA antibody (Abcam 
9110). The immunoprecipitated material was washed and eluted twice in TES, and the 
samples were then treated with Proteinase K and de-cross linked for 5 hours at 65ºC. 
Following de-cross linking, RNA was digested for 1 h at 37ºC. DNA was extracted once 
with phenol/chloroform/isoamyl alcohol and precipitated with 3M NaAc and 100% 
ethanol. Precipitated DNA pellets were air-dried and resuspended in 20 µl double-
distilled water.  
ChIP-chip assay and data analysis 
For Laz1, we performed 3 independent biological ChIP-chip repeats for samples from 
cells collected at 25°C and 4 independent biological repeats for samples from cells 
grown one hour at 36°C. These experiments were done using strain number JCF 7429 
(wt with laz1-HA tagged). For the Agilent platform, input and immunoprecipitated 
material were amplified by random PCR amplification as described (Bernstein, 
Humphrey et al. 2004). For labelling of amplified DNA, 500 ng per sample was used for 
incorporation of Cy3 (input) and Cy5 (IP material) d-CTP nucleotides as recommended 
in the genomic DNA bioprime labelling kit (Invitrogen). For dye swap experiments, Cy3 
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was used for IP material and Cy5 for input material. Hybridization and washes were 
carried out according to the manufacturer’s instructions and guidelines for the 4x44K 
Chip-on-chip whole genome DNA microarray platform (Agilent).   
The Agilent arrays were scanned in a GenePix 4000B laser scanner at 5 μm resolution, 
and the acquired fluorescent signals were subsequently processed for analysis with 
GenePix Pro 6.0 software (Axon instruments). The data were then imported in 
Bioconductor version 2.6.1, and systematic or array bias was removed by the variance 
stabilization algorithm (vsn) (Huber, von Heydebreck et al. 2002). Briefly, each column 
(Cy3 and Cy5) on the array was calibrated by an affine transformation and then the 
data were transformed by a glog2 variance stabilizing transformation. After 
normalization, Cy5/Cy3 or Cy3/Cy5 (dye swap) ratios were obtained for each array 
element. In order to determine enrichment ratios at promoter regions, we calculated 
the mean intensity of all probes within 1000 bp upstream of each open reading frame.  
In order to determine statistically significant enrichment over a promoter or coding 
region, we applied SAM statistics (Significance Analysis of Microarrays; (Tusher, 
Tibshirani et al. 2001). We compared four independent repeats at 36°C and three 
independent repeats at 25°C. We determined a conservative list of significantly 
enriched promoters using 0% FDR (false discovery rate).   
 
2.8 – RNA extraction 
 
RNA was extracted by hot phenol method (Lyne, Burns et al. 2003). 25 ml of cells were 
grown until OD at 600 nm was 0.2, centrifuged for 2 mins at 2000 rpm and 
supernantant was discarded. Pellet was resuspended in 1 ml of DEPC treated water. 
Tubes were centrifuged 10 sec at 5000 rpm and cells resuspended in 750 µl of TES (10 
mM Tris pH 7.5, 10 mM EDTA pH 8.0, 0.5% SDS; final volume made with DEPC treated 
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water). 750 µl of acidic phenol-chloroform (P1944, Sigma) was added and tubes were 
vortexed and incubated in a heat block at 65°C inside a hood for 1 hour, vortexing for 
10 sec every 10 mins. Samples were placed on ice for 1 min, vortexed 20 sec and 
centrifuged for 15 mins at 20000 g at 4°C. 2 ml phase-lock tubes (Eppendorf) were 
centrifuged for 10 sec and 700 µl of acidic phenol chloroform. 700 µl of sample (water 
phase upon centrifugation) were added to phase-lock tubes and the solution was 
mixed by inverting and centrifuged 5 mins at 20000 g at 4°C. More 2 ml phase lock 
tubes were centrifuged for 10 sec and 700 µl of chloroform:isoamyl alcohol (24:1) were 
added. 700 µl of water phase of the sample were added to phase-lock tubes, and the 
tubes and the solution was mixed by inverting and centrifuged 5 mins at 20000 g at 
4°C. 2 ml normal tubes were prepared with 1.5 ml of 100% ethanol stored at -20°C and 
50 µl of 3 M NaAcetate pH 5.2. 500 µl of the water phase of the sample was transferred 
to these tubes, and the solution was vortexed well. Samples were left for nucleic acids 
precipitation overnight at -20°C or at -70° for 30 mins. Tubes were then centrifuged 
for 10 mins at 20000 g and supernatant was discarded. Samples were washed (without 
mixing) with 500 µl of 70% ethanol (diluted with DEPC water). Supernatant was 
discarded and pellet dried at room temperature for 5 minutes. Afterwards, 100 µl of 
DEPC water was added to dissolve the pellet. RNA was quantified (Nanodrop, 
Thermoscientific) and 100 µg were purified (RNeasy mini kit, Qiagen). Adjust RNA 
concentration to 2 µg/ µl. 
 
2.9 – Expression microarrays 
 
RNA was processed for microarray hybridization as described before (Lyne, Burns et al. 
2003). 20ug total RNA from sample and reference was directly labeled with Cy3 and 
Cy5 dCTP (GE Healthcare) incorporation was carried out using the Invitrogen 
Superscript direct cDNA labelling system according to manufacturer's instructions. 
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Biological repeats were carried out with dye swap and averaged at analysis step. The 
resulting labeled cDNA was hybridized to glass slide microarrays containing probes 
for 99.3% of all known and predicted S.pombe genes. Microarrays were scanned using 
an Axon GenePix 4000B scanner and analyzed with GenePix 6.0 software. Quality 
control and data normalization was carried out using a custom perl script as described 
(Lyne, Burns et al. 2003). Results were visualized with GeneSpring GX 7.3 (Agilent). 
 
2.10 – G1 Nitrogen starvation arrest and release 
 
Minimal medium was inoculated with a single colony of the prototrophic strain to be 
analyzed and grown until the required volume, maintaining the cells in log phase. Cells 
were harvested and washed with minimal medium without NH4Cl. Pellet was 
resuspended with the adequate volume of minimal medium without NH4Cl so as the 
OD at 600 nm was 0.2. Then, 1.5 ml sample was taken for FACS and 25 ml for western 
analysis (sample a – asynchronous). Cells were left growing overnight (between 16 h to 
20 h) at 25°C, and other sample of 1.5 ml was taken for FACS and a volume equivalent 
to 5 ODs was taken to run in a western (0A). Cells were then shifted to 36°C for one 
hour and a half, and novel samples of 1.5 ml and of 5 ODs were taken (0B). Afterwards, 
cells were re-feed with 1 X NH4Cl (40 X stock is 200 mg/l). Samples of 1.5 ml and of 5 
ODs were taken immediately after this step and every half an hour until 5 hours 
passed.  
 
2.11 – FACS analysis 
 
A minimum of 1 ml of cells in liquid culture with OD at 600 nm of 0.3 is necessary. Cells 
were centrifuged and supernatant was discarded. Cells were resuspended in cold 70% 
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ethanol and vortexed well. 500 µl of 50mM NaCitrate were added and tubes were 
mixed again by vortexing. After novel centrifugation (13000 rpm, 1 min), cells were 
resuspended in 1 ml of 50mM NaCitrate. After another spin down, pellet was 
resuspended in 500 µl of NaCitrate containing 0,1 mg/ml of RNase A, and tubes were 
incubated 2 hours at 37°C. Propidium iodide was diluted in 50mM NaCitrate to the 
concentration of 16 µg/ml, and 500 µl of this solution was added to each sample. Cells 
were sonicated at 10 microamplicons for 6 seconds and were then processed in a 
FACS machine. 
   
2.12 – Protein extraction 
 
Samples were prepared by TCA extraction as follows: 10-15 ml of liquid culture was 
grown until OD at 600 nm reached 0.4-0.6. Cells were collected and resuspended in 1 
ml 20% TCA. Cells were collected and washed in 1 ml of 1M Tris-Base. After another 
centrifugation, the pellet was resuspended in 50 µl of 4X Loading buffer (NuPAGE LDS 
Sample Buffer, Invitrogen) plus 5,5 µl of reducing agent (NuPAGE Sample Reducing 
Agent (10X), Invitrogen). The mixture was boiled for 5 min. 200 µl of glass beads were 
added and the solution boiled again for 5 min, followed by vortexing 2X 45 sec on 
maximum speed, using a FastPrep machine (Q-Biogene). The tubes were boiled again 
and the cell debris moved to a new 1.5 ml tube. The tubes were centrifuged at 13000 
rpm for 10 min, and boiled for another 5 min. Samples could then be diluted to final 
volume of 200 µl and to be loaded (10 to 20 µl) on a gel.  
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2.13 – SDS-PAGE and Western blot 
 
Commercial precast gels were used (NuPAGE Novex 4-12% Bis-Tris Gel, Invitrogen). 
After running the gel with a suitable commercial running buffer (NuPAGE MOPS SDS 
Running Buffer, Invitrogen), proteins were transferred to a methanol-activated PVDF 
membrane using the appropriate transfer buffer (NuPAGE Transfer Buffer (20X), 
Invitrogen) supplemented with 10% (v/v) methanol, at 25 V for 1 hour at 4°C. 
Membranes were blocked in PBS buffer with 0.1% Tween (PBST) containing 5% (w/v) 
milk prior to incubation with antibodies. Primary antibodies were incubated in the 
appropriate dilution for one hour (at RT) up to 24 hours (at 4°). After that, membranes 
were washed 3x 10 min in PBST and were then incubated with the secondary antibody 
for 45 min to one hour at RT. Membranes were washed again 3X 10 min in PBST and 
binding of each antibody was detected using ECL (Amersham).  
 
2.14 – Indirect immunofluorescence 
 
10 ml of cells were grown until OD at 600 nm was 0.5, and were then harvested and 
resuspended in 770 µl of PEM (100 mM PIPES, 1 mM EGTA, 1 mM MgSO4 , pH 6.9). 230 
µl of fresh 16% paraformaldehyde were added and the solution was mixed and 
incubated for 15 min at room temperature. Cells were washed 3 times with 1 ml of 
PEM, with centrifugations at 12000 rpm for 30 sec between washes. Cells were 
resuspended in 1 ml of PEMS (100 mM PIPES, 1 mM EGTA, 1 mM MgSO4 , pH 6.9 plus 1 
M sorbitol). Zymolyase-100T was added to make final concentration of 1 mg/ml, and 
tubes were incubated at 37°C for 90 min, with some gentle shaking every 15 mins. 
After novel centrifugation, cells were resuspended in 1 ml of PEMS plus 1% Triton X-
100, and tubes incubated between 1 to 5 min at RT. PEM was then used for washing 3 
times, with centrifugations of 12000 rpm for 30 sec between each wash. Cells were 
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resuspended in 0,3 ml of PEMBAL (100 mM PIPES, 1 mM EGTA, 1 mM MgSO4 , pH 6.9 
plus 1% (w/v) BSA, 0.1% (w/v) NaN3 and 100 mM Lysine) and incubated for 30 min at 
room temperature. Afterwards, they were centrifuged and resuspended in 40 to 300 µl 
with primary antibody and incubated overnight in a wheel rotor at room temperature. 
Cells were washed with 300 µl of PEMBAL and resuspended in 200 to 250 µl of 
PEMBAL with the secondary antibody at room temperature, and this step was followed 
by 3 washes with 300 µl of PEMBAL. Finally, the pellet was resuspended with 1 µg/ml 
DAPI solution and visualized at the microscope.   
 
2.15 – Micrococcal Nuclease 
 
Cells (1000 ml) were grown in rich media (YE4S) until OD at 600 nm was around 0.9. 
Cells were filtered and resuspended with water in a pre-weighed tube until volume 
reaches 50 ml and then centrifuged. This washing step was repeated 2 more times. 
Cells were gently resuspended in 30 ml of DTT ice cold solution (10 mM DTT, 20 mM 
potassium phosphate pH 7.0, 1 M sorbitol, 2 mM PMSF and inhibitor tablets (complete 
protease inhibitor cocktail, Roche). Weigh pellet and resuspend cells in 4 ml/g cell 
weigh in S buffer (1 M sorbitol, 20 mM KH2PO4, 0.5 mM CaCl2 and one inhibitor tablet) 
containing zymolyase 100T (5 mg/ml). Incubate tube in a shaker at 30°C for 20 mins 
and look at the microscope to confirm that more than 95% of cells are refractive to 
SDS. All the steps described beyond this point were done at 4°C, except when noted 
otherwise. Cells were collected and washed with 15 ml of SPC buffer (1 M sorbitol, 20 
mM PIPES pH 6.3, 0.1 mM CaCl2, 2 mM PMSF, inhibitor tablets) in a pre-weighed tube. 
The tubes were centrifuged and pellet resuspended in 1 or 2 ml of SPC buffer. These 
were added to a 25 ml of F-buffer (9% Ficoll-400, 20 mM PIPES pH 6.3, 0.1 mM CaCl2, 2 
mM PMSF, inhibitor tablets). Tubes were centrifuged at 20000 g, for 20 mins and then 
the pellet resuspended in 15 ml of SPC buffer. After novel centrifugation, at 10000 g 
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for 10 mins, pellet was resuspended in 4 mg/g of wet cell in SPC buffer. 500 µl was 
transferred to different eppendorf 1.5 ml tubes. The cell nuclei were warmed for 5 
mins at 37°C. The following amount of MNase (EN0181, Fermentas) was added to 
different tubes: 0, 1.5, 5, 15, 50 and 150 U; for 10 mins. Reaction was stopped with the 
addition of 50 µl of 0.5 M EDTA and 50 µl of 20% SDS. RNA that was present in 
solution was degraded by the addition of RNase for 1 hour, at 42°C. Proteinase K (20 
mg/µl of proteinase K, 20 µl 5 M NaCl, 60 µl 22% Sarkosyl) was added and left acting 
overnight at 42°C. Phenol chloroform extraction was performed 3 times. Ethanol 
precipitation (2 volumes of ethanol and 1/10 volume of NaAcetate) was performed 
and pellet was resuspended in 100 µl of water. 10 µl of each sample are normally 
sufficient to run in an agarose gel. 
  
2.16 – Antibodies used  
 
In this thesis, it was used the following antibodies: 
Western analysis: 
- Rabbit anti-Cdc2 (p34 PSTAIRE, Santa Cruz Biotechnology) -1:1000 
- Rabbit anti-H3 (ab1791, Abcam) – 1:3000  
- Mouse anti-V5-TAG (MCA1360, Serotec) – 1:5000 
- Anti-mouse IgG-HRP (NA931V, GE Healthcare) – 1:4000 
- Anti-rabbit IgG-HRP (NA9340, Amersham Biosciences) – 1:4000 
 
Indirect Immunofluorescence: 
- Sheep anti-Cnp1CENP-A serum (Alison Pidoux) – 1:3000 
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- Rabbit anti-RFP (AB3216, Chemicon international) – 1:100 
- Anti-Sheep alexa 488 (A1101-5, Invitrogen) – 1:1000 
 
- Anti-Rabbit Cy3 (C-2306, Sigma) – 1:200  
 
Chromatin IP 
- Rabbit anti-HA tag (abcam 9110) – 3 µl/ 50µl of beads 
- Sheep anti-Cnp1CENP-A serum (Alison Pidoux) – 10 µl/ 50µl of beads 
2.17 – Bacterial media and strains 
 
Escherichia coli bacterial strains XL10 and XL1 –Blue (Stratagene) were used for all the 
cloning procedures necessary for this thesis. Bacteria was grown at 37°C in liquid or 
solid LB media (each autoclaved litre contains 10 g Bacto-peptone, 5 g yeast extract 
and 10 g NaCl; solid media contains agar). Ampicilin or chloramphenicol was used as 
antibiotics when selection was required.  
 
2.18 – Plasmid construction and isolation 
 
Plasmid construction and fragments amplification were made using, respectively, 
restriction enzymes and Vent polymerase from New England Biolabs, following the 
instructions supplied by the manufacturer. The following plasmids, carrying the 
identified gene under control of the NMT81 promoter, were constructed using the 
pNMT TOPO Expression kit (Invitrogen): pNMT81-tbf1, pNMT81-tbf1-V5, pNMT81-tbf1-
ΔMYB-V5 (V5=V5 epitope tag).   
  
 
 
 
 
 
 
 
 
3. LAZ1 CHARACTERIZATION 
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3.1 – Overview 
 
There is a long standing mystery surrounding the protein previously known as Teb1, 
Mug152 or SpX, here renamed as Laz1 (standing for Localization of CENP-A in 
Schizosaccharomyces pombe). Despite its recurrent identification, Laz1 biological 
function is still controversial. On different occasions, scientists believed that it could be 
involved in telomere regulation (Vassetzky, Gaden et al. 1999; Spink, Evans et al. 2000). 
However, such function is yet to be established. In Julie Cooper’s laboratory, in 
Cancer Research UK, it was found that Laz1 interacts with the telomeric protein Pot1 in 
a yeast-two hybrid screen (Kuznetsov, manuscript in preparation). This finding 
prompted the characterization of Laz1 protein presented in this thesis, which aimed to 
understand its function in the fission yeast cell and its role, if any, in telomere 
physiology. It is shown here that Laz1 is an essential nuclear protein that directly binds 
many sites in the genome. In particular, this protein binds to the promoter of many 
genes, some of which are dependent on Laz1 for their normal transcriptional 
regulation. This work shows that Laz1 regulates the transcription of all the canonical 
histones. Additionally, Laz1 was found to be involved in histone degradation, exerting 
a conspicuous role in the post translational clipping of histone H3. Moreover, Laz1 
also interferes with deposition of the histone variant CENP-A at the centromere central 
core. Interestingly, although no evidence linking Laz1 to the telomeres could be found, 
it was observed that this protein also has the peculiar ability to bind very close to the 
ends of the chromosomes arms. Its binding at both ends of chromosome 1 occurs in 
exactly the same region where neocentromeres can arise upon disruption of the 
centromere of that same chromosome (Ishii, Ogiyama et al. 2008). This fact suggests 
that Laz1 may have a role in neocentromere formation. 
Overall, the work presented in this thesis allowed the identification of new roles for 
Laz1, which are critical for the survival and health of the fission yeast cell.  
 
Laz1 characterization 
 
66 
 
It should be noted that while this thesis was being written, another article was 
published using the Teb1 name for this protein. Therefore we are considering naming 
Laz1 as Teb1 in future publications. 
Results shown in chapter 3.5 were obtained in collaboration with S. Watt, S. Aligianni 
and J. Bähler, from the Fission Yeast Functional Genomics Group in the Wellcome Trust 
Sanger Institute, Cambridge, United Kingdom. 
 
3.2 - Laz1 is an essential protein 
 
In order to study Laz1 function in S. pombe cells, a loss-of-function approach was 
initially taken. One of the copies of the laz1 gene in a diploid cell was deleted, creating 
a strain heterozygous for this gene. The deleted copy was replaced by a gene that 
confers resistance to G418 antibiotic. The diploid was then grown on a sporulation 
medium that leads to starvation, and cells consequently started meiosis. Tetrads were 
selected and then each spore was separated. The genotype of the different spores was 
analyzed using the ability of the deletion to confer resistance to G418. While the 
spores with one copy of the laz1 gene (G418 sensitive) were able to divide normally 
and survive, the laz1- spores (G418 resistant) did not form viable colonies. 
Nevertheless, after careful examination, it was seen that most of the laz1- spores were 
able to germinate and undergo several rounds of division, forming micro-colonies of 
elongated cells (Fig. 3.1). This result shows that laz1+ is an essential gene, but its 
absence can be overcome in the first cell divisions, either because the detrimental 
effect is cumulative and greater in each round of division, or because a small pool of 
protein of maternal origin might still exist. 
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Fig. 3.1 – laz1 is an essential gene. Homozygous (laz1 +/+) and heterozygous 
diploids (laz1+/-) were sporulated and tetrad dissection was performed. Heterozygous 
diploids gave origin to only two viable spores (laz1+), while the two remaining spores 
(laz1-) did not form normal viable colonies but could frequently form microcolonies 
(arrow). 
 
Seeing that strains carrying a laz1 deletion were not viable, conditional alleles for the 
laz1 gene were created. laz1 was randomly mutagenized and strains viable at 25°C but 
not at 36°C were selected. Several hypomorphic mutant alleles isolated displayed 
sickness at the permissive temperature (25°C) and die when grown at the restrictive 
temperature (36°C) (Fig. 3.2 and Fig. 3.3). 
 
 
Fig. 3.2 – Generated laz1 hypomorphic alleles are temperature sensitive. Wt and 
laz1 mutant strains were grown in liquid until exponential phase and then plated in 
successive 5 fold dilutions. laz1-1 and laz1-2 and A, B and D strains behave as 
hypomorphic alleles at 25°C and are ts, unable to grow at 36°C.  
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Fig. 3.3 – laz1-1 cells have abnormal phenotypes when grown at 36 degrees. 
Cells were grown at 25 degrees or 6 hours at 36 degrees. Cells at higher temperature 
display abnormal phenotype. They have different shape and are more elongated. 
 
Upon sequencing, it was seen that two of these conditional mutants, laz1-1 and laz1-
2, exhibited mutation of conserved arginine residues of one or the other Myb domain 
(Fig. 3.4). laz1-1, with Arg (residue 184) mutated to Cys, is sicker at the permissive 
temperature than laz1-2, which has Arg (residue 92) mutated to Gly.  
 
Fig. 3.4 – Characterization of the generated ts strains. Sequence alignment of 
different Myb domains of several proteins: Human TRF1 and TRF2, and S. pombe Taz1, 
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Tbf1 and Teb1. Hypomorphic laz1-1 and laz1-2 display single point mutations in 
conserved regions of the first (laz-2, Arginine residue, number 92, black square) or the 
second (laz1-1, arginine residue, number 184, grey square) Myb domains.  
 
The created strains also have slower growth than wt in liquid media (not shown). 
Backcrossing showed that the mutations in the arginine residues (and not any other 
random mutation that could arise elsewhere in the genome) are responsible for the 
phenotype. laz1-1 cells transformed with a plasmid overexpression library were grown 
at 36°C, and plasmids from surviving cells were isolated. Sequencing of these plasmids 
showed that they contained the wt laz1 gene sequence, validating the screen.   
 
3.3 - Laz1 localizes to the nucleus 
 
To analyse the subcellular localization of Laz1, a fusion of the laz1 gene with a GFP C-
terminal tag was integrated at the endogenous laz1 locus. . The created strain (Laz1-
GFP) was fully viable and the GFP signal showed a nuclear localization pattern (fig. 3.5). 
However, foci were not distinguishable and the GFP signal looked fairly dispersed 
throughout the entire nucleus. When trying to compare Laz1 localization with nuclear 
proteins that show specific localization patterns like Taz1 (telomere associated) and 
CENP-A (centromere associated), by live imaging or indirect immunofluorescence, the 
Laz1 signal was always very weak, and again no Laz1 foci could be established (not 
shown). These results indicate that although it is beyond doubt that Laz1 localizes to 
the nucleus, it cannot be concluded by microscopy whether it associates with a 
particular part of the chromosomes. The weak and dispersed pattern of Laz1 suggests 
that the protein might bind in low levels to many places in the genome.  
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Fig. 3.5 - Laz1 protein localizes to the nucleus. Laz1-GFP live cells were stained 
with Hoechst dye and were visualized by fluorescence microscopy.  
 
3.4 – Does Laz1 have a telomere-associated function?  
 
In spite of having been indirectly implicated with telomeres in other studies 
(Vassetzky, Gaden et al. 1999; Spink, Evans et al. 2000), no in vivo study has ever been 
done to clarify if Laz1 has a role in maintaining the normal telomere physiology. The 
creation of hypomorphic mutants provided a useful tool to study normal Laz1 
function. Therefore, these new strains were examined by southern blotting, searching 
for any alteration of telomere size in the mutants, as an altered size would mean that 
Laz1 has an impact in controlling the telomeres, either directly or indirectly. laz1-1 and 
wt strains were grown at 25°C or 36°C for 16 hours. After genomic DNA extraction and 
digestion using ApaI, the telomere were resolved in an agarose gel and analyzed by 
Southern blot analysis with a telomeric probe. laz1-1 and wt telomeres are 
comparable in size at both permissive and restrictive temperatures (Fig. 3.6). This fact 
indicates that the specific laz1-1 mutation, which confers temperature sensitivity and 
impairs binding to promoters (see below) does not affect telomere size. However, a 
role for Laz1 at telomeres, independent of functions impaired by the laz1-1 mutation, 
cannot be ruled out, although it is unlikely. Other approaches, like looking at the 
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telomere size in the laz1- spores, will be needed to ensure that this gene does not have 
any significant role in telomere size control.  
 
 
Fig. 3.6 – laz1-1 strain displays normal telomere length. Telomere length was 
assayed at both wt and one ts mutant after 16 hours of growth at both 25° and 36°. No 
significant differences in sizes were observed when comparing the different strains (wt 
vs. ts) or temperatures (25°C vs. 36°C). The same results were obtained for the other 
ts mutants (data not shown). 
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3.5 – Is Laz1 a transcription factor? 
3.5.1 - Laz1 binds to the promoters of many genes 
 
As shown above (sections 3.1 and 3.2), Laz1 is an essential nuclear protein. However, 
little is known about its DNA-binding activity, apart from the fact that it binds in vitro 
to vertebrate telomeric repeats (TTAGGG multiples) (Vassetzky, Gaden et al. 1999). In 
the fission yeast genome, these repeats occur at the promoters of many genes 
(Vassetzky, Gaden et al. 1999) and not at the telomeres (see Introduction). Similarly to 
what Vassetzky and colleagues have done in 1999, we carried out a bioinformatic 
analysis with the aim of finding sequence stretches that resemble three tandem 
TTAGGG repeats in the fission yeast genome. BLAST search returned 29 different 
sequences showing some degree of similarity to the triple tandem repeat (Appendix 
1). Almost all of these sequences mapped to intergenic regions (Appendix 1). This 
suggested that Laz1 acts as a transcription regulator, an idea suggested previously 
(Vassetzky, Gaden et al. 1999). A thorough analysis was then performed, by 
individually looking at each one of the 29 sequences led to the identification of 50 
ORFs that localize within 2000 bp of the triple tandem repeat. These 50 ORFs are listed 
in Appendix 2.  
Interestingly, this list includes all the canonical S. pombe histones. Histone promoters 
display the TTAGGG repeats in the so-called AACCCT box, a 17 bp sequence that is 
present in the intergene spacer sequences or in the 5’ upstream region of the 
histones (Matsumoto and Yanagida 1985) (see Introduction). In order to discover if 
Laz1 was binding to the AACCCT box of histone genes in vivo, we performed 
chromatin immunoprecipitation assay (ChIP) and subsequent qPCR analysis, using 
primers specific for the promoters for the histone genes hht2 and hhf2 (H3.2 and H4.2) 
in a strain carrying Laz1 endogenously tagged with 3HA tag (laz1-3HA). A significant 
enrichment of hht2/hhf2 promoter was observed in laz1-3HA cells when compared 
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with wt (untagged Laz1). The ade6 promoter, used as a control, was present at 
equivalent levels of enrichment in cells harbouring either tagged or untagged Laz1. 
These results confirm that Laz1 binds to the hht2/hhf2 promoter in vivo (Fig. 3.7).  
 
  
Fig. 3.7 – Laz1 binds specifically to histone hht2 and hhf2 promoter. Wt (laz1+ 
non tagged) and Laz1 cells (laz1-3HA) were tested for binding using HA antibody and 
specific primers for hht2-hhf2 promoter and for the ade6 promoter (control).  
Chromatin IP shows Laz1 specific binding to the hht2-hhf2 promoter. This experiment 
was repeated three times with reproducible results, in which the laz1-HA was always 
enriched at the histone promoter. 
 
To confirm the hypothesis that Laz1 is also binding in vivo to other promoters of other 
genes present in the list, the hsp90 promoter was randomly selected and analysed by 
ChIP. It was found that, indeed, Laz1 was binding specifically to this promoter too (Fig 
3.8).  
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Fig. 3.8 – Laz1 binds specifically to heat shock protein 90 (hsp90) promoter. Wt 
(laz1+ non tagged) and Laz1 cells (laz1-3HA) were tested for binding using HA antibody 
and specific primers for hsp90 and for the ade6 promoters (control).  Chromatin IP 
shows Laz1 specific binding to the hsp90 promoter. This experiment was repeated twice 
with reproducible results. 
 
The individual ChIP analysis for each one of the promoters present in the list would be 
not only time consuming, but would also fail to reveal if Laz1 was binding generally 
across the genome or only to the small number of genes included in the putative 
target list. Hence, it was decided to test its binding using the genome-wide approach, 
ChIP-chip technique. In this method, small sequences of the DNA where Laz1-HA 
binds were isolated (using crosslinked sheared chromatin and an HA antibody) and 
hybridized to a microarray. Analysis of the microarray then allowed the identification 
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of the protein binding sites (see Material and Methods). The data obtained showed a 
distinct and reproducible pattern of binding of Laz1 to the three chromosomes (Fig. 
3.9). The experiment was carried out at both 25°C (3 repeats) and 36°C (4 repeats). 
These temperatures were chosen because it was important to know if Laz1 was 
binding differently at higher temperatures. In fact, in genome-wide studies, it was 
found that transcription of the laz1 gene is increased at more elevated temperatures 
(Chen, Toone et al. 2003). Furthermore, having the DNA-binding information on wt 
cells at both 25°C and 36°C is crucial for interpreting the results of binding assays 
using the laz1 ts strains at permissive and restrictive temperature (see section 3.5.2). 
The data was then analysed aiming to identify Laz1 binding to gene promoters (see 
Material and Methods) A very conservative analysis of the data showed Laz1 binding 
to the promoters of 53 genes at 25°C, and to the promoters of 114 genes at 36°C. This 
data is summarized in Tables I and II.  
The fact that more promoters were detected as targets for Laz1 binding at 36°C than 
at 25°C may indicate a different binding activity depending on the temperature, or be 
a consequence of more laz1 transcripts being available, as Laz1 transcription is known 
to be increased after heat shock (Chen, Toone et al. 2003). This could suggest that 
Laz1 has a more important role at higher temperatures and it is therefore reasonable 
to speculate that, if Laz1 is working as a transcription factor, it could be modulating 
transcriptional responses to heat. There is also the possibility that this result is a mere 
technical artefact due to an uneven normalization of the Laz1 protein levels which are 
lower at 25°C. This implies that less protein was crosslinked at lower temperatures, 
possibly affecting the detection sensitivity. With the available data we cannot rule out 
any of the two hypotheses. 
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Fig. 3.9 – Laz1 shows specific and reproducible binding throughout the 
genome. ChIP-chip data was analysed and the enrichment levels (Y axes) are shown 
plotted against the genome (X axis). This figure shows Laz1 binding in the chromosome 
1 (A), chromosome 2 (B), and 3 (C). Note that the highest value used for the 
enrichment (5) does not correspond to a maximum value and it is used only for easier 
visualization. 
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Table I – List of genes detected at 25°C as putative Laz1 targets, using ChIP-chip data analysis software.  
Gene ID Gene name Gene product Gene location 
SPSNRNA.05 snu5 small nuclear RNA U5 chromosome2: 3236617..3237051 
SPAC926.04c hsp90 Hsp90 chaperone chromosome1: complement(3888774..3890888) 
SPBPB8B6.02c  urea transporter (predicted) chromosome2: complement(44810..46831) 
SPBPB8B6.03  acetamidase (predicted) chromosome2: 47428..49071 
SPAC222.09 seb1 RNA-binding protein Seb1 chromosome1: 960061..962113 
SPSNRNA.02 snu2 small nuclear RNA U2 chromosome1: complement(959305..959770) 
SPAC4H3.11c ppc89 spindle pole body protein Ppc89 chromosome1: complement(3848133..3850484) 
SPAC29E6.09  sequence orphan chromosome1: 4417470..4418489 
LTR.4414197.2    
SPAC29E6.06c  cytoplasmic cysteine-tRNA ligase Crs1 (predicted) chromosome1: complement(4411655..4413919) 
SPAC29E6.07  sequence orphan chromosome1: 4414824..4415174 
SPNCRNA.253  non-coding RNA (predicted) chromosome1: complement(4787154..4787928) 
SPBC19F8.04c  Nuclease chromosome2: complement(3234821..3235513) 
SPAC631.02  bromodomain protein chromosome1: 2107470..2110123 
SPBC1289.03c spi1 Ran GTPase Spi1 chromosome2: complement(4386347..4387316) 
SPCC1739.13 ssa2 heat shock protein Ssa2 chromosome3: 2057243..2059186 
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SPSNORNA.21 snoU14 small nucleolar RNA U14 chromosome2: 1308634..1308745 
SPAC959.04c  mannosyltransferase (predicted) chromosome1: complement(3392886..3393949) 
SPSNORNA.20 snoU17 small nucleolar RNA U17 chromosome1: 3394875..3395200 
SPAPYUK71.03c  C2 domain protein chromosome1: complement(2903369..2907046) 
SPAC513.02  phosphoglycerate mutase family chromosome1: 2911719..2912369 
SPBC1105.11c hht3 histone H3 h3.3 chromosome2: complement(3529119..3529529) 
SPBC1105.12 hhf3 histone H4 h4.3 chromosome2: 3529767..3530078 
SPBC1709.06 dus2 tRNA dihydrouridine synthase Dus2 (predicted) chromosome2: 1108728..1110446 
SPAC513.01c eft201 translation elongation factor 2 (EF-2) Eft2,A chromosome1: complement(2907701..2910229) 
SPNCRNA.209  non-coding RNA (predicted) chromosome1: 2910333..2910975 
SPAC821.08c slp1 sleepy homolog Slp1 chromosome1: complement(995476..996942) 
SPNCRNA.163  non-coding RNA (predicted) chromosome1: 998045..998413 
SPAC13G7.02c ssa1 heat shock protein Ssa1 (predicted) chromosome1: complement(2295819..2297753) 
SPAC13G7.03  up-frameshift suppressor3 family chromosome1: 2298979..2299924 
SPAC19G12.06c hta2 histone H2A beta chromosome1: complement(4052852..4053247) 
SPAC29E6.08 tbp1 TATA-binding protein (TBP) chromosome1: 4415547..4416619 
SPAC1834.03c hhf1 histone H4 h4.1 chromosome1: complement(4699085..4699396) 
SPAC1834.04 hht1 histone H3 h3.1 chromosome1: 4699829..4700239 
SPCC622.09 htb1 histone H2B alpha Htb1 chromosome3: 1412484..1412864 
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SPBPB10D8.03  pseudo transporter chromosome2: 87727..89029 
SPAC27E2.11c  sequence orphan chromosome1: complement(4009573..4009818) 
SPBC1348.13  Pseudogene chromosome2: 36901..37263 
SPAC869.02c  nitric oxide dioxygenase (predicted) chromosome1: 5517959..5519242 
SPBC1289.14  Adducing chromosome2: 4412376..4413350 
LTR.5496305.1    
SPAC23H4.06 gln1 glutamate-ammonia ligase Gln1 chromosome1: complement(1596492..1597571) 
SPBPB2B2.08  conserved fungal protein chromosome2: 4476012..4476674 
SPAC14C4.14 atp1 F1-ATPase alpha subunit chromosome1: 5256781..5258829 
SPCC1672.02c sap1 switch-activating protein Sap1 chromosome3: complement(562353..563117) 
SPNCRNA.466  non-coding RNA (predicted) chromosome3: 564187..565519 
SPBC1685.10 rps27 40S ribosomal protein S27 chromosome2: 517344..517837 
SPBPB21E7.02c  pseudo SPAC5H10.03 chromosome2: complement(60553..61205) 
SPAC977.15  dienelactone hydrolase family chromosome1: 62989..63732 
SPAC186.01  cell surface glycoprotein (predicted), DIPSY family chromosome1: 5527692..5528672 
SPBC713.12 erg1 squalene monooxygenase Erg1 (predicted) chromosome2: 892679..894052 
SPBC359.02 alr2 alanine racemase Alr2 chromosome2: 107759..108871 
SPNCRNA.561   non-coding RNA (predicted) chromosome1: complement(3440092..3441229) 
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Table II - List of genes detected at 36° as putative Laz1 targets, using a ChIP-chip data analysis software.  
Gene ID Gene name Gene product Gene location 
SPAC27E2.11c  sequence orphan chromosome1: complement(4009573..4009818) 
SPNCRNA.145  non-coding RNA (predicted) chromosome1: 239730..240571 
SPCC548.06c ght8 hexose transporter Ght8 (predicted) chromosome3: complement(226757..228400) 
SPAC14C4.14 atp1 F1-ATPase alpha subunit chromosome1: 5256781..5258829 
SPAPB15E9.02c  Dubious chromosome1: complement(3991878..3992444) 
SPAC959.04c  mannosyltransferase (predicted) chromosome1: complement(3392886..3393949) 
SPSNORNA.20 snoU17 small nucleolar RNA U17 chromosome1: 3394875..3395200 
SPAC4H3.11c ppc89 spindle pole body protein Ppc89 chromosome1: complement(3848133..3850484) 
SPBC1826.01c mot1 TATA-binding protein associated factor Mot1 chromosome2: complement(2619704..2625565) 
SPAC1F8.07c  pyruvate decarboxylase (predicted) chromosome1: complement(101836..103544) 
SPAC1F8.08  sequence orphan chromosome1: 103941..104303 
LTR.4140539.1    
SPAC29E6.08 tbp1 TATA-binding protein (TBP) chromosome1: 4415547..4416619 
SPAC513.01c eft201 translation elongation factor 2 (EF-2) Eft2,A chromosome1: complement(2907701..2910229) 
SPNCRNA.209  non-coding RNA (predicted) chromosome1: 2910333..2910975 
SPAC26F1.06 gpm1 monomeric BPG-dependent PGAM, Gpm1 chromosome1: complement(5173972..5174607) 
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SPAC9E9.09c  aldehyde dehydrogenase (predicted) chromosome1: complement(4453560..4455071) 
SPSNORNA.21 snoU14 small nucleolar RNA U14 chromosome2: 1308634..1308745 
SPNCRNA.93  non-coding RNA (predicted) chromosome1: 3876757..3877223 
SPAC4A8.04 isp6 vacuolar serine protease Isp6 chromosome1: 2545350..2546753 
SPAC19G12.06c hta2 histone H2A beta chromosome1: complement(4052852..4053247) 
SPAC222.08c  imidazoleglycerol-phosphate synthase (predicted) chromosome1: complement(957646..958350) 
SPAC869.02c  nitric oxide dioxygenase (predicted) chromosome1: 5517959..5519242 
SPAC631.02  bromodomain protein chromosome1: 2107470..2110123 
SPSNORNA.13 snoR69b small nucleolar RNA (pers. comm. Todd Lowe) chromosome1: 4154912..4155002 
SPAC13G7.02c ssa1 heat shock protein Ssa1 (predicted) chromosome1: complement(2295819..2297753) 
SPAC13G7.03  up-frameshift suppressor3 family chromosome1: 2298979..2299924 
SPAC26H5.10c tif51 translation elongation factor eIF5A (predicted) chromosome1: complement(4141740..4142213) 
SPBC32F12.11 tdh1 glyceraldehyde-3-phosphate dehydrogenase Tdh1 chromosome2: 2807637..2808647 
SPCC1739.13 ssa2 heat shock protein Ssa2 chromosome3: 2057243..2059186 
SPAC1039.02  phosphoprotein phosphatase (predicted) chromosome1: 5449717..5451522 
SPSNORNA.29 sno52 small nucleolar RNA R52 chromosome1: 339548..339642 
SPCC24B10.21 tpi1 triosephosphate isomerise chromosome3: 939945..940694 
SPAC869.01  amidase (predicted) chromosome1: complement(5521357..5523108) 
SPBPB2B2.13  galactokinase Gal1 (predicted) chromosome2: 4488491..4490050 
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SPAC821.08c slp1 sleepy homolog Slp1 chromosome1: complement(995476..996942) 
SPNCRNA.163  non-coding RNA (predicted) chromosome1: 998045..998413 
SPBC1105.11c hht3 histone H3 h3.3 chromosome2: complement(3529119..3529529) 
SPBC1105.12 hhf3 histone H4 h4.3 chromosome2: 3529767..3530078 
SPBC3D6.02 but2 But2 family protein But2 chromosome2: 1269748..1270920 
SPBC1815.01 eno101 Enolase chromosome2: 2201237..2202556 
SPAC1F8.01 ght3 hexose transporter Ght3 chromosome1: 82936..84603 
SPBC1683.01  inorganic phosphate transporter (predicted) chromosome2: 134303..136024 
SPAC926.04c hsp90 Hsp90 chaperone chromosome1: complement(3888774..3890888) 
SPAC1F7.05 cdc22 ribonucleoside reductase large subunit Cdc22 chromosome1: 4226982..4229733 
SPAC25B8.12c  nucleotide-sugar phosphatase (predicted) chromosome1: complement(4177021..4177932) 
SPAC9E9.01  Dubious chromosome1: 4434861..4435201 
SPNCRNA.99  non-coding RNA (predicted) chromosome1: complement(4434321..4434475) 
SPBC1289.03c spi1 Ran GTPase Spi1 chromosome2: complement(4386347..4387316) 
SPBPB2B2.12c  UDP-glucose 4-epimerase chromosome2: complement(4485277..4487418) 
SPCC1672.02c sap1 switch-activating protein Sap1 chromosome3: complement(562353..563117) 
SPNCRNA.466  non-coding RNA (predicted) chromosome3: 564187..565519 
SPCC569.05c  spermidine family transporter (predicted) chromosome3: 2424336..2426066 
LTR.54499.1    
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SPBC21C3.08c  ornithine aminotransferase chromosome2: complement(3809411..3810727) 
SPBPB2B2.03c  pseudo-very degraded permease chromosome2: complement(4462609..4464024) 
SPBPB2B2.04  pseudo-very degraded transporter chromosome2: 4464941..4465474 
SPAC631.01c acp2 F-actin capping protein beta subunit (predicted) chromosome1: complement(2104197..2105249) 
SPBC25H2.16c  adaptin (predicted) chromosome2: 3246584..3248624 
SPAC3A12.18 zwf1 glucose-6-phosphate 1-dehydrogenase (predicted) chromosome1: 1454911..1456529 
SPBC1347.11 sro1 Stress Responsive Orphan 1 chromosome2: 4082207..4082527 
LTR.5325149.1    
SPAP8A3.06  U2AF small subunit, U2AF-23 chromosome1: 5325611..5326261 
SPAC17G6.13  sequence orphan chromosome1: 3615626..3616927 
SPBC1685.13  non classical export pathway protein (predicted) chromosome2: 526091..526642 
SPAC664.06 rpl703 60S ribosomal protein L7 chromosome1: 1712817..1713783 
SPAC25B8.02 sds3 Clr6 histone deacetylase complex subunit Sds3 chromosome1: 4156539..4157342 
SPNCRNA.253  non-coding RNA (predicted) chromosome1: complement(4787154..4787928) 
SPAC1420.02c cct5 chaperonin-containing T-complex epsilon subunit  chromosome1: complement(1263902..1265542) 
SPAC222.09 seb1 RNA-binding protein Seb1 chromosome1: 960061..962113 
SPSNRNA.02 snu2 small nuclear RNA U2 chromosome1: complement(959305..959770) 
SPAC14C4.13 rad17 RFC related checkpoint protein Rad17 chromosome1: 5253358..5255278 
SPBPB2B2.06c  phosphoprotein phosphatase (predicted) chromosome2: complement(4469200..4471005) 
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SPAC1071.10c pma1 P-type proton ATPase Pma1 chromosome1: complement(3871920..3874679) 
SPNCRNA.92  non-coding RNA (predicted) chromosome1: 3875656..3876105 
SPAC22H10.12c gdi1 GDP dissociation inhibitor Gdi1 (predicted) chromosome1: complement(2395415..2396822) 
SPBC336.12c cdc10 MBF transcription factor complex subunit Cdc10 chromosome2: complement(2761287..2763590) 
SPBC17G9.11c pyr1 pyruvate carboxylase chromosome2: complement(2190874..2194431) 
LTR.4436890.2    
LTR.4437498.2    
SPNCRNA.80  non-coding RNA (predicted) chromosome1: complement(1572010..1572308) 
SPCC622.09 htb1 histone H2B alpha Htb1 chromosome3: 1412484..1412864 
SPAC821.09 eng1 endo-1,3-beta-glucanase Eng1 chromosome1: 998953..1002003 
SPAC1F8.03c str3 siderophore-iron transporter Str3 chromosome1: complement(88367..90259) 
SPNCRNA.139  non-coding RNA (predicted) chromosome1: 90868..91753 
SPAPYUK71.03c  C2 domain protein chromosome1: complement(2903369..2907046) 
LTR.4414197.2    
SPCC1795.06 map2 P-factor pheromone Map2 chromosome3: complement(986079..986684) 
LTR.63206.2    
SPNCRNA.288  non-coding RNA (predicted) chromosome2: complement(61601..62885) 
SPBPB2B2.09c  2-dehydropantoate 2-reductase (predicted) chromosome2: complement(4479110..4480162) 
SPBC1685.10 rps27 40S ribosomal protein S27 chromosome2: 517344..517837 
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SPNCRNA.385  non-coding RNA (predicted) chromosome2: 2022111..2022686 
SPBC359.04c  cell surface glycoprotein (prediected), DIPSY family chromosome2: complement(118252..119328) 
SPBPB21E7.04c  human COMT homolog 2 chromosome2: complement(64669..65514) 
SPBTRNAALA.07 tRNA Alanine chromosome2: 285676..285749 
SPBTRNAGLY.04 tRNA Glycine chromosome2: complement(285389..285459) 
SPAC3H5.04 aar2 U5 snRNP-associated protein Aar2 chromosome1: complement(3437021..3438061) 
SPAC926.05c  diphthamide biosynthesis protein Dph4 (predicted) chromosome1: complement(3892300..3892758) 
SPSNORNA.37 snR10 small nucleolar RNA snR10 chromosome3: 992436..992602 
SPAC3A12.17c cys12 cysteine synthase Cys12 chromosome1: complement(1451957..1453144) 
SPCC1442.11c  sequence orphan chromosome3: complement(1788002..1788550) 
SPCTRNAPRO.09 tRNA Proline chromosome3: 1788949..1789020 
SPAC1834.03c hhf1 histone H4 h4.1 chromosome1: complement(4699085..4699396) 
SPAC1834.04 hht1 histone H3 h3.1 chromosome1: 4699829..4700239 
LTR.1629525.3    
SPCC663.02 wtf14 wtf element Wtf14 chromosome3: 1630438..1631226 
SPBC713.12 erg1 squalene monooxygenase Erg1 (predicted) chromosome2: 892679..894052 
SPCTRNAGLY.12 tRNA Glycine chromosome3: 2037352..2037422 
SPNCRNA.422  non-coding RNA (predicted) chromosome2: 3530807..3530914 
SPCTRNASER.12 tRNA Serine chromosome3: complement(1775992..1776073) 
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SPAC1F8.05 isp3 sequence orphan chromosome1: 96000..96548 
SPAC23H4.06 gln1 glutamate-ammonia ligase Gln1 chromosome1: complement(1596492..1597571) 
SPAPB15E9.01c   sequence orphan chromosome1: complement(3987239..3990349) 
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Importantly, many of the putative targets for Laz1 binding found by sequence 
homology (Appendix 1 and 2) were also identified by our ChIP-chip approach (Tables I 
and II). In fact, more than 75% (22 out of 29) of the sequences identified as having 
homology to three tandem vertebrate telomere repeats had significant Laz1 
enrichment in vivo at one or both of the temperatures tested. In addition, it was 
recently reported that a slight less stringent version of the AACCCT motif (which 
contains two vertebrate telomere repeats) is present in the promoters of several 
functionally unrelated genes, such as slp1, stn1, SPAC631.02 and spi1 (Song, Liu et al. 
2008). The ChIP-chip analysis showed that Laz1 binds to three of these four promoters 
(Fig. 3.10). Taken together these observations imply that Laz1 binds in vivo specifically 
to many but not all AACCCT-like motifs which contain TTAGGG-like repeats. 
 
 
 
Fig. 3.10 – Laz1 binds AACCCT-like motifs. (A-D) ChIP-chip data shows specific 
Laz1 binding at AACCCT-like motifs (A) Laz1 binds slp1 promoter (B) Laz1 does not 
bind SPAC22E12.19 (stn1) promoter (C) Laz1 binds SPAC631.02 promoter (D) Laz1 
binds spi1 promoter. 
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However, not all the promoters to which Laz1 would be predicted to bind were 
identified by the ChIP-chip analysis software. For example, enrichment in the hht2 
promoter was not identified by the programme, but looking at the distribution of Laz1 
binding throughout this area of the genome (Fig. 3.15) and at the ChIP results 
presented above (Fig. 3.7), it is clear that enrichment can be seen in this particular site. 
The probable explanation for the failure of the software to distinguish these positive 
targets of binding can be the highly conservative analysis that was made, which 
minimized the possibility that false positives were included in the list, but also led to 
lower levels of detection. Other analysis programmes were also used but none proved 
to be more effective. Therefore, it can be concluded that using this approach many, 
but not all, of the target promoters for Laz1 have been identified.  
The genes identified by Chip-chip are potentially regulated by Laz1. Using the list of 
genes isolated in the experiment done at 36°C, the data was analysed using a 
bioinformatic tool available online (http://www.geneontology.org/). This tool allowed 
us to categorize the set of genes into functional groups of common characteristics, 
allowing comparisons with the database for the S. pombe genome. It was found that 
genes related with alcohol, glucose and hexose metabolism as well as glycolysis were 
present in our list at a significantly higher percentage than their percentage of the 
genome (see Appendix 3). Furthermore, a group of genes associated with the 
nucleosome was identified by the same approach. The genes included in this group 
are the histones H3.1, H4.1. H3.3 and H4.4. 
 
3.5.2 – Expressional profiling reveals a role for Laz1 in transcriptional 
regulation  
 
Given that Laz1 was found to bind to the promoters of a number of genes, we wanted 
to know how it was affecting transcription. Therefore the transcriptional profiles of 
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laz1-1 were compared to those of a wt strain, using microarray technology. Cells from 
both the mutant and wt growing at 25°C were analyzed. RNA extracted from wt and 
laz1-1 cells was differentially labelled with Cy3 and Cy5 dCTP incorporation, using a 
cDNA labelling system. The cDNA was then hybridized with the microarray, allowing 
the comparison of the transcriptional profiles of wt versus laz1-1 cells. The exact same 
procedure was carried out for the cells grown at 36°C for one hour. The data was 
analysed and a comprehensive list of the expression profile results can be found in the 
CD included in this thesis. The full list of the genes upregulated or downregulated 
more than two fold can be checked in Appendix 3. The results show that more genes 
are upregulated than downregulated upon inhibition of Laz1 function (Table III). Also, 
more laz1-1 genes were altered at 25°C than at 36°C, whereas around 35% of its 
downregulated genes at 25°C were also downregulated at 36°C (Table III). 
 
 
Table III – Overall numbers of genes upregulated or downregulated more than 
2 fold in laz1-1 compared to wt 
 
 
 
 
25 °C 
 
 
36 °C 
 
 
 
Both 
temperatures 
  
 
Genes upregulated more than 2 fold 
 
 
 
244 
 
 
 
224 
 
152 
 
 
Genes downregulated more than 2 fold 
 
 
 
84 
 
41 
 
29 
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3.5.3 - laz1-1 cells sustain altered transcriptional regulation of specific 
groups of genes 
 
The expression microarrays provided relevant insights into groups of genes of related 
function that are altered in laz1-1 strains. One example is the downregulation of four 
genes involved in the iron homeostasis. In a random distribution of genes, one would 
expect only approximately 0.2% of genes from this group in the list. However, they 
represent ~5% and ~10% of the genes downregulated by the laz1-1 mutation at 25°C 
and 36°C, respectively. Nonetheless, it is still unclear why these four genes (str1, str3, 
fip1 andfrp1) are downregulated, as the only member of this group that shows 
detectable Laz1 promoter binding is str3 (Table II). Therefore, either this regulation is 
indirect, or the levels of Laz1 binding to these promoters may be under the detection 
limit. Interestingly, it was reported in the literature that a Malus xiaojinensis Myb 
protein, when expressed in Arabidopsis, regulates the expression of an iron 
transporter gene and a ferritin encoding gene (Shen, Xu et al. 2008). However, only 
further studies including many other Myb domain containing proteins will reveal if the 
control of the iron homeostasis is a common function of proteins containing this 
domain.  
Another group which was found to be overrepresented in the list of downregulated 
genes at 25°C was the ribosomal genes (see Appendix 3). Moreover, it was observed 
that many ribosomal genes were also downregulated, but slightly below the defined 
threshold of 2 fold. Hence, a less stringent analysis was carried out and genes were 
divided into four groups: 1 - Highly downregulated (≤0.666), genes downregulated 
more than 1.5 fold; 2 – Downregulated (0.666<x<1), genes slightly downregulated, 
less than 1.5 fold; 3 – Upregulated (1≥x>1.5), genes slightly upregulated, less than 1.5 
fold; 4 - Highly Upregulated (x ≥1.5), genes upregulated more than 1.5 fold (Tables IV 
and V). One striking result was that the majority (61%) of the one hundred and twelve 
40S and 60S genes analysed were classified as highly downregulated, whereas only 6% 
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to 8% of all genes are highly downregulated. Correspondingly, none of the ribosomal 
genes analysed is highly upregulated (Fig. 3.11 to 3.14). Although classification to class 
numbers 2 and 3 needs to be interpreted with caution as they fall well below 
reasonable threshold values, they appear to confirm the tendency that ribosomal 
genes as a whole are downregulated. It was concluded that the regulation of this type 
of genes is dependent on Laz1, but probably by indirect means, as no evidence of Laz1 
binding to their promoters was found. Interestingly, it was found that, in Candida 
albicans , a Myb-domain protein called Tbf1 has a role in controlling this same subset 
of genes (Hogues, Lavoie et al. 2008). 
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Table IV – Distribution of genes from laz1-1 strain, according to their expression levels when compared to wt, at 25°C 
 
 
 
Gene expression compared to wt (microarray cells 25°C) 
 
  
 
1- Highly downregulated 
(≤0.666) 
2- Downregulated 
(0.666<x<1) 
3- Upregulated 
(1≥x>1.5) 
4- Highly Upregulated 
(x≥1.5) Total 
A - Ribosomal 40S and 60S 
genes analysed 70 29 15 0 114 
B - All genes analysed 
 
404 2014 2075 589 5082 
% of A (x/114) 
 
61.40350877 25.43859649 13.15789474 0 100 
% of B (x/5082) 
 
7.949626131 39.6300669 40.83038174 11.58992523 100 
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Table V - Distribution of genes from laz1-1 strain, according to their expression levels when compared to wt, at 36°C 
 
 
 
Gene expression compared to wt (microarray cells 36°C) 
 
  
 
1- Highly downregulated 
(≤0.666) 
2- Downregulated 
(0.666<x<1) 
3- Upregulated 
(1≥x>1.5) 
4- Highly Upregulated 
(x≥1.5) Total 
Ribosomal 40S and 60S 
genes analysed 70 42 2 0 114 
All genes analysed 
 
323 2156 2141 537 5157 
% of A (x/114) 
 
61.40350877 36.84210526 1.754385965 0 100 
 
% of B (x/5157) 
 
6.263331394 41.80725228 41.5163855 10.41303083 100 
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Fig. 3.11 – distribution of all laz1-1 genes by their expression level when 
comparing to wt at 25°C. 
 
Fig. 3.12 – Distribution of the analysed laz1-1 ribosomal 40S and 60S genes by 
their expression level, when comparing to wt. In contrast to the complete 
genome distribution, this class of genes is generally highly downregulated, 
and no single gene is highly upregulated. 
Highly 
downregulated 
(≤0.666)
Downregulated 
(0.666<x<1)Upregulated 
(1≥x>1.5)
Highly 
Upregulated (≥ 
1.5fold)
Distribution of general transcription 
changes in laz1-1 (25°C)
Highly 
downregulated 
(≤0.666)
Downregulated 
(0.666<x<1)
Upregulated 
(1≥x>1.5)
Distribution of ribossomal 40S and 
60S genes transcription changes in 
laz1-1 (25°C)
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Fig. 3.13 – Distribution of all laz1-1 genes by their expression level when 
comparing to wt at 36°C. 
 
Fig. 3.14 – Distribution of the analysed laz1-1 ribosomal 40S and 60S genes by 
their expression level, when comparing to wt. In contrast to the complete 
genome distribution, this class of genes generally highly downregulated, and 
no single gene is highly upregulated. 
Highly 
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(≤0.666)
Downregulated 
(0.666<x<1)Upregulated 
(1≥x>1.5)
Highly 
Upregulated (≥ 
1.5fold)
Distribution of general transcription 
changes in laz1-1 (36°C)
Highly 
downregulated 
(≤0.666)
Downregulated 
(0.666<x<1)
Upregulated 
(1≥x>1.5)
Distribution of ribossomal 40S and 60S 
genes transcription changes in laz1-1
(36°C)
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Using the lists of the putative Laz1 targets found in the ChIP-chip, it was possible to 
select the genes that both exhibit Laz1 promoter binding and are either up- or down-
regulation in laz1-1 strain. In this analysis, the data from each experiment was 
matched with corresponding result obtained at the same temperature, i.e., ChIP-chip 
targets at 25°C or 36°C were only paired with up or downregulated genes in laz1-1 at 
25°C or 36°C, respectively. The results, summarized in tables VI and VII, revealed a 
limited number of genes which seem to be real and direct targets of Laz1 regulation. 
This does not mean that Laz1 binds and regulates only these genes, but may reflect 
the very conservative analysis done for both ChIP-chip and expression microarrays.  
 
Table VI – Genes that exhibit Laz1 binding in the promoter region, and are up 
(red) or downregulated (green) more than 2 fold in laz1-1 strain, at 25°C. 
Gene ID 
 
 
Expression levels 
(compared to wt) 
 
Gene 
 
Gene function 
 
 
SPBC1289.03c 0.2865 spi1 Ran GTPase Spi1 
 
SPSNORNA.20 3.2805 snoU17 Small nucleolar RNA U17 
 
SPBC1105.11c 0.3135 hht3 Histone H3 h3.3 
 
SPBC1105.12 0.4115 hhf3 Histone H4 h4.3 
 
SPAC19G12.06c 0.286 hta2 Histone H2A beta 
 
SPAC1834.03c 0.321 hhf1 Histone H4 h4.1 
 
SPAC1834.04 0.3915 hht1 Histone H3 h3.1 
 
SPBC1289.14 25.3945  Adducing 
 
SPAC977.15 2.3355  Dienelactone hydrolase family 
 
SPBC713.12 0.464 erg1 Squalene monooxygenase Erg1 (predicted) 
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Table VII - Genes that exhibit Laz1 binding in the promoter region, and are up 
(red) or downregulated (green) more than 2 fold in laz1-1 strain, at 36°C. 
Gene ID 
 
 
Expression levels 
(compared to wt) 
 
Gene 
 
Gene function 
 
 
SPSNORNA.20 5.7595 snoU17 Small nucleolar RNA U17 
 
SPBC1826.01c 0.479 mot1 TATA-binding protein associated factor Mot1 
 
SPAC513.01c 0.465 eft201 Translation elongation factor 2 (EF-2) Eft2,A 
 
SPAC4A8.04 0.257 isp6 Vacuolar serine protease Isp6 
 
SPAC19G12.06c 0.3395 hta2 Histone H2A beta 
 
SPAC869.02c 2.674  Nitric oxide dioxygenase (predicted) 
 
SPAC1039.02 0.345  Phosphoprotein phosphatase (predicted) 
 
SPBPB2B2.13 0.375  Galactokinase Gal1 (predicted) 
 
SPBC1105.11c 0.37 hht3 Histone H3 h3.3 
 
SPBC1105.12 0.429 hhf3 Histone H4 h4.3 
 
SPBC1289.03c 0.3155 spi1 Ran GTPase Spi1 
 
SPBPB2B2.12c 0.4065  UDP-glucose 4-epimerase 
 
SPCC569.05c 3.646  Spermidine family transporter (predicted) 
 
SPAC17G6.13 2.4725  Sequence orphan 
 
SPAC1F8.03c 0.1395 str3 Siderophore-iron transporter Str3 
 
SPBPB2B2.09c 0.168  2-dehydropantoate 2-reductase (predicted) 
 
SPBC359.04c 0.462  Cell surface glycoprotein (predicted)DIPSY fam. 
 
SPBPB21E7.04c 2.8  Human COMT homolog 2 
 
SPAC1834.03c 0.3465 hhf1 Histone H4 h4.1 
 
SPAC1834.04 0.4505 hht1 Histone H3 h3.1 
 
SPAC1F8.05 6.7645  Sequence orphan 
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It must be noted that the histone-encoding genes are again highly represented in this 
table, as not only does Laz1 bind to their promoters, but also histones expression 
levels are altered in the laz1-1 mutant. This fact will be discussed in more detail in the 
next section.  
 
3.6 – Is Laz1 involved in histone regulation? 
3.6.1 – Laz1 binds all canonical histone gene promoters 
 
The ChIP-chip analysis detected Laz1 binding to histone promoters. However, it was 
particularly intriguing that Laz1 should bind on the promoters of some of the histones, 
but not all, as all the canonical histones share homology on their promoters. In order 
to further explore this data, the enrichment levels for each of the histone promoters 
were checked manually, using the ChIP-chip information plotted in a graphic 
representing the genome map. Upon thorough examination, it was concluded that 
Laz1 actually binds to all five promoters of the nine canonical histone promoters (Fig 
3.15), and not just the three detected by the software. 
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Fig. 3.15 – Laz1 binds all histone promoters. (A-E) ChIP-chip data shows specific 
Laz1 binding at the histone promoters (A) hta1-htb1 promoter (B) hta2 promoter (C) 
hht1-hhf1 promoter (D) hht2-hhf2 promoter (E) hht3-hhf3 promoter. 
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The binding to all these promoters was expected, as the conserved region of histone 
promoters, the AACCCT box, contains two TTAGGG repeats where Laz1 would be 
predicted to bind (Fig 3.16).  
 
 
 
 
Fig. 3.16 – AACCCT-box includes TTAGGG repeats. A – Illustration of a typical 
histone promoter. Histone genes are divergently transcribed and share the same 
promoter. B – Alignment of the AACCCT box with the vertebrate telomere TTAGGG 
repeats shows similarity between both sequences. 
 
As described above, Ams2 also binds to the AACCCT-box and Ams2 is responsible for 
mediating the periodicity of histone transcription, (Takayama and Takahashi 2007). 
Even though there is no genome-wide data available for Ams2 binding so far, this 
protein is known to bind the SPAC631.02 ORF promoter (Takayama and Takahashi 
2007) to which Laz1 also binds (Fig. 3.10. This suggests that Laz1 and Ams2 are 
binding and possibly regulating the same set of genes, a possibility which will be 
addressed with further detail below.  
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One must bear in mind that the microarrays currently used do not include probes for 
repetitive regions. Therefore, the only way to test Laz1 binding to telomeres was using 
ChIP followed by qPCR with specific primers that can detect enrichment in that region. 
However, it was not possible to detect any enrichment (not shown). Nonetheless, it 
cannot be excluded that Laz1 binds to the telomeres below the detection level of the 
conditions used. 
As shown, Laz1 binds in many places throughout the genome. Looking closely into the 
additional putative Laz1 targets, several genes with crucial functions such as cell cycle 
control, or chromatin structure maintenance were identified. The proteins encoded by 
these genes include slp1, ppc89, some histones, sds3 and cdc10, among others. 
Nevertheless, although the ChIP-chip experiments detected numerous Laz1 binding 
sites, they did not provide any further information on the functional significance of the 
presence of Laz1 at these promoters. In order to clarify this, the following sections will 
focus on Laz1 cellular functions.  
 
3.6.2 – Laz1 Myb domain is essential for binding to histone promoters 
 
After discovering that Laz1 was binding to the promoters of all histones it was 
important to know which domains were involved in this process. Therefore, the ts 
strain laz1-1 (see section 3.1) was tested for its ability to bind histone promoters in 
vivo. ChIP analysis showed that Laz1 could no longer bind to hht2 and hhf2 (histone 
H3.2 and H4.2) promoter at either permissive (Fig. 3.17) or restrictive temperatures 
(Fig 3.18), which indicated the importance of a single residue within the Myb domain 
for the maintenance of the DNA-binding ability of this protein. 
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Fig. 3.17 –Histone promoter binding ability is lost in laz1-1. Wt, laz1 (HA tagged) 
and laz1-1 (HA tagged) strains were used for Chromatin Immunoprecipitation using HA 
antibody at 25°C degrees. Purified DNA was amplified by qPCR using primers for 
histone hht2/hhf2 promoter region or for the ade6 promoter. The values of enrichment 
correspond to Laz1 binding at the histone promoter. These were normalized to the ade6 
promoter and to wt (non-tagged). This experiment was done in triplicate and the error 
bars correspond to the SEM. Unlike laz1+, laz1-1 cells do not bind to the histone 
promoter.  
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Fig. 3.18 –Histone promoter binding ability is lost in laz1-1. Wt, laz1 (HA tagged) 
and laz1-1 (HA tagged) strains were used for Chromatin Immunoprecipitation using HA 
antibody at 36°C degrees. Purified DNA was amplified by qPCR using primers for 
histone hht2/hhf2 promoter region or for the ade6 promoter. The values of enrichment 
correspond to Laz1 binding at the histone promoter. These were normalized to the ade6 
promoter and to wt (non-tagged). This experiment was done in triplicate and the error 
bars correspond to the SEM. Unlike laz1+, laz1-1 cells do not bind to the histone 
promoter.  
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3.6.3 – Histone-encoding genes are downregulated in laz1-1. 
 
The four different types of canonical histones were among the downregulated genes 
in laz1-1 (Table VIII). However, for hta1 and for htb1, the downregulation was lower 
than for the other histones, being well under the 2 fold cut-off used. Intriguingly, the 
very slight downregulation of these two copies of histones is alleviated when cells are 
grown for one hour at the restrictive temperature, 36°C. This might indicate that Laz1 
exerts only a minor effect, if any, in the regulation of the hta1 and htb1 pair of genes. 
Taken together, these results support the notion that Laz1 is a transcription factor that 
contributes to canonical histone gene regulation, but that factors independent of Laz1 
should also be involved in the regulation of at least hta1 and htb1. Due to the way the 
microarrays were designed, it is not possible to make a clear distinction between the 
three histone H3 or H4 copies that exist in the S. pombe genome, because the probes 
share homology. This fact prevents us from ascertaining whether Laz1 is, like Ams2 
(see Introduction), regulating these copies differentially. A search for any alteration of 
transcripts among some histone variants was also carried out. Expression of the 
SPBC800.13 (H4 variant), pht1 (H2a) and cnp1 (H3 variant) genes was not significantly 
altered. 
 
Table VIII – Histone average expression levels in laz1-1 strain at 25°C and 36°C  
Histone genes 
 
Gene expression 
compared to wt 
(microarray cells 25°C) 
Gene expression 
compared to wt 
(microarray cells 36°C) 
hta1 0.77 1.022 
htb1 0.6025 0.697 
hta2 0.286 0.3395 
h3.1: hht1 0.3915 0.4505 
h3.2: hht2 0.4215 0.5745 
h3.3: hht3 0.3135 0.37 
h4.1: hhf1 0.321 0.3465 
h4.2: hhf2 0.409 0.5155 
h4.3: hhf3 0.4115 0.429 
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The fact that Laz1 binds histone promoters and affects their expression adds a new 
player to a function previously attributed mainly to Ams2. Ams2 is a GATA binding 
factor that also binds to the centromeres (Chen, Saitoh et al. 2003), where GATA 
sequences are present. Interestingly, however, AACCCT boxes do not have the normal 
GATA motif. Indeed, only three of the nine histones have a GATA motif in the entire 
promoter region (Song, Liu et al. 2008). It was proposed that Ams2 might be able to 
bind GATA-like sequences present in the AACCCT box reverse strand, like 5’-GATn-
3’ and 5’-GtTA-3’ or that Ams2 would need other proteins to bind this motif 
(Takayama and Takahashi 2007). As both Ams2 and Laz1 were found binding to the 
same small conserved sequence and both positively influence histone mRNA levels, it 
would be most interesting to analyse in the future what is precisely the relationship 
between them. We propose two possible situations: a) Laz1 is in charge of the basal 
level of histone transcription outside S-phase and Ams2 confers the periodic 
expression of histones in S-phase or b) Laz1 is the only protein binding directly to the 
DNA during the cell cycle, serving as a platform where Ams2 (during S-phase) and 
other positive and negative regulators could bind. We favour this second model, 
which is really a specific subset of the first model, since it gives a reasonable 
explanation of how the GATA binding factor Ams2 can bind non-GATA sequences. 
This question was addressed by performing Ams2 ChIP in wt and in laz1-1 mutants 
(described in section 3.1). However, it was not possible to isolate any enriched DNA in 
the histone promoter region, even in wt, probably due to the poor quality of the 
antibody. It also remains to be revealed whether Laz1 is controlling the normal basal 
levels of histones or, like Ams2, histone periodicity. Future work will be crucial to 
understand Laz1 exact role and its relationship with Ams2. 
Once the effect of Laz1 on histone transcription levels was evident, the subsequent 
step was the analysis of its impact on histone protein levels through the cell cycle. 
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3.6.4 - Laz1 regulates degradation of histone H3 upon nitrogen 
starvation 
 
The results described above shown that Laz1 is binding to the AACCCT box and 
controlling histone expression, but they do not reveal the impact that Laz1 has on the 
final product of histone gene expression, the histone protein levels. Therefore, the 
histone protein levels during the cell cycle in the wt and in the laz1-1 mutant were 
analysed. Cells were synchronized in G1 by nitrogen (N) starvation-induced arrest. In 
wt, Cdc2 levels (used here as a control) were severely reduced following nitrogen 
starvation. Ponceau staining showed that this downregulation was not Cdc2 specific, 
but a general outcome reflecting a global reduction in protein synthesis (data not 
shown). This effect has been described as being dependent on the serine protease 
Isp6 and on the nuclease Pnu1 (Nakashima, Yoshida et al. 2002). Unexpectedly, in the 
same cells, histone H3 was clipped during G1 arrest and further clipping occurred 
upon releasing from G1, when a N source was added back, as shown by western blot 
(Fig. 3.19). This is the first evidence of histone clipping in S. pombe. Full-length histone 
H3 protein tends to return slowly to the levels observed in cycling cells, and clipped 
histones tend to disappear. On the other hand, results were completely different in the 
laz1-1 background. First, the Cdc2 levels remained stable, even after N starvation. 
Furthermore, in contrast to wt, no histone clipping was observed. A plausible 
explanation for the lack of degradation of Cdc2 in our laz1-1 mutant can reside in the 
Isp6 protein levels. As mentioned, Isp6 mediates general protein levels upon N 
starvation. Interestingly, it was seen that Laz1 binds the isp6+ promoter and Isp6 
mRNA levels are downregulated in laz1-1 (Table VII). It seems probable that the lack of 
degradation is caused by the lower levels of Isp6 in the mutant. The lack of histone 
clipping may be due to the same reason. Histone clipping was recently reported both 
in the budding yeast (Santos-Rosa, Kirmizis et al. 2009) and in mouse stem cells 
(Duncan, Muratore-Schroeder et al. 2008). In S. cerevisiae, an unidentified serine 
protease was responsible for this phenomenon. It can be hypothesized that the effect 
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of Laz1 on Isp6 serine protease levels indirectly regulates this clipping effect. However, 
it should be noted that the budding yeast homologue of Isp6 (PRB1) is not the sole 
effector of histone clipping in that organism (Santos-Rosa, Kirmizis et al. 2009). In 
addition, the microarray data was obtained from cells grown under normal conditions. 
Therefore, regardless of Isp6 being the only downregulated protease identified in 
laz1-1, further analysis in cells grown in the absence of a N source, or experiments 
directly altering normal Isp6 levels in the cells will be useful to confirm these 
assumptions.
 
 
Fig. 3.19 – Laz1 is involved in post transcriptional regulation of histones Wt cells 
and laz1-1 cells were arrested cells in G1 after 16hours of nitrogen (N) starvation at 
25°C, then shifted to 36°C degrees for one and a half hours before release (see 
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Material and Methods). Samples were collected before starvation (a) after 16h of 
starvation (0), after 1.5 hours at 36°C but before N being added (0b), after N addition, 
and every half an hour for 5 hours. Progression through the cell cycle was monitored by 
FACS and the rate of recovery from G1 seems to be the same in both strains. Protein 
degradation (Cdc2) and histone clipping occurs in G1 arrested cells (left panel). Neither 
Cdc2 nor histone clipping are observed in laz1-1 cells (right panel). 
 
3.7 – Does Laz1 have a centromere-associated role? 
3.7.1 – Laz1 is essential to maintain centromere identity 
 
Laz1 binds to the AACCCT box where Ams2, another histone regulator previously 
described in fission yeast, also binds. Ams2 was initially found in a screen for 
multicopy suppressors of the CENP-A ts mutant phenotype of cnp1-1 (Chen, Saitoh et 
al. 2003) (see Introduction). The same authors observed that Ams2 not only binds to 
histone promoters but also binds the centromere central core. However, the precise 
mechanism by which Ams2 controls CENP-A deposition is still unclear. There is the 
possibility that Laz1 is also involved in centromere identity and in normal CENP-A 
recruitment to the central core, based in three main reasons: a) the binding sites of 
Ams2 and Laz1 are very similar, b) Laz1 deleted cells were often able to divide, forming 
microcolonies, before dying (see section 3.1), a phenotype resembling that observed 
in mutants that cannot load de novo CENP-A, and c) it is known that normal relative 
levels of histones are needed to maintain normal CENP-A loading at the centromeres 
(Castillo, Mellone et al. 2007) and it was shown above that Laz1 controls histone levels.  
To test the involvement of Laz1 in the CENP-A deposition, laz1-1 strains with markers 
integrated in regions that are normally silent, such as the centromere and the 
telomere, were created. Specifically, the markers were: a) arginine inserted in the 
centromere central core, b) uracil in the centromere outer repeats, and c) histidine 
inserted in the telomere. Normal silencing of the reporter genes inserted in the outer 
repeats and at the telomere (Fig. 3.20) was observed, indicating that there was no 
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general loss of silencing. However, the reporter gene introduced in laz1-1 central core 
displayed a clear loss of silencing (Fig. 3.20).  
 
Fig. 3.20 laz1-1 was tested for silencing defects and sensibility to TBZ drug. laz1-1 
strain shows derepression of silencing specifically in the central core region (ARG) of 
the centromere and some sensitivity to TBZ, when compared to Wt, and to laz1-1 cells 
growing in rich media (5S). However, no significant alteration in silencing at the 
telomere (HIS) or at the centromere outer repeats (-URA and FOA) occurred in laz1-1 
cells. rik1∆ strain was used as positive controls for telomere and centromere outer 
repeats silencing defects. mis6-302 was used for centromere central core silencing 
defects.  
 
Silencing defects at the central core are specifically correlated with defective CENP-A 
deposition and normal kinetochore formation, which made us wonder if, in fact, 
CENP-A deposition was abnormal in the mutant strains. To address that, ChIP in wt 
and laz1-1 cells was carried out, using specific CENP-A antibody. It was found that in 
laz1-1 the levels of CENP-A enrichment were significantly reduced at the central core 
whereas in the control locus CENP-A seemed slightly more enriched than in wt (Fig. 
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3.21). This is either an indirect effect, if this slight increase is due to an altered 
proportion of the relative levels of histone H3 and CENP-A in the mutant, or a direct 
effect if Laz1 is a CENP-A loading factor in the centromeres.  
 
Fig. 3.21 - CENP-A chromatin immunoprecipitation showed a reduction in protein 
binding to the centromere central core in laz1-1 cells when comparing with wt (laz1-
3HA). In the control loci used, it seems that CENP-A levels remain more or less 
unaltered in the mutants when comparing to the wt. The values of enrichment 
correspond to CENP-A binding at the different sequences (CEN-centromere central core, 
ade6 promoter, act1 ORF and hht2 promoter). This experiment was done in triplicate 
and the error bars correspond to the SEM. 
 
0
1
2
3
4
5
6
CEN ade6 act1 hht2
IP
 /
 W
C
E
Chromatin IP
Laz1 characterization   
112 
 
Unlike human cells, where de novo loading of CENP-A only occurs in G1 phase 
(Jansen, Black et al. 2007), two independent pathways of CENP-A loading in S. pombe 
have been reported (Takayama, Sato et al. 2008). One occurs in G2 phase and is 
dependent on the centromere protein Mis6, while the other occurs during S-phase 
and depends on Ams2. Indirect immunofluorescence microscopy of cells grown for 6 
hours at 36°C was used to look at the Mis6 and CENP-A foci in both wt and laz1-1 
strains. As the culture was grown in log phase, most cells were in G2. In wt, all cells had 
one focus of Mis6 and one of CENP-A (fig. 7C). laz1-1 strains also exhibited a Mis6 
signal in almost every cell. However, many cells have a clearly less intense CENP-A 
signal and some cells do not have any signal at all. These results confirm that Laz1 has 
a role in CENP-A deposition in the central core and indicate that it acts in the CENP-A 
loading pathway independently or downstream of Mis6.  
These results indicate that Laz1 has a role in CENP-A deposition in the central core.  
 
 
Fig. 3.22 - Indirect immunofluorescence shows the localization of Mis6 and 
CENP-A in wt and laz1-1 cells. Both Mis6 and CENP-A localize at the centromere in 
wt cells, while in many laz1-1 cells Mis6 protein localizes in a single focus. In this same 
strain, CENP-A co-localization with Mis6 is dramatically reduced when compared to the 
wt.  
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3.7.2 - Laz1 binds to terminal region of the chromosome where 
neocentromeres can be formed 
 
As mentioned in section 3.4.1, ChIP-chip data revealed that Laz1 binds to many places 
in the S .pombe genome. This can be perceived by the enrichment peaks observed in 
Fig. 3.9. However, a much broader peak of binding of Laz1 was identified in the 
terminal region of the chromosomes, close to the subtelomeres. This enrichment was 
observed in both chromosomes 1 and 2. In chromosome 3 the equivalent terminal 
region was not covered by the microarray because the rDNA repeats present at both 
termini of Chr III are missing from the array. It was shown recently that, following 
centromere 1 deletion, neocentromeres are formed at one of the two ends of the 
chromosome (Ishii, Ogiyama et al. 2008). These authors observed that the deposition 
of CENP-A and other centromere components occurs on these terminal areas. 
Remarkably, the subtelomeric CENP-A binding pattern in those centromere 1 
defective strains completely overlaps the one we observed for Laz1 protein (Fig. 3.23). 
Notably, this pattern is distinct from that of the Swi6 heterochromatin protein, 
suggesting a specific role for the Laz1-enriched sites. 
 
Taken together with the role of Laz1 in maintaining CENP-A levels at the central core, 
this observation suggests that Laz1 might have a function in recruiting CENP-A upon 
disruption of centromere 1, allowing neocentromeres to be formed. 
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Fig. 3.23 – Laz1 binds wt chromosome1 ends in the same place CENP-A binds 
upon centromere1 disruption A) Representation of ChIP-chip data highlighting Laz1 
binding in the terminal part of chromosome 1 left arm (figure in the left) or in the 
terminal chromosome1 right arm (figure in the right).B) Figure taken from Ishii, K., Y. 
Ogiyama, et al. (2008) highlighting the CENP-A binding upon centromere1 disruption 
and neocentromere formation.Boxes highlighting the left arm or the right arm are 
placed in the same place of the genome, allowing for direct comparison between a) and 
b) 
 
3.8 – Discussion 
 
Laz1 is an intriguing protein, whose essential function has puzzled scientists for more 
than ten years. Because of its domain organization, Laz1 was a candidate telomere 
binding protein. In fact, Myb domains are often associated with telomeric binding (see 
Introduction) and Laz1 has, like the telomeric protein Rap1, two of these domains in its 
N-terminal half. The possible telomere link was pursued by Vassetsky and colleagues, 
who did several in vitro affinity tests. Their work showed that Laz1 (previously called 
SpX or Teb1) had higher affinity to vertebrate telomere repeats than to fission yeast 
telomere repeats (Vassetzky, Gaden et al. 1999). However, they could not exclude the 
possibility that the protein was binding to the S. pombe telomeres in vivo. It must be 
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noted that in S. pombe, contrary to what happens in other organisms, no telomere 
specific protein was ever found to be essential nor are telomeres themselves essential. 
When telomeres disappear, the protection that impedes chromosome fusions is also 
gone. As the fission yeast possesses only three chromosomes there is a relatively high 
possibility that each end fuses with the end of the same chromosome, forming circular 
chromosomes that contain only one centromere and are therefore stable (Nakamura, 
Cooper et al. 1998). The fact that laz1 deleted strain is not viable suggested that Laz1 
should have another function besides the putative telomeric one. Laz1-GFP tagged 
protein localization only reinforced this hypothesis, as it was never possible to observe 
clear spots of the protein, but only dispersed fluorescence all over the nucleus. The 
possibility of Laz1 binding to telomeres in vivo was explored by ChIP, but no 
significant enrichment was detected, in agreement with previous results. There is still 
the possibility that Laz1 binds to telomeres at very low levels, below the threshold for 
detection in these experiments.  
Vassetsky et al. also speculated about the possibility of Laz1 being a transcription 
factor, as they found vertebrate telomeric repeats to be present mainly in intergenic 
regions. The work presented in this thesis strongly supports this hypothesis as it was 
seen that Laz1 was binding to many promoter regions. Furthermore, several genes 
that do have Laz1 binding at their promoters depend on Laz1 to have normal 
transcription levels. Interestingly, many of the binding sites came to confirm the 
suspicion that Laz1 was binding to sequences very similar to vertebrate telomere 
TTAGGG repeats.  
One must bear on mind that it is possible that many other genes not included in the 
list of targets due to the stringency of the analysis are also affected by Laz1. In fact, the 
abundance of this protein seems to be quite low (though protein quantification was 
not done). Therefore, the enrichment levels detected by ChIP were also low. One could 
expect that, making a less stringent analysis, changing the antibody and other steps of 
the IP or doing the experiment during meiosis (when laz1+ transcription levels are 
several times higher), other additional targets could also be identified.  
Laz1 characterization   
116 
 
 
Another striking observation was that Laz1 protein could affect groups of genes. In 
particular, Laz1 seems to control ribosomal proteins (RP) gene expression. However, in 
this case, no general binding of the protein at the promoters of this class of genes was 
detected. Once again, it cannot be said that Laz1 does not bind the RP promoters, but 
that binding could not be detected under the conditions used. It is important to note 
that the RP gene promoters in fission yeast are highly enriched in HomoIE elements 
(AGGGTAGGGT), which are very similar to the TTAGGG repeats (Gross and Kaufer 
1998). Also, it must be pointed out that MYB domain proteins have been related with 
ribosomal protein transcription: Rap1 is one of the transcription factors that forms a 
complex at the RP promoters in the budding yeast (Warner 1999) and Tbf1 has similar 
functions in Candida albicans (Hogues, Lavoie et al. 2008). Further analysis looking in 
detail to these promoters in S. pombe will shed light in this issue. 
Besides RP gene expression, Laz1 also plays a key role in controlling histone gene 
expression. Laz1 binds to all histone gene promoters, and almost all histones seem to 
be affected by the point mutation present in laz1-1. Curiously, general transcription 
levels of histones H3 and histones H4 drop around 50% to 70%, a similar effect to that 
conferred by the loss of Ams2 in the ams2-shut-off strain (Takayama and Takahashi 
2007). The histone promoters are not the only common binding sites for these two 
proteins. Ams2 binds to the promoter of a bromodomain containing protein, to which 
Laz1 also binds, suggesting a widespread overlap between Ams2 and Laz1 binding 
sites. Furthermore, as laz1-1 and ams2-shut-off strains seem to have similar effects in 
the histone transcription levels we propose that they cooperate somehow, allowing 
transcription. Two hypotheses are plausible. One is that Laz1 is in charge of histone 
transcription basal levels throughout the cell cycle, while Ams2 only plays a role during 
S-phase. The other is that they need each other to allow periodic expression in S-
phase (Fig. 3.24). 
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Fig. 3.24 – Representation of two hypothesis of Laz1 action at the histone 
promoter. A) Ams2 and Laz1 compete for binding. Ams2 is in charge of the periodical 
expression during S-phase, while Laz1 is responsible for the basal levels of transcription 
throughout the cell cycle. B) Ams2 works as a platform where positive (Ams2) and 
negative regulators bind, affecting histone transcription. 
 
We favour this last model, as Ams2 is a GATA binding factor and there are no perfect 
sequences at the AACCCT box for Ams2 to bind. It seems likely that the Myb domain 
protein could act as a platform for Ams2 to bind and allow transcription. There are 
several ways to test this model. An obvious experiment is to detect interaction 
between the two proteins, by Co-IP, which was tried but unfortunately did not work, as 
technical improvement is needed to purify these two very low abundance proteins. 
Another experiment that can address the relationship between Ams2 and Laz1 is the 
Ams2 ChIP in a laz1-1 background. Again, this experiment was not successful until 
now, probably because of the poor quality of the Ams2 antibody used.   
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Besides acting on histones transcription levels, results indicate that Laz1 may have an 
additional role in histone H3 protein levels during cell cycle. Upon G1 arrest in N 
starvation histones are cleaved, similarly to what occurs in budding yeast but has not 
yet been reported in fission yeast. Remarkably, this clipping does not occur in laz1 
mutant cells. Although is still not clear what is happening, it can be speculated that 
this effect occurs via Isp6, the only protease controlled by Laz1 in cycling cells. Future 
work in this subject, addressing Isp6 function in vivo, by shutting it off or by 
overexpressing it, will hopefully clarify whether Isp6 is the protease involved in this 
process. Finding the protease responsible for the H3 clipping will provide valuable 
tools to study the impact and the function of the different truncated forms that exist in 
the fission yeast. Nonetheless, it is remarkable that a single protein, Laz1, can regulate 
histone levels in multiple ways. 
 
Fig. 3.25 – Representation of Laz1 hypothetical role on histone H3 clipping 
upon N starvation. A) Laz1 activates Isp6 expression and Isp6 cleaves histone H3. B) 
Laz1 mutant is not able to properly activate Isp6 transcription and therefore no histone 
H3 clipping occurs. 
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When Laz1 was found to be essential, it was observed that cells that could not express 
the protein were able to perform several rounds of division before dying. 
Subsequently, similarities between Ams2 and Laz1 roles were found. These two 
apparently unrelated factors led us to think that Laz1 could be having an impact in 
CENP-A loading. In fact, Ams2 was reported as a cnp1-1 ts mutant multicopy 
suppressor (Chen, Saitoh et al. 2003). Although it is not the case for Ams2, many 
proteins involved with CENP-A loading are essential, and in their absence cells start 
dying after some rounds of cell division. This phenomenon resembles what happened 
in Laz1 deletion. Also, relative canonical histone levels are known to influence CENP-A 
deposition (Castillo, Mellone et al. 2007) and Laz1 affects histone transcription. 
Correspondingly, CENP-A levels were reduced in the laz1-1 mutant and silencing in 
the central core was specifically disrupted although Mis6 localization was normal. This 
is an indication that Laz1 acts independently, or downstream, of Mis6. ChIP 
experiments did not detect Laz1 binding to the centromeres, and for that reason it is 
impossible to tell whether its effect in CENP-A levels is direct or indirect, through 
histone level regulation. Experiments in which CENP-A, H3 or H4 levels are 
manipulated could aid understanding exactly how the protein impairs CENP-A 
deposition. It could also be worthwhile to assess whether Laz1 and CENP-A interact 
and whether Laz1 acts as a chaperone for CENP-A. It should be also mentioned that 
Myb-like domain proteins have been recently implicated in centromere function. In 
both C. elegans (KNL2) and human cells (Mis18BP1), a protein with such domain was 
shown to be critical for CENP-A loading (Maddox, Hyndman et al. 2007). This suggests 
a possible conserved role for Myb domain proteins in maintaining centromere 
identity.  
Despite the microarrays not having repeated regions and therefore not including the 
telomeres, it was possible to distinguish binding of Laz1 at the ends of the 
chromosomes 1 and 2, very close to the referred telomeres. Astonishingly, the pattern 
of binding in that region of chromosome 1 resembles the pattern of binding of CENP-
A upon disruption of centromere 1. In fact, Laz1 normally binds in wt to the exact same 
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region where neocentromeres are formed when the normal centromere is deleted. 
This suggests that Laz1 might be needed, or might work as a signal or a seed for 
CENP-A to be loaded de novo when the normal centromere is there. Inducing and 
mapping neocentromere formation in the absence of Laz1 binding to those 
chromosome extremes would reveal the real impact that this protein has in 
neocentromere formation.  
In this chapter it was shown the importance of Laz1 in multiple events essential for cell 
survival. Many genes depend on Laz1, and the work described focused on the 
unanticipated Laz1 role in controlling histone levels and histone in multiple ways.  
Following chapters will focus on other Myb domain proteins, and in their roles in 
maintaining a normal telomere.  
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4.1 – Overview 
 
In the previous chapter it was revealed the importance that Laz1, a Myb domain 
protein, has in regulating transcription, degradation and centromere identity. 
This chapter will focus on another S. pombe Myb domain protein, called Tbf1. Tbf1 is a 
protein found a long time ago in the fission yeast cell, and its characteristics have 
stimulated scientists’ curiosity throughout the years. However, the TBF1 gene was 
first identified in S. cerevisiae. Like Laz1, TBF1 was described as an essential gene that 
encodes a protein that binds specifically in vitro to the vertebrate telomere sequence, 
which is itself interspersed between subtelomeric elements in budding yeast (Brigati, 
Kurtz et al. 1993). This protein is thought to play a role in the regulation of gene 
silencing at telomeres (Fourel, Revardel et al. 1999; Fourel, Boscheron et al. 2001). TBF1 
also seems to have a role in controlling telomere length in tel1∆ cells (TEL1 is the yeast 
ATM kinase homologue), which lose the Rap1 dependent counting mechanism that 
regulates telomere length (Berthiau, Yankulov et al. 2006; Hediger, Berthiau et al. 
2006).  
Despite of all this information about the role of this protein in budding yeast, little is 
known about its counterpart in S. pombe. Interestingly, Tbf1 protein includes a Myb 
domain in its C-terminal region, similar to the arrangement in Taz1, the double strand 
telomeric binding protein.  
Together, all this information led us to suspect the existence of a Tbf1 role at the 
telomere. This thesis addresses this question by characterizing Tbf1 protein in the 
fission yeast. It was found that the Tbf1 is an essential protein and that its C-terminal 
part is indispensable for cell survival. Furthermore, it is shown here that Tbf1, when 
overexpressed, alters telomere length, indicating a role in the telomere physiology.  
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Results shown in this chapter were obtained in collaboration with C. Pitt, from the 
Telomere Biology Laboratory, London Research Institute, United Kingdom. 
 
4.2 – Tbf1 is an essential protein 
 
In order to study Tbf1 function in S. pombe cells a loss-of-function approach was 
initially taken. More specifically, one of the copies of the tbf1 gene that exist in a 
diploid cell was deleted, creating a heterozygous diploid strain for this gene. The 
deleted copy was replaced by a gene that confers resistance to G418 antibiotic. The 
diploid was then grown on a sporulation medium that leads to starvation, and cells 
consequently started meiosis. Tetrads were selected and then each spore was 
separated. The genotype of the different spores was analyzed using the ability of the 
deletion to confer resistance to G418. While the spores with one copy of the tbf1 gene 
(G418 sensitive) were able to divide normally and survive, the tbf1- spores (G418 
resistant) did not form viable colonies (Fig. 4.1). This result shows that tbf1+ is an 
essential gene. 
 
 
Fig. 4.1 – tbf1 is an essential gene. Homozygous (tbf1 +/+) and heterozygous 
diploids (tbf1+/-) were sporulated and tetrad dissection was performed. Heterozygous 
   Tbf1 characterization  Laz1 characterization 
125 
 
diploids gave origin to only two viable spores (tbf1+), while the two remaining spores 
(tbf1-) did not form normal viable colonies.  
 
4.3 – Tbf1 localizes to the nucleus 
 
To analyse the subcellular localization of Laz1, a fusion of the tbf1 gene with a GFP C-
terminal tag was integrated in the cell, replacing the normal laz1 gene. However, this 
strain was not viable. Therefore, a LGS linker (leucine-glycine-serine) between the ORF 
and the GFP tag was used, in order to give stability to the protein. The created strain 
(Laz1-GFP) was fully viable and the GFP signal showed a nuclear localization pattern 
(Fig. 4.2). However, foci were not distinguishable and the GFP signal looked fairly 
dispersed throughout the entire nucleus. This indicates that Tbf1 localizes to the 
nucleus, but it cannot be concluded whether it associates with a particular region of 
the chromosomes.  
 
 
 
Fig. 4.2 – Tbf1 protein localizes to the nucleus. Tbf1-GFP fixed cells were stained 
with DAPI and were visualized by fluorescence microscopy.  
 
4.4 – Tbf1 C-terminal portion is essential for viability 
 
The Tbf1 protein has, as mentioned, a C-terminal Myb-domain. This was of particular 
interest, as this domain is present in many telomeric proteins. Therefore, a deletion of 
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the C-terminal portion of the protein, including the Myb domain and additional 22 
amino acids, was made. To do so, the portion of the gene that codes for that region 
was replaced by a 3HA tag and a G418 resistance cassette, at one allele of a diploid 
strain (Fig 4.3 A). Western blot analysis of the tagged truncated Tbf1 protein of the 
heterozygous diploid showed that the protein was still being expressed (Fig. 4.3 B). 
Upon sporulation it was observed that cells that do not carry the full size Tbf1 were 
unable to grow and form viable colonies (Fig. 4.3 C). The Tbf1 C-terminal portion is, 
therefore, essential for viability.  
 
However, in this experiment, 22 aminoacids that are not part of the Myb domain were 
also deleted. In order to understand if the phenotype observed was solely caused by 
the Myb deletion, the last 22 aminoacids were deleted, leaving the Myb domain intact. 
This deletion also proved to impair survival as spores lacking these terminal few Tbf1 
amino acids fail to form viable colonies (Fig. 4.4). Hence, we cannot unambiguously 
assign essentiality to the Myb domain itself.  
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Fig. 4.3 – Tbf1 C-terminal part is essential for viability. A) The C-terminal part 
that includes the Myb domain and the last 22 aminoacids was deleted in one of the tbf1 
copies of a diploid strain. B) Protein extract from the diploid strain having one intact 
and one truncated tbf1 gene was isolated. A western blot analysis using an antibody 
against HA tag detected the truncated Tbf1 form, indicating that the truncated protein 
is stable. C) Viability of cells expressing the truncated Tbf1 form was analysed. While 
diploids containing the two complete versions of the gene were able to complete 
meiosis and form four viable colonies, the diploid strain with one truncated form of tbf1 
generated only two viable spores. The two viable spores corresponded to the haploid 
cells that contained the full version of the tbf1 gene. Tbf1 C-terminal part is therefore 
essential. 
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Fig. 4.4 – Tbf1 last 22 aminoacids are essential for viability. A) C-terminal last 22 
aminoacids were deleted in one of the tbf1 copies of a diploid strain. B) Viability of cells 
expressing the truncated Tbf1 form was analysed. While diploids containing the two 
complete versions of the gene were able to complete meiosis and form four viable 
colonies, the diploid strain with one truncated form of tbf1 generated only two viable 
spores. The two viable spores corresponded to the haploid cells that contained the full 
version of the tbf1 gene. The C-terminal last 22 aminoacids are therefore essential. 
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4.5 – Tbf1 overexpression leads to telomere elongation 
 
To address the role of S. pombe Tbf1 protein in telomere length regulation, tbf1+ was 
overexpressed on plasmids under control of the NMT81 promoter. Expression from 
this promoter can be repressed by growing in medium containing thiamine. The 
culture is induced if it lacks thiamine and repressed if it contains thiamine. 
Transformants were isolated under repressing conditions, then induced or repressed 
in liquid medium for 6 days. A transformant carrying epitope-tagged tbf1+ (pNMT81-
tbf1-V5) displayed telomere elongation by around 100–150 bp when induced (Fig. 4.5, 
lane 2), relative to the same strain carrying an empty vector (Fig. 4.5, lane 11). Similar 
elongation was seen when untagged tbf1+ (pNMT81-tbf1) was induced (Fig. 4.5, lane 
8). The elongation seen for full-length tbf1+ was not observed in a C-terminal deletion 
epitope-tagged tbf1 (pNMT81-tbf1-ΔMYB-V5), which lacks the last 82 Myb-
containing amino acids (Fig. 4.5, lane 5). We saw intermediate telomere elongation at 
day 0 (repressed) for transformants carrying full-length tbf1+ constructs (Fig. 4.5, lanes 
1 and 7). This is probably due to incomplete repression of the NMT81 promoter by 
thiamine. Indeed, after a further 6 days growth in repressing medium, we see a further 
slight increase in telomere length (Fig. 4.5, lanes 3 and 9), consistent with incomplete 
repression. It was also found that the stronger promoter, pNMT41, led to equivalent 
telomere elongation (150 bp) under repressing and inducing conditions (data not 
shown). However, the telomeres never elongated beyond 150 bp, suggesting a new 
mean telomere length is maintained when tbf1+ is overexpressed. In agreement with 
these observations, the S. cerevisiae TBF1 protein was recently reported to provide a 
telomere length-sensing mechanism, which allows telomerase to preferentially 
elongate short telomeres, in tel1 cells (Arneric and Lingner 2007). To determine that 
Tbf1 was overexpressed, we visualized samples from the above experiment by 
Western blot (Fig. 4.5B, same loading order as 4.5A). We were able to detect high 
levels of Tbf1-V5 (predicted calculated molecular mass 57.6 kDa) and Tbf1-ΔMYB-V5 
(predicted calculated molecular mass 48.2 kDa) when induced, and low levels of the 
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full-length protein when repressed (consistent with the mild telomere elongation 
discussed above). In conclusion, the in vivo experiments reveal that the tbf1 gene is 
essential for survival, that the encoded spTbf1p can affect telomere length, and that 
this elongation is dependent upon the presence of the C-terminal region that includes 
the Myb domain.  
However it remains undetermined whether it is solely the absence of the Myb domain 
which is responsible for this phenotype or if the terminal 22 aminoacids alone can also 
have this effect, as their deletion proved to be lethal.  
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Fig. 4.5 – Overexpression of tbf1 leads to MYB-dependent telomere elongation. 
Fission yeast transformed with plasmids containing thiamine repressible (NMT81 
promoter) tbf1, tbf1ΔMyb, or empty vector grown in medium containing thiamine 
(+thi; expression repressed) or lacking thiamine (-thi; expression induced). V5, C-
terminal fusion with V5 epitope tag. A) Southern blot analysis for telomere length: Lane 
1, tbf1-V5 0 days+thi; lane 2, tbf1-V5 6 days -thi; lane 3, tbf1-V5 6 days +thi; lane 4, 
tbf1ΔMyb-V5 0 days +thi; lane 5, tbf1ΔMyb-V5 6 days-thi; lane 6, tbf1ΔMyb-V5 6 
days+thi; lane7, tbf1 0 days +thi; lane 8, tbf1 6 days -thi; lane 9, tbf1 6 days +thi; 
lane 10, empty vector 0 days +thi; lane 11, empty vector 6 days -thi; lane 12, empty 
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vector 6 days +thi. B), Western blot analysis of samples in A (same loading order). 
Calculated MW of Tbf1-V5 is 57.6 kDa, Tbf1ΔMyb-V5 is 48.2 kDa. Loading control, 
Cdc2, MW is 34.4 kDa. 
 
4.6 – Discussion 
 
The role of Tbf1 in S. pombe cells remained obscure for many years. Like Laz1, Tbf1 is 
an essential protein that localizes in the nucleus. The same reasoning that was used for 
Laz1 (see section 3.9) can be applied for this protein: Tbf1, being essential, should have 
a non-telomeric role, as telomeric specific proteins are not essential for viability in the 
fission yeast. Upon telomere disruption, survivors with circular chromosomes and one 
single centromere can arise with relative high frequency. However, in Tbf1, no 
survivors were detected. It is possible, and to some extent probable, that Tbf1 has, like 
Laz1, functions related to transcription of groups of genes, as many Myb domain 
proteins exert such functions. Development of conditional mutant and microarray 
analysis will be essential to reveal Tbf1 essential functions. 
The presence of a Myb domain distinguishes this protein, as it is the only DNA-binding 
domain detectable in its sequence. Therefore, it was important to identify the effects 
of truncating the Tbf1 C-terminal region that includes the Myb domain and the last 22 
aminoacids. The truncated form proved to be unviable. This was somehow expected, 
as the deleted domain should be responsible for binding to the DNA. A more 
unexpected observation resulted from the deletion of only the last 22 aminoacids in 
the C-terminus of the protein. This deletion also impairs viability, making it difficult to 
conclude about the importance of the Myb domain in the function of this protein. Still, 
it could be the case that these 22 aminoacids are only necessary for maintaining the 
protein stability and avoiding degradation. A western blot analysis using a diploid 
strain carrying one copy of this truncated and tagged form of the tbf1 gene will be 
helpful to clarify if this is the case.  
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Independently of the relevance of the Myb domain, it was crucial to understand if Tbf1 
has a role in the telomere maintenance. However, conditional strains for Tbf1 were not 
available. Therefore, the telomere effect upon Tbf1 overexpression was tested. It was 
observed that higher levels of the protein cause mild telomere elongation. The reason 
why this elongation occurs is still obscure. It could be the case that Tbf1 directly binds 
to the telomere and partially controls telomere size. However, ChIP experiments could 
not detect significant enrichment of Tbf1 at the telomeres (not shown). Another 
hypothesis is that Tbf1 may be a transcription factor, controlling other protein levels 
that have a telomeric function. One other possibility is that overexpressing Tbf1 leads 
it to bind to places where normally would not, forcing it to compete, for example, with 
Taz1 for the telomere sequences. This last hypothesis is unlikely because, as 
mentioned, using a stronger promoter did not promote further elongation, 
suggesting that competition of binding is not taking place. Furthermore it was 
recently shown by Cockell and colleagues that, upon sporulation, null Tbf1 cells also 
have mild telomere elongation (Cockell, Lo Presti et al. 2009). This data supports the 
idea that Tbf1 has a telomere role, but further studies are necessary to reveal the 
mechanism behind its function.  
In conclusion, the results presented in this chapter revealed a novel function of a Myb 
domain protein, Tbf1, in controlling the telomere length in fission yeast. 
The next chapter will focus on the telomere chromatin structure and the importance of 
two Myb domain proteins, Rap1 and Taz1, to maintain it.   
      
 
 
 
Tbf1 characterization       Laz1 characterization 
134 
 
 
 
 
   Laz1 characterization 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. TELOMERE CHROMATIN STRUCTURE AND 
MYB DOMAIN PROTEINS 
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5.1 – Overview 
 
In the previous two chapters it was shown and discussed the impact that previously 
uncharacterized Myb domain proteins have in crucial events in the cell. It was also 
tested the role that these proteins have on the telomere, with distinct results for Laz1 
and for Tbf1. In this chapter, telomere structure is studied and the profound 
alterations on the telomere architecture upon Myb domain proteins Rap1 and Taz1 
deletion are described.  
Studies in human cell lines describe telomeric chromatin as being unusual 
(Tommerup, Dousmanis et al. 1994). However, this was only observed in shorter 
telomeres, whereas in longer telomeres a normal pattern of the nucleosome ladder 
can be observed after MNase digestion. Recently, it was confirmed that the entire 
mammalian long telomeres are organized in nucleosomes identical in periodicity to 
the ones from the bulk chromatin (Wu and de Lange 2008), dismissing the idea that 
long telomeres might have a “normal”chromatin structure in the majority of their 
length, but an altered chromatin in their very end.   
In S. cerevisiae it was described that the terminal telomeric repeats are organized in a 
non-nucleosome chromatin structure called the telosome, while the subtelomeric 
DNA elements X and Y’ or genes next to telomeres are in nucleosome (Wright, 
Gottschling et al. 1992; Gilson, Laroche et al. 1993). 
Little is known about chromosome structure in S. pombe telomeres. For example, it is 
still not clear whether in telomeres nucleosomes are excluded.  
However, an extensive set of experiments have been performed by several members 
of the Telomere Biology Laboratory, which allowed to establish the telomere 
chromatin pattern and a Taz1 role in forming it (unpublished data). In this chapter it 
will be reviewed the peculiar telomere chromatin structure visible by MNase digestion 
in wt and the alterations that occur in taz1 cells. It will also be shown preliminary 
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original data that shows evidence that Rap1 is needed for the chromatin structure and 
that internal telomere sequences can disrupt the normal nucleosome periodicity. 
It should be noted that some technical difficulties did not allow a perfect visualization 
of the chromatin preparations. Therefore, further experimentation is needed to 
improve the quality of the data.   
 
5.2 – S. pombe telomeres have a specific chromatin structure 
 
In order to study telomere chromatin structure in the fission yeast, chromatin from wt 
strain was isolated and subjected to MNase digestion with increasingly higher 
concentrations of the enzyme for five minutes. A southern blot using a probe 
originated from a fission yeast genomic locus was used as a control, to look at the 
nucleosome ladder that characterizes the bulk of the chromatin. The same membrane 
was reprobed with a telomeric specific probe. As it can be observed in fig. 5.1, the 
typical nucleosomic ladder that arises from digestion of the majority of the chromatin 
can be detected in the control southern blot. However, the same pattern is not 
distinguishable when using the telomeric probe. In fact, even with the presence of 
high concentrations of MNase, mono or dinuclosomes cannot be detected. There are 
at least two bands, one of around 1.1 kb and the other of around 1.4 kb, that seem to 
be protected from digestion (fig. 5.1). This result confirms unpublished data first seen 
by other researchers in this laboratory, and it is evidence that telomeres have a specific 
chromatin structure that resists to MNase digestion.   
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Fig. 5.1 – Wt telomeres show a distinct chromatin structure. Wt cells were grown 
and DNA was isolated and digested with increasing concentration of MNase enzyme, for 
5 minutes. A Southern blot using a bulk genomic probe (for cdc2 gene) was performed 
(A) and the membrane was then washed and reprobed with a telomeric specific probe 
(telo) (B). The typical nucleosome ladder observed in A is not present in B, where 
higher-order structures appear to be resistant to digestion. 
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5.3 – Telomere chromatin structure is altered in taz1-.  
 
Taz1, a TRF1 and TRF2 homologue, is the only protein found so far that binds in vivo to 
the double strand telomeric repeats in S. pombe and is implicated in a wide range of 
functions. These include the regulation of telomere length and telomeric silencing 
(Cooper, Nimmo et al. 1997), telomeric clustering during meiosis (Cooper, Watanabe 
et al. 1998; Nimmo, Pidoux et al. 1998), protection from end to end fusions (Ferreira 
and Cooper 2001) and telomere DNA replication (Miller, Rog et al. 2006). Therefore it 
is an obvious candidate to test if it also influences telomeric higher order architecture. 
Indeed, in the Telomere Biology Laboratory it was found that Taz1 is essential for the 
maintenance of the telomere chromatin structure. Here, we have repeated this 
experiment, and it is possible to see that the two distinctive bands of around 1.1 kb 
and 1.4 are no longer present, and a big smear is visible, indicating that the enzyme is 
cutting pieces of a wide range of sizes, and that structures of a constant size in all cells 
are not present in this strain (fig. 5.2).     
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Fig. 5.2 – taz1- telomeres loose the distinct chromatin structure. taz1- cells were 
grown and DNA was isolated and digested with increasing concentration of MNase 
enzyme, for 5 minutes. (A) A Southern blot using a bulk genomic probe (for cdc2 gene) 
was performed and the nucleosome ladder was observed. (B) The membrane was then 
washed and reprobed with a telomeric specific probe (telo), but the telomere structure 
observed in wt (fig.5.1) is absent, and only a smear can be distinguished.  
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5.4 – Telomere chromatin structure is altered in rap1-. 
 
Rap1 protein binds to telomeres via Taz1 and also negatively regulates telomere 
length and is involved in telomere silencing (Kanoh and Ishikawa 2001). However, 
while it regulates telomerase-dependent telomere replication, it does not seem to 
have a function in semi-conservative telomere DNA replication (Miller, Rog et al. 
2006). The similarities and differences of the telomere phenotype in taz1- and rap1- 
mutants were therefore explored. By looking at the telomere chromatin structure in 
the absence of Rap1, we are able to test if normal replication of the telomeres 
depends on normal higher order architecture at the telomeres. Interestingly, the 
chromatin structure in rap1- telomeres appears to resemble that observed at taz1- 
telomeres. The absence of the wt protected structures in both mutant strains tested 
implies that normal telomere replication does not depend on the typical telomere 
chromatin structure.       
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Fig. 5.3 – rap1- telomeres have the same telomere chromatin structure as taz1-
. rap1- cells were grown and DNA was isolated and digested with increasing 
concentration of MNase enzyme, for 5 minutes. (A) A Southern blot using a bulk 
genomic probe (for cdc2 gene) was performed and the nucleosome ladder was 
observed. (B) The membrane was then washed and reprobed with a telomeric specific 
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probe (telo), but the telomere structure observed in wt (fig.5.1) is, like in taz1-, absent, 
and only a smear can be distinguished.  
 
5.5 – Chromatin structure is altered in the presence of telomere 
repeats 
 
The bands that characterize wt chromatin structure are dependent on Taz1 and on 
Rap1. However it is still not understood why wt telomeres do not show the normal 
nucleosome pattern. One hypothesis is that telomere DNA sequence is not organized 
in nucleosomes. Another possibility is that the described peculiar organization is 
originated from folding of the end, because of the presence of a 3’overhang. To test 
these theories we utilized a strain that does not have telomerase and therefore has 
survived with circular chromosomes. At an internal site in one of the circular 
chromosomes, a telomere sequence, here referred as the internal telomere, was 
inserted. MNase digestion of its DNA shows that the telomere sequence itself is 
sufficient to alter the nucleosome ladder, which cannot be distinguished when using a 
telomeric probe, but is present when using the control cdc2 probe (Fig. 5.4). 
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Fig. 5.4 – Internal telomeres also do not have regular nucleosome ladder. trt1- 
cells that have circular chromosomes upon losing telomeres, but in which it was 
inserted an internal telomere sequence were used. DNA was isolated and digested with 
increasing concentration of MNase enzyme, for 5 minutes. (A) A Southern blot using a 
bulk genomic probe (for cdc2 gene) was performed and the nucleosome ladder was 
observed. (B) The membrane was then washed and reprobed with a telomeric specific 
probe (telo), but the telomere structure observed in wt (fig.5.1) is absent, and only a 
smear can be distinguished.  
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5.6 – Discussion 
 
Telomeres are necessary for maintaining genome integrity. Here it is shown that S. 
pombe telomeres have a chromatin structure quite distinct from the rest of the bulk of 
the genome. Upon MNase digestion, wt telomeres resist to the enzyme action, and at 
least two structures can be reproducibly identified: one of around 1.1 kb and the other 
of 1.4 kb. These structures represent undigested material. Normally MNase cuts the 
DNA in the linker region of the nucleosomes. If the telomere is organized as 
nucleosomes, high concentrations of the enzyme should isolate mono and 
dinucleosomes that can be seen in a southern as bands of little less than 150 bp and 
300 bp, respectively. There are several hypotheses that can explain why nucleosomes 
cannot be isolated on the telomeres by MNase digestion. One possible explanation is 
that nucleosomes are masked by higher order structures. For example, it is possible 
that folding of the telomere and/or the high concentration of proteins binding to the 
DNA is protecting the linker regions between two adjacent nucleosomes. Other 
hypothetical justification is that fission yeast telomeres are not organized in normal 
nucleosomes, and other proteins are in charge of maintaining the DNA organization 
and compaction. It was described in Drosophila that other proteins rather than the 
typical histones are able to control chromatin structure, replacing the nucleosome 
(Lehmann 2004). Also, in budding yeast centromeres, it was recently proposed that 
Smc3 protein is able to replace H2A-H2B dimer, forming a hexameric nucleosome 
together with CENP-A and histone H4 (Mizuguchi, Xiao et al. 2007). It is possible that 
similar mechanisms of maintaining structure of the chromatin take place at the fission 
yeast telomere, leading to the atypical pattern observed after MNase digestion.  
It was also shown here that telomeric sequences are enough to disrupt the normal 
nucleosome ladder observed upon MNase digestion, which indicates that it is not 
solely the presence of an end and of putative loops that dictate the typical telomere 
structure in the fission yeast. Future work should focus on the detail of the telomere 
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organization, in order to determine whether histones and nucleosomes are really 
present in S. pombe telomeres. Also, it will be interesting to look at telomere structure 
during the cell cycle, as one could expect that events like replication and transcription 
might be anticipated by or provoke alterations of the chromatin structure. 
Understanding the specificities of the telomere chromatin in the different organisms 
will be essential to comprehend one of the fundamental events of the cell, the 
protection of the chromosome. Furthermore, it should unravel new players with a role 
in the telomere physiology, and introduce new targets for cancer therapies.      
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6. CONCLUSION AND FUTURE DIRECTIONS 
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The work presented on this thesis allows a better understanding of the role of Myb 
domain proteins in the maintenance of the chromosome integrity in fission yeast.  
In particular, it was shown here that essential Laz1 protein binds to many promoters, 
many of them having TTAGGG-like repeats. Microarray data suggests that this protein 
is a transcriptional regulator of groups of genes. However, it remains to be elucidated 
which mechanisms allow this protein to control only a subset of its binding targets. 
Probably, other proteins are also involved in this regulation. The results pointed to a 
possible physical connection between Laz1 and Ams2. Thus, future work addressing 
this and other putative Laz1 interactions will help to clarify the pathways that allow, for 
example, temporal regulation of histone transcription.  
 Also, it remains to be elucidated why Laz1 was found to bind to the telomere protein 
Pot1 in a yeast-two-hybrid screen. Therefore a deeper analysis into this interaction is 
needed. Laz1 was not found binding at the telomeres. However, it must be noted that 
this protein is present in the cell in a very low abundance and it is difficult to detect. 
Furthermore, it is possible that it only binds to the telomere in a cell cycle dependent 
manner. In addition, it is also probable that Pot1 has other functions outside the 
telomere, and that the interaction between the two proteins represents processes that 
happen during telomere-unrelated processes. Other less attractive hypothesis is that 
the interaction found is a mere artefact from the yeast-two-hybrid screen.   
It should be noted that Laz1 is a meiotic upregulated gene (mug), and that during 
meiosis both the telomeres and centromeres are subjected to changes that do not 
happen during mitosis. Therefore, Laz1 protein function during meiosis should be 
addressed and interactors might be easier to find in this stage, as protein levels are 
much higher during this division. 
Besides controlling histone transcription, it was also shown here that Laz1 controls 
histone H3 clipping. This task is carried out probably indirectly, through an Isp6 serine-
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protease dependent mechanism. Preliminary data from the Telomere Biology 
Laboratory seems to corroborate that, as Isp6 depleted cells, do not seem to induce 
H3 clipping (Pierre-Marie Dehe, personal communication). However, these cells do not 
arrest so efficiently upon starvation. Therefore, it will be important to validate these 
results, by overexpressing Isp6 in laz1-1 mutant. If Isp6 is the protein that clips histone 
H3, it should rescue the clipping.    
Other set of experiments carried out revealed that Laz1 participates in the CENP-A 
loading at the centromere central domain. This fact can be explained by interference 
from its histone transcription role. In fact, a precise balance of free histones is needed 
for CENP-A incorporation at the centromeres. However it remains to be tested a more 
direct role of Laz1 in CENP-A loading. It will be important to test, for example, 
interactions of this protein with known CENP-A loading factors, and which of them, if 
any, do not localize properly in the laz1-1 mutant.  
Another important information exposed in this thesis is based on Laz1 binding to the 
exact same chromosome terminal sequences that are able to originate 
neocentromeres when the normal centromere is deleted. To test if Laz1 is involved in 
neocentromere formation it will be crucial to test whether this phenomenon occurs in 
Laz1 mutants that do not bind DNA, by deleting the centromeres in those cells. laz1-1 
mutants might be good candidates for this experiment. However, binding of the 
normal protein in these terminal repeats is independent of TTAGGG repeats, as these 
are inexistent in the binding region. Therefore it needs to be tested first if laz1-1 
mutant has lost its ability to bind in those terminal regions. 
 
Tbf1, the other Myb domain protein characterized here, is also essential and localizes 
to the nucleus. It was shown here that its C-terminal part, which includes the Myb 
domain, is essential for viability. In this document it was shown that Tbf1 
overexpression leads to telomere elongation, fact that suggests that this protein has a 
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telomere-associated role. Future work should focus on discovering this function. For 
that, it will be crucial to develop conditional tbf1 alleles, which will allow to perform 
loss of function analysis in growing cells. Analysis of its DNA binding ability, by in vitro 
or in vivo studies, will also provide valuable information that will allow understanding 
if the protein binds directly to the telomere DNA or is, for example, a transcription 
factor that controls expression of telomere proteins. 
 
Finally, it was also shown how the typical telomere chromatin, made of MNase 
protected structures, is altered upon deletion of the Myb domain proteins Rap1 or 
Taz1. Importantly, an internal telomere sequence is enough to alter the normal 
nucleosome ladder, showing that is not solely the presence of an end that directs the 
chromatin structure normally observed at the telomeres. However, many questions 
remain unanswered. One of the crucial issues is related with the presence and 
composition of nucleosomes in the telomere. In fact, it is not known if nucleosomes 
are present or are replaced by any other specific proteins. And even if a telomere 
nucleosome can be isolated, it will be important to investigate if the normal histone 
octamer is present, or if any other protein is able to replace a histone inside the 
nucleosome, similarly to what happens in budding yeast centromere.  
 
Together, the findings presented in this thesis not only provide novel insights on the 
role of several fission yeast Myb domain proteins in fundamental processes such as 
histone level regulation, centromere integrity maintenance and telomere structure 
preservation, but also open new perspectives for future research in these subjects.
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   Abbreviations 
 
µ Micro 
5-FOA 5-Fluoroorotic acid 
Ade Adenine 
ADP Adenosine di-phosphate 
ALT Alternative lengthening of telomeres 
Ams2 CENP-A multicopy surpressor 2 
Arg Arginine 
ATM Ataxia Telangiectasia mutated (Tel1 in yeast) 
ATR ATM and Rad3 related 
Bp Base pairs 
BSA Bovin serum albumin 
CAF1 Chromatin assembly factor-1 
cDNA Complementary DNA 
Cen Centromere 
CENP-A Centromere protein A 
ChIP Chromatin IP 
Clr4 Cryptic loci regulator 4 
Cnt Central core sequence 
DAPI 4,6-diamidino-2-phenylindole 
dATP Deoxyadenine triphosphate 
dCTP Deoxycytidine triphosphate 
ddH2O Deionised water 
DEPC Diethyl pyrocarbonate 
dGTP Deoxyguanine triphosphate 
DMSO Dimethyl sulfoxide 
dNTP Deoxyribonucleotide triphosphate 
DNA Deoxyribonucleic acid 
DSB Double strand break 
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dsDNA Double-stranded DNA 
dsRNA Double-stranded RNA 
DTT  Dihiothreitol 
ECL Enhanced chemiluminescence 
E. coli  Escherichia coli 
EDTA acid Ethylene-dinitrilo tetraacetic 
EGTA Ethylene glycol tetraacetic acid 
Est Ever shorter telomere 
 
FACS  Fluorescence-activated cell sorter 
FITC  Fluorescein isothiocyanate 
FOA 5- fluoroorotic acid 
g Gravity 
g Gram 
GFP  Green fluorescent protein 
h  Hour 
H  Histone 
H3K9 Histone H3 lysine 9 
HEPES acid 4-(2-hydroxyethyl)-1- piperazineethanesulfonic 
Hir Histone cell cycle regulation 
HP1  Heterochromatin protein 1 
HU Hidroxyurea 
IF  Immunofluorescence 
imr Inner most repeats 
IP Immunoprecipitation 
K  Lysine 
Kb  Kilobase pair 
kDa  KiloDalton 
l Litre 
LINE  Long interspersed element 
LTRs Long terminal repeats 
m  Milli 
M Molar 
Mb  Mega base pair 
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min  Minute 
Mis Minichromosome instability 
 
MNase Micrococcal Nuclease 
mRNA Messenger RNA 
N Nitrogen 
n Nano 
NP-40  Nonidet P-40 
OD Optical density 
ORF  Open reading frame 
otr  Outer repeats 
PBS  Phosphate buffered saline 
PCR  Polymerase chain reaction 
PEG  Polyethylene glycol 
PEM PIPES, EDTA and magnesium chloride solution 
PEMS PEM with sorbitol 
PEV  Position effect variegation 
PI  Propidium iodide 
PIPES Piperrazine-N,N'-bis(2-ethanesulfonic acid) 
PMSF Phenylmethylsulphonyl fluoride 
qPCR  Real-time quantitative PCR 
rDNA Ribosomal DNA 
RITS  RNA induced initiation of transcriptional silencing 
RNA  Ribonucleic acid 
RNAi  RNA interference 
RNAse Ribonuclease 
rpm  Rotations per minute 
RT  Room temperature 
RT-PCR  Reverse transcription PCR 
S. cerevisiae  Saccharomyces cerevisiae, budding yeast 
S. pombe Schizosaccharomyces pombe, fission yeast 
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
 
 
Sim  Silencing in the middle 
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SEM Standard error of the mean  
siRNA Small interfering RNA 
Swi6 Trans-acting switch locus 6 
t-loop Telomere loop 
TCA Trichloroacetic acid 
TE Tris-EDTA solution 
TPE Telomere position effect 
Tris Tris(hydroxymethyl)aminomethane 
TSA Tricostatin A 
UV Ultraviolet 
ts Temperature sensitive 
v Volume 
w Weight 
YES Yeast extract supplemented medium 
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APPENDIX 1 
 
As mentioned in this thesis (see Introduction), Laz1 was shown to bind with high 
affinity to TTAGGG repeats in vitro. 
In order to establish putative targets for Laz1 in vivo binding we searched the genome 
and looked for sequences containing three TTAGGG tandem repeats. This was done 
using BLASTN (DNA vs DNA), available online at 
http://www.genedb.org/genedb/pombe/blast.jsp 
The search parameters used were default, and. The maps of the regions of the 
sequences retrieved were retrieved in www.genedb.org. The maps include 2000 base 
pairs upstream and downstream the sequence containing similarities to the 
(TTAGGG)3. The sequence of homology is always exactly on the centre of the map, but 
it is not represented on it, as it is quite small when compared to the total size of the 
map (approximately 15 bp comparing to around 4000 bp). The horizontal lines in each 
figure represent the coordinates in the genome.  
Blast results indicate 32 sites of homology, but only 29 of them are unique (3 are 
repeated).  
Table A2.I, which can be consulted in Appendix 2, is based on the maps shown in this 
appendix. 
Here are the results retrieved from the BLASTN programme: 
 
 
BLASTN 2.0MP-WashU [04-May-2006] [linux26-x64-I32LPF64 2006-05-10T17:22:28] 
 
Copyright (C) 1996-2006 Washington University, Saint Louis, Missouri USA. 
All Rights Reserved. 
 
Reference:  Gish, W. (1996-2006) http://blast.wustl.edu 
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Notice:  this program and its default parameter settings are optimized to 
find nearly identical sequences rapidly.  To identify weak protein 
similarities encoded in nucleic acid, use BLASTX, TBLASTN or TBLASTX. 
 
Query=  UNKNOWN-QUERY 
        (18 letters) 
 
Database:  GeneDB_Spombe_Contigs 
           5 sequences; 12,611,379 total letters. 
Searching....10....20....30....40....50....60....70....80....90....100% done 
 
                                                                     Smallest 
                                                                       Sum 
                                                              High  
Probability 
Sequences producing High-scoring Segment Pairs:              Score  P(N)      
N 
 
chromosome1 [~/pombe/curated/chr1/chromosome1.contig]           66  0.9999    
1 
chromosome2 [~/pombe/curated/chr2/chromosome2.contig]           65  0.99999   
1 
chromosome3 [~/pombe/curated/chr3/chromosome3.contig]           62  1.00000   
1 
 
 
>chromosome1 [~/pombe/curated/chr1/chromosome1.contig] 
        Length = 5,579,133 
 
  Plus Strand HSPs: 
 
1 
 Score = 66 (16.0 bits), Expect = 9.0, P = 0.9999  Identities = 14/15 (93%), 
Positives = 14/15 (93%), Strand = Plus / Plus 
 
Query:       1 TTAGGGTTAGGGTTA 15 
               | ||||||||||||| 
Sbjct: 3850929 TCAGGGTTAGGGTTA 3850943 
 
 
 
2 
 Score = 65 (15.8 bits), Expect = 9.0, P = 0.9999  Identities = 13/13 (100%), 
Positives = 13/13 (100%), Strand = Plus / Plus 
 
Query:       2 TAGGGTTAGGGTT 14 
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               ||||||||||||| 
Sbjct: 3394812 TAGGGTTAGGGTT 3394824 
 
 
 
3 
 Score = 62 (15.4 bits), Expect = 9.0, P = 0.9999  Identities = 14/16 (87%), 
Positives = 14/16 (87%), Strand = Plus / Plus 
 
Query:       3 AGGGTTAGGGTTAGGG 18 
               |||||||||||  ||| 
Sbjct: 2544781 AGGGTTAGGGTACGGG 2544796 
 
 
 
4 
 Score = 61 (15.2 bits), Expect = 9.0, P = 0.9999  Identities = 13/14 (92%), 
Positives = 13/14 (92%), Strand = Plus / Plus 
 
Query:       1 TTAGGGTTAGGGTT 14 
               | |||||||||||| 
Sbjct: 4142407 TAAGGGTTAGGGTT 4142420 
 
 
 
5 
 Score = 60 (15.1 bits), Expect = 9.0, P = 0.9999  Identities = 12/12 (100%), 
Positives = 12/12 (100%), Strand = Plus / Plus 
 
Query:       3 AGGGTTAGGGTT 14 
               |||||||||||| 
Sbjct: 4053371 AGGGTTAGGGTT 4053382 
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6 
 Score = 55 (14.3 bits), Expect = 9.0, P = 0.9999  Identities = 11/11 (100%), 
Positives = 11/11 (100%), Strand = Plus / Plus 
 
Query:       8 TAGGGTTAGGG 18 
               ||||||||||| 
Sbjct: 3394812 TAGGGTTAGGG 3394822 
 
 
 
7 
 Score = 55 (14.3 bits), Expect = 9.0, P = 0.9999  Identities = 11/11 (100%), 
Positives = 11/11 (100%), Strand = Plus / Plus 
 
Query:       5 GGTTAGGGTTA 15 
               ||||||||||| 
Sbjct: 1234381 GGTTAGGGTTA 1234391 
 
 
 
  Minus Strand HSPs: 
8 
 Score = 62 (15.4 bits), Expect = 9.0, P = 0.9999  Identities = 14/16 (87%), 
Positives = 14/16 (87%), Strand = Minus / Plus 
 
Query:      18 CCCTAACCCTAACCCT 3 
               ||  |||||||||||| 
Sbjct: 3891196 CCAAAACCCTAACCCT 3891211 
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9 
 Score = 62 (15.4 bits), Expect = 9.0, P = 0.9999  Identities = 14/16 (87%), 
Positives = 14/16 (87%), Strand = Minus / Plus 
 
Query:      18 CCCTAACCCTAACCCT 3 
               | | |||||||||||| 
Sbjct: 2298022 CACCAACCCTAACCCT 2298037 
 
 
 
10 
 Score = 61 (15.2 bits), Expect = 9.0, P = 0.9999  Identities = 13/14 (92%), 
Positives = 13/14 (92%), Strand = Minus / Plus 
 
Query:      14 AACCCTAACCCTAA 1 
               |||||||||||| | 
Sbjct: 4415423 AACCCTAACCCTGA 4415436 
 
 
 
11 
 Score = 61 (15.2 bits), Expect = 9.0, P = 0.9999  Identities = 13/14 (92%), 
Positives = 13/14 (92%), Strand = Minus / Plus 
 
Query:      14 AACCCTAACCCTAA 1 
               |||||||||||| | 
Sbjct: 2106957 AACCCTAACCCTGA 2106970 
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12 
 Score = 60 (15.1 bits), Expect = 9.0, P = 0.9999  Identities = 12/12 (100%), 
Positives = 12/12 (100%), Strand = Minus / Plus 
 
Query:      13 ACCCTAACCCTA 2 
               |||||||||||| 
Sbjct: 5525156 ACCCTAACCCTA 5525167 
 
 
 
13 
 Score = 60 (15.1 bits), Expect = 9.0, P = 0.9999  Identities = 12/12 (100%), 
Positives = 12/12 (100%), Strand = Minus / Plus 
 
Query:      14 AACCCTAACCCT 3 
               |||||||||||| 
Sbjct: 4699652 AACCCTAACCCT 4699663 
 
 
 
14 
 Score = 60 (15.1 bits), Expect = 9.0, P = 0.9999  Identities = 12/12 (100%), 
Positives = 12/12 (100%), Strand = Minus / Plus 
 
Query:      14 AACCCTAACCCT 3 
               |||||||||||| 
Sbjct: 4009974 AACCCTAACCCT 4009985 
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15 
 Score = 60 (15.1 bits), Expect = 9.0, P = 0.9999  Identities = 12/12 (100%), 
Positives = 12/12 (100%), Strand = Minus / Plus 
 
Query:      14 AACCCTAACCCT 3 
               |||||||||||| 
Sbjct: 2910307 AACCCTAACCCT 2910318 
 
 
 
16 
 Score = 55 (14.3 bits), Expect = 9.0, P = 0.9999  Identities = 11/11 (100%), 
Positives = 11/11 (100%), Strand = Minus / Plus 
 
Query:      18 CCCTAACCCTA 8 
               ||||||||||| 
Sbjct: 5525157 CCCTAACCCTA 5525167 
 
 
 
17 
 Score = 55 (14.3 bits), Expect = 9.0, P = 0.9999  Identities = 11/11 (100%), 
Positives = 11/11 (100%), Strand = Minus / Plus 
 
Query:     13 ACCCTAACCCT 3 
              ||||||||||| 
Sbjct: 997680 ACCCTAACCCT 997690 
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>chromosome2 [~/pombe/curated/chr2/chromosome2.contig] 
        Length = 4,539,804 
 
  Plus Strand HSPs: 
18 
 Score = 62 (15.4 bits), Expect = 11., P = 0.99999  Identities = 14/16 (87%), 
Positives = 14/16 (87%), Strand = Plus / Plus 
 
Query:       3 AGGGTTAGGGTTAGGG 18 
               |||||||||||| | | 
Sbjct: 3236806 AGGGTTAGGGTTTGAG 3236821 
 
 
 
19 
 Score = 61 (15.2 bits), Expect = 11., P = 0.99999  Identities = 13/14 (92%), 
Positives = 13/14 (92%), Strand = Plus / Plus 
 
Query:       5 GGTTAGGGTTAGGG 18 
               ||||||||||| || 
Sbjct: 2339307 GGTTAGGGTTATGG 2339320 
 
 
 
20 
 Score = 61 (15.2 bits), Expect = 11., P = 0.99999  Identities = 13/14 (92%), 
Positives = 13/14 (92%), Strand = Plus / Plus 
 
Query:       1 TTAGGGTTAGGGTT 14 
               | |||||||||||| 
Sbjct: 1365058 TCAGGGTTAGGGTT 1365071 
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21 
 Score = 60 (15.1 bits), Expect = 11., P = 0.99999  Identities = 12/12 
(100%), Positives = 12/12 (100%), Strand = Plus / Plus 
 
Query:       3 AGGGTTAGGGTT 14 
               |||||||||||| 
Sbjct: 1307627 AGGGTTAGGGTT 1307638 
 
 
 
  Minus Strand HSPs: 
22 
 Score = 65 (15.8 bits), Expect = 11., P = 0.99999  Identities = 13/13 
(100%), Positives = 13/13 (100%), Strand = Minus / Plus 
 
Query:     14 AACCCTAACCCTA 2 
              ||||||||||||| 
Sbjct: 892097 AACCCTAACCCTA 892109 
 
 
 
23 
 Score = 61 (15.2 bits), Expect = 11., P = 0.99999  Identities = 13/14 (92%), 
Positives = 13/14 (92%), Strand = Minus / Plus 
 
Query:      14 AACCCTAACCCTAA 1 
               |||||||||||| | 
Sbjct: 4387420 AACCCTAACCCTGA 4387433 
 
Appendix 1 
169 
 
 
 
24 
 Score = 60 (15.1 bits), Expect = 11., P = 0.99999  Identities = 12/12 
(100%), Positives = 12/12 (100%), Strand = Minus / Plus 
 
Query:      14 AACCCTAACCCT 3 
               |||||||||||| 
Sbjct: 3529627 AACCCTAACCCT 3529638 
 
 
 
25 
 Score = 60 (15.1 bits), Expect = 11., P = 0.99999  Identities = 14/15 (93%), 
Positives = 14/15 (93%), Strand = Minus / Plus 
 
Query:     15 TAACCCTAACCCTAA 1 
              ||||||||||| ||| 
Sbjct: 624112 TAACCCTAACC-TAA 624125 
 
 
 
26 
 Score = 58 (14.8 bits), Expect = 11., P = 0.99999  Identities = 14/17 (82%), 
Positives = 14/17 (82%), Strand = Minus / Plus 
 
Query:      17 CCTAACCCTAACCCTAA 1 
               |||||||||||   ||| 
Sbjct: 1851103 CCTAACCCTAAGGATAA 1851119 
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27 
 Score = 56 (14.5 bits), Expect = 11., P = 0.99999  Identities = 12/13 (92%), 
Positives = 12/13 (92%), Strand = Minus / Plus 
 
Query:      16 CTAACCCTAACCC 4 
               | ||||||||||| 
Sbjct: 2626000 CAAACCCTAACCC 2626012 
 
 
 
28 
 Score = 55 (14.3 bits), Expect = 11., P = 0.99999  Identities = 11/11 
(100%), Positives = 11/11 (100%), Strand = Minus / Plus 
 
Query:      14 AACCCTAACCC 4 
               ||||||||||| 
Sbjct: 4475843 AACCCTAACCC 4475853 
 
 
 
29 
 Score = 55 (14.3 bits), Expect = 11., P = 0.99999  Identities = 11/11 
(100%), Positives = 11/11 (100%), Strand = Minus / Plus 
 
Query:     18 CCCTAACCCTA 8 
              ||||||||||| 
Sbjct: 892099 CCCTAACCCTA 892109 
 
 
 
>chromosome3 [~/pombe/curated/chr3/chromosome3.contig] 
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        Length = 2,452,883 
 
  Plus Strand HSPs: 
30 
 Score = 62 (15.4 bits), Expect = 21., P = 1.00000  Identities = 14/16 (87%), 
Positives = 14/16 (87%), Strand = Plus / Plus 
 
Query:       3 AGGGTTAGGGTTAGGG 18 
               ||||||||||||  || 
Sbjct: 2056968 AGGGTTAGGGTTTTGG 2056983 
 
 
 
31 
 Score = 60 (15.1 bits), Expect = 21., P = 1.00000  Identities = 12/12 
(100%), Positives = 12/12 (100%), Strand = Plus / Plus 
 
Query:       3 AGGGTTAGGGTT 14 
               |||||||||||| 
Sbjct: 1412300 AGGGTTAGGGTT 1412311 
 
 
 
  Minus Strand HSPs: 
32 
 Score = 55 (14.3 bits), Expect = 21., P = 1.00000  Identities = 11/11 
(100%), Positives = 11/11 (100%), Strand = Minus / Plus 
 
Query:     15 TAACCCTAACC 5 
              ||||||||||| 
Sbjct: 618027 TAACCCTAACC 618037 
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Parameters: 
  cpus=1 
  warnings 
  S=10 
  B=100 
  V=100 
 
  ctxfactor=2.00 
  E=2.19101e+06 
 
  Query                        -----  As Used  -----    -----  Computed  ---- 
  Strand MatID Matrix name     Lambda    K       H      Lambda    K       H 
   +1      0   +5,-4           0.192   0.182   0.357    same    same    same 
               Q=10,R=10       0.104   0.0151  0.0600    n/a     n/a     n/a 
   -1      0   +5,-4           0.192   0.182   0.357    same    same    same 
               Q=10,R=10       0.104   0.0151  0.0600    n/a     n/a     n/a 
 
  Query 
  Strand MatID  Length  Eff.Length     E    S  W   T   X   E2     S2 
   +1      0       18        18   1.1e+06  10 11 n/a  73  6.7e+02 10 
                                                     134  85.     10 
   -1      0       18        18   1.1e+06  10 11 n/a  73  6.7e+02 10 
                                                     134  85.     10 
 
Statistics: 
 
  Database:  /data/blastdb/yeastpub/GeneDB_Spombe_Contigs 
   Title:  GeneDB_Spombe_Contigs 
   Posted:  10:39:12 AM BST Jul 16, 2008 
   Created:  10:39:12 AM BST Jul 16, 2008 
   Format:  XDF-1 
   # of letters in database:  12,611,379 
   # of sequences in database:  5 
   # of database sequences satisfying E:  3 
  No. of states in DFA:  13 (26 KB) 
  Total size of DFA:  27 KB (2051 KB) 
  Time to generate neighborhood:  0.00u 0.00s 0.00t   Elapsed:  00:00:00 
  No. of threads or processors used:  1 
  Search cpu time:  0.00u 0.01s 0.01t   Elapsed:  00:00:00 
  Total cpu time:  0.00u 0.01s 0.01t   Elapsed:  00:00:00 
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APPENDIX 2  
 
A bioinformatic analysis was carried on, aiming of finding sequences similar to three 
TTAGGG tandem repeats in the fission yeast genome. BLAST search returned 29 
different sequences that were shown in Appendix 1. It was observed that 50 ORFs 
localized less than 2000 bp upstream or downstream the recognised sequences. These 
50 ORFs and their products/description are listed below:   
 
 
ppc89 spindle pole body protein Ppc89 
SPAC959.04c mannosyltransferase (predicted)     
snoU17 small nucleolar RNA U17 
isp6 vacuolar serine protease Isp6 
tif51 translation elongation factor eIF5A (predicted)   
hta2 histone H2A beta 
SPAC10F6.14c ABC1 kinase family protein 
mrp1  
snoZ16 small nucleolar RNA Z16 (predicted) 
SPAC10F6.15 S. pombe specific UPF0300 family protein 1 
hsp90 Hsp90 chaperone 
ssa1 heat shock protein Ssa1 (predicted)     
SPAC13G7.03 up-frameshift suppressor 3 family protein (predicted)   
tbp1 TATA-binding protein (TBP)     
SPAC30.10c cytoplasmic cysteine-tRNA ligase Crs1 (predicted)   
SPAC631.02 bromodomain protein   
SPNCRNA.284 non-coding RNA (predicted)     
hhf1 4.1 histone H4 h4.1  
hht1 3.1 histone H3 h3.1     
SPAC27E2.11c sequence orphan     
SPAC27E2.12 sequence orphan  
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prl163  
eft201 translation elongation factor 2 (EF-2) Eft2,A     
SPNCRNA.209 non-coding RNA (predicted)  
SPAC513.02 phosphoglycerate mutase family  
SPNCRNA.284 non-coding RNA (predicted) 
slp1 sleepy homolog Slp1 
SPNCRNA.163 non-coding RNA (predicted)     
eng1 endo-1,3-beta-glucanase Eng1     
SPBC19F8.04c nuclease     
SPBC19F8.05 sequence orphan  
SPBC24C6.09c phosphoketolase family protein (predicted)   
hhf2 histone H4 h4.2  
hht2 histone H3 h3.2  
SPBC30B4.03c adhesion defective protein     
erg1 squalene monooxygenase Erg1 (predicted)     
spi1 Ran GTPase Spi1 
uap2 U2 snRNP-associated protein Uap2  
hht3 histone H3 h3.3   
hhf3 histone H4 h4.3   
SPNCRNA.422 non-coding RNA (predicted) 
rpl1601 60S ribosomal protein L13/L16  
mot1 TATA-binding protein associated factor Mot1  
ppk30 Ark1/Prk1 family protein kinase Ppk30     
SPBPB2B2.07c S. pombe specific DUF999 protein family 7  
SPBPB2B2.08 conserved fungal protein  
ssa2  heat shock protein Ssa2 
hta1 histone H2A alpha     
htb1 histone H2B alpha Htb1   
snoU14 small nucleolar RNA U14  
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Putative target genes after Laz1 ChIP-chip and laz1-1 expression microarrays were categorized into functional groups regarding the 
biological process or cellular component contexts. This was done using the bioinformatic tools available in 
http://amigo.geneontology.org 
 
 
Table A3.I – GO (gene ontology) biological process and cellular component terms enriched in the list of genes identified as having 
Laz1 binding at their promoter (36°C). 
Biological Process - GO Term Aspect P-value Sample frequency Background frequency Genes 
GO:0046164 alcohol catabolic process  P  1.83e-02  6/85 (7.1%)  36/5270 (0.7%)  SPAC9E9.09c eno101 zwf1 tdh1 tpi1 gpm1  
GO:0006007 glucose catabolic process  P  3.04e-02  5/85 (5.9%)  24/5270 (0.5%)  eno101 zwf1 tdh1 tpi1 gpm1  
GO:0019320 hexose catabolic process  P  3.04e-02  5/85 (5.9%)  24/5270 (0.5%)  eno101 zwf1 tdh1 tpi1 gpm1  
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GO:0006096 glycolysis  P  3.78e-02  4/85 (4.7%)  13/5270 (0.2%)  eno101 tdh1 tpi1 gpm1  
 
 
 
Cellular Component - GO Term Aspect P-value Sample frequency Background frequency Genes 
GO:0000788 nuclear nucleosome  C  8.66e-04  4/85 (4.7%)  6/5270 (0.1%)  hht1 hht3 hhf3 hhf1  
GO:0000786 nucleosome  C  2.00e-03  4/85 (4.7%)  7/5270 (0.1%)  hht1 hht3 hhf3 hhf1  
 
Database filter(s): GeneDB_Spombe. The p-value cutoff was: 0.05  The minimum number of gene products: 2.  
Appendix 3 
177 
 
Genes that had altered levels (more than 2 fold difference) of transcription in laz1-1 when comparing to wt, were categorized into functional 
groups regarding the biological process or cellular component contexts. This was done using the bioinformatic tools available in 
http://amigo.geneontology.org 
 
Table A3.II – GO (gene ontology) biological process and cellular component terms enriched in the list of genes downregulated more than 2 
fold at 36°C. 
Biological Repeats - GO Term Aspect P-value Sample frequency Background frequency Genes 
GO:0033212 iron assimilation  P  1.18e-04  4/38 (10.5%)  9/5213 (0.2%)  fip1 str3 str1 frp1  
GO:0055072 iron ion homeostasis  P  7.68e-03  4/38 (10.5%)  23/5213 (0.4%)  fip1 str3 str1 frp1  
GO:0006879 cellular iron ion homeostasis  P  7.68e-03  4/38 (10.5%)  23/5213 (0.4%)  fip1 str3 str1 frp1  
Back to top  
Cellular component - GO Term Aspect P-value Sample frequency Background frequency Genes 
GO:0000788 nuclear nucleosome  C  1.42e-05  4/38 (10.5%)  6/5213 (0.1%)  hhf1 hht1 hht3 hhf3  
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Cellular component - GO Term Aspect P-value Sample frequency Background frequency Genes 
GO:0000786 nucleosome  C  3.30e-05  4/38 (10.5%)  7/5213 (0.1%)  hhf1 hht1 hht3 hhf3  
 
Database filter(s): GeneDB_Spombe The p-value cutoff was: 0.01 The minimum number of gene products: 2  
 
 
 
Table A3.III – GO (gene ontology) biological process and molecular function terms enriched in the list of genes upregulated more than 2 fold 
at 36°C 
Biological Process - 
GO Term 
Aspect P-
value 
Sample 
frequency 
Background 
frequency 
Genes 
GO:0033554 cellular 
response to stress  
P  1.54e-
34  
91/184 
(49.5%)  
625/5213 
(12.0%)  
bfr1 SPAC513.06c SPAC4D7.02c tps1 SPBC1105.13c SPCC338.06c gld1 SPBC4F6.17c 
SPAC11D3.01c mug35 rhp42 SPBC21C3.19 SPCC569.05c SPAC19G12.09 SPCC1281.07c 
SPAC22E12.03c SPAC23D3.05c SPBC725.03 srx1 mug182 SPAPB1A11.03 SPAC139.05 
pol4 plr1 SPAC11D3.13 nab3 SPCC663.08c ntp1 SPAC27D7.09c SPAC1F8.04c 
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Biological Process - 
GO Term 
Aspect P-
value 
Sample 
frequency 
Background 
frequency 
Genes 
SPAPJ691.02 SPCC1235.01 SPBC16D10.08c SPBC1289.14 SPAC513.07 psi1 SPCC576.17c 
SPCC338.12 SPAC2E1P3.01 atf31 etr1 SPBC215.11c SPBC2A9.02 SPBC11C11.06c 
SPBC16A3.02c Tf2-1 SPAC1B3.06c mug158 SPACUNK4.17 SPACUNK4.16c SPAC513.02 
SPAC23H3.15c SPBC8E4.05c ish1 SPCC757.03c SPAC26F1.07 SPBC1773.06c hsp16 grx1 
SPAC22A12.17c ctt1 SPAC1486.01 SPBC12C2.04 SPAC17G6.13 isp3 SPCC338.18 
SPAC4H3.08 SPBC1348.06c SPBC24C6.09c SPCC1393.12 SPCC1281.04 SPAC869.02c 
SPAC15E1.02c plg7 mug147 SPAC869.09 SPBC725.10 gst2 tms1 SPBC30D10.14 tpx1 
SPBC119.03 zym1 SPAC4H3.03c SPAC23C11.06c SPCC663.06c obr1 SPAC16A10.01 lsd90 
SPAPB24D3.08c SPCC16A11.15c  
GO:0051716 cellular 
response to 
stimulus  
P  2.94e-
33  
91/184 
(49.5%)  
647/5213 
(12.4%)  
bfr1 SPAC513.06c SPAC4D7.02c tps1 SPBC1105.13c SPCC338.06c gld1 SPBC4F6.17c 
SPAC11D3.01c mug35 rhp42 SPBC21C3.19 SPCC569.05c SPAC19G12.09 SPCC1281.07c 
SPAC22E12.03c SPAC23D3.05c SPBC725.03 srx1 mug182 SPAPB1A11.03 SPAC139.05 
pol4 plr1 SPAC11D3.13 nab3 SPCC663.08c ntp1 SPAC27D7.09c SPAC1F8.04c 
SPAPJ691.02 SPCC1235.01 SPBC16D10.08c SPBC1289.14 SPAC513.07 psi1 SPCC576.17c 
SPCC338.12 SPAC2E1P3.01 atf31 etr1 SPBC215.11c SPBC2A9.02 SPBC11C11.06c 
SPBC16A3.02c Tf2-1 SPAC1B3.06c mug158 SPACUNK4.17 SPACUNK4.16c SPAC513.02 
SPAC23H3.15c SPBC8E4.05c ish1 SPCC757.03c SPAC26F1.07 SPBC1773.06c hsp16 grx1 
SPAC22A12.17c ctt1 SPAC1486.01 SPBC12C2.04 SPAC17G6.13 isp3 SPCC338.18 
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Biological Process - 
GO Term 
Aspect P-
value 
Sample 
frequency 
Background 
frequency 
Genes 
SPAC4H3.08 SPBC1348.06c SPBC24C6.09c SPCC1393.12 SPCC1281.04 SPAC869.02c 
SPAC15E1.02c plg7 mug147 SPAC869.09 SPBC725.10 gst2 tms1 SPBC30D10.14 tpx1 
SPBC119.03 zym1 SPAC4H3.03c SPAC23C11.06c SPCC663.06c obr1 SPAC16A10.01 lsd90 
SPAPB24D3.08c SPCC16A11.15c  
GO:0006950 
response to stress  
P  4.41e-
33  
92/184 
(50.0%)  
666/5213 
(12.8%)  
bfr1 SPAC513.06c SPAC4D7.02c tps1 SPBC1105.13c SPCC338.06c gld1 SPBC4F6.17c 
SPAC11D3.01c mug35 rhp42 SPBC21C3.19 SPCC569.05c SPAC19G12.09 SPCC1281.07c 
SPAC22E12.03c SPAC23D3.05c SPBC725.03 srx1 mug182 SPAPB1A11.03 SPAC139.05 
pol4 plr1 SPAC11D3.13 aif1 nab3 SPCC663.08c ntp1 SPAC27D7.09c SPAC1F8.04c 
SPAPJ691.02 SPCC1235.01 SPBC16D10.08c SPBC1289.14 SPAC513.07 psi1 SPCC576.17c 
SPCC338.12 SPAC2E1P3.01 atf31 etr1 SPBC215.11c SPBC2A9.02 SPBC11C11.06c 
SPBC16A3.02c Tf2-1 SPAC1B3.06c mug158 SPACUNK4.17 SPACUNK4.16c SPAC513.02 
SPAC23H3.15c SPBC8E4.05c ish1 SPCC757.03c SPAC26F1.07 SPBC1773.06c hsp16 grx1 
SPAC22A12.17c ctt1 SPAC1486.01 SPBC12C2.04 SPAC17G6.13 isp3 SPCC338.18 
SPAC4H3.08 SPBC1348.06c SPBC24C6.09c SPCC1393.12 SPCC1281.04 SPAC869.02c 
SPAC15E1.02c plg7 mug147 SPAC869.09 SPBC725.10 gst2 tms1 SPBC30D10.14 tpx1 
SPBC119.03 zym1 SPAC4H3.03c SPAC23C11.06c SPCC663.06c obr1 SPAC16A10.01 lsd90 
SPAPB24D3.08c SPCC16A11.15c  
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Biological Process - 
GO Term 
Aspect P-
value 
Sample 
frequency 
Background 
frequency 
Genes 
GO:0050896 
response to 
stimulus  
P  3.68e-
30  
93/184 
(50.5%)  
738/5213 
(14.2%)  
bfr1 SPAC513.06c SPAC4D7.02c tps1 SPBC1105.13c SPCC338.06c gld1 SPBC4F6.17c 
SPAC11D3.01c mug35 rhp42 SPBC21C3.19 SPCC569.05c SPAC19G12.09 SPCC1281.07c 
SPAC22E12.03c SPAC23D3.05c SPBC725.03 srx1 mug182 SPAPB1A11.03 SPAC139.05 
pol4 plr1 SPAC11D3.13 aif1 nab3 SPCC663.08c ntp1 SPAC27D7.09c SPAC1F8.04c 
SPAPJ691.02 SPCC1235.01 SPBC16D10.08c SPBC1289.14 SPAC513.07 psi1 SPCC576.17c 
SPCC338.12 SPAC2E1P3.01 atf31 etr1 SPBC215.11c SPBC2A9.02 SPBC11C11.06c 
SPBC16A3.02c Tf2-1 SPAC1B3.06c mug158 SPACUNK4.17 SPACUNK4.16c SPAC513.02 
SPAC23H3.15c SPBC8E4.05c ish1 SPCC757.03c SPAC26F1.07 SPBC1773.06c hsp16 grx1 
SPAC22A12.17c ctt1 SPAC1486.01 SPBC12C2.04 SPAC17G6.13 isp3 SPCC338.18 
SPAC4H3.08 caf5 SPBC1348.06c SPBC24C6.09c SPCC1393.12 SPCC1281.04 SPAC869.02c 
SPAC15E1.02c plg7 mug147 SPAC869.09 SPBC725.10 gst2 tms1 SPBC30D10.14 tpx1 
SPBC119.03 zym1 SPAC4H3.03c SPAC23C11.06c SPCC663.06c obr1 SPAC16A10.01 lsd90 
SPAPB24D3.08c SPCC16A11.15c  
GO:0009408 
response to heat  
P  4.17e-
03  
8/184 
(4.3%)  
29/5213 
(0.6%)  
tps1 SPBC1105.13c SPCC338.06c ntp1 psi1 SPBC11C11.06c hsp16 SPAC17G6.13  
GO:0034605 cellular P  4.17e- 8/184 29/5213 tps1 SPBC1105.13c SPCC338.06c ntp1 psi1 SPBC11C11.06c hsp16 SPAC17G6.13  
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Biological Process - 
GO Term 
Aspect P-
value 
Sample 
frequency 
Background 
frequency 
Genes 
response to heat  03  (4.3%)  (0.6%)  
GO:0009266 
response to 
temperature 
stimulus  
P  5.52e-
03  
8/184 
(4.3%)  
30/5213 
(0.6%)  
tps1 SPBC1105.13c SPCC338.06c ntp1 psi1 SPBC11C11.06c hsp16 SPAC17G6.13  
  
Molecular function - GO Term Aspect P-
value 
Sample 
frequency 
Background 
frequency 
Genes 
GO:0016614 oxidoreductase activity, 
acting on CH-OH group of donors  
F  2.70e-
04  
12/184 
(6.5%)  
55/5213 (1.1%)  gld1 SPAC19G12.09 SPAPB1A11.03 plr1 SPAC2E1P3.01 etr1 
SPBC16A3.02c SPAC26F1.07 SPBC1773.06c SPAC4H3.08 SPCC1281.04 
tms1  
GO:0016616 oxidoreductase activity, 
acting on the CH-OH group of donors, 
NAD or NADP as acceptor  
F  5.04e-
04  
11/184 
(6.0%)  
48/5213 (0.9%)  gld1 SPAC19G12.09 plr1 SPAC2E1P3.01 etr1 SPBC16A3.02c 
SPAC26F1.07 SPBC1773.06c SPAC4H3.08 SPCC1281.04 tms1  
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Molecular function - GO Term Aspect P-
value 
Sample 
frequency 
Background 
frequency 
Genes 
GO:0016491 oxidoreductase activity  F  5.90e-
04  
23/184 
(12.5%)  
206/5213 
(4.0%)  
gld1 gpd3 SPAC19G12.09 srx1 SPAPB1A11.03 SPAC139.05 plr1 aif1 
zta1 SPAC2E1P3.01 etr1 SPBC16A3.02c SPAC26F1.07 SPBC1773.06c 
grx1 ctt1 SPCC132.04c SPAC1486.01 SPAC4H3.08 SPCC1281.04 
SPAC869.02c tms1 tpx1  
 
Database filter(s): GeneDB_Spombe The p-value cutoff was: 0.01 The minimum number of gene products: 2  
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Table A3.IV – GO (gene ontology) biological process and cellular component terms enriched in the list of genes downregulated more than 2 
fold at 25°C. 
Biological Process - GO Term Aspect P-
value 
Sample 
frequency 
Background 
frequency 
Genes 
GO:0033212 iron assimilation  P  3.25e-
03  
4/77 (5.2%)  9/5213 (0.2%)  str3 fip1 str1 frp1  
GO:0006519 cellular amino acid 
and derivative metabolic process  
P  6.88e-
03  
13/77 
(16.9%)  
213/5213 (4.1%)  SPBC23E6.10c SPBC12C2.07c yrs1 met14 SPAC977.12 SPAPYUG7.05 
SPBC3H7.07c SPCC1223.14 SPBPB2B2.09c SPBC1711.04 SPAC24H6.10c 
SPBC19F5.04 his1  
Back to top  
Cellular component - GO 
Term 
Aspect P-value Sample 
frequency 
Background 
frequency 
Genes 
GO:0000788 nuclear 
nucleosome  
C  5.29e-
09  
6/77 (7.8%)  6/5213 (0.1%)  hht2 hhf1 hht3 hhf3 hhf2 hht1  
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Cellular component - GO 
Term 
Aspect P-value Sample 
frequency 
Background 
frequency 
Genes 
GO:0000786 nucleosome  C  3.66e-
08  
6/77 (7.8%)  7/5213 (0.1%)  hht2 hhf1 hht3 hhf3 hhf2 hht1  
GO:0005840 ribosome  C  1.12e-
03  
16/77 (20.8%)  276/5213 (5.3%)  rpl1602 rps001 rps403 rpl901 rpl702 rps7 tif11 rpl301 rpl102 rps402 
rpl1801 rps401 rpl801 rps101 zuo1 rpl1603  
GO:0033279 ribosomal 
subunit  
C  1.84e-
03  
14/77 (18.2%)  220/5213 (4.2%)  rpl1602 rps001 rps403 rpl901 rpl702 rps7 rpl301 rpl102 rps402 rpl1801 
rps401 rpl801 rps101 rpl1603  
GO:0022626 cytosolic 
ribosome  
C  2.19e-
03  
13/77 (16.9%)  192/5213 (3.7%)  rpl1602 rps403 rpl901 rpl702 rps7 rpl301 rpl102 rps402 rpl1801 rps401 
rpl801 rps101 rpl1603  
GO:0044445 cytosolic 
part  
C  6.21e-
03  
13/77 (16.9%)  211/5213 (4.0%)  rpl1602 rps403 rpl901 rpl702 rps7 rpl301 rpl102 rps402 rpl1801 rps401 
rpl801 rps101 rpl1603  
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Database filter(s): GeneDB_Spombe The p-value cutoff was: 0.01 The minimum number of gene products: 2  
 
 
 
 
Table A3.V – GO (gene ontology) biological process and molecular function terms enriched in the list of genes upregulated more than 2 
fold at 25°C.  
 
Biological Process 
- GO Term 
Aspect P-
value 
Sample 
frequency 
Background 
frequency 
Genes 
GO:0033554 
cellular response 
to stress  
P  2.21e-
47  
109/201 
(54.2%)  
625/5213 
(12.0%)  
SPAC513.06c SPAC4D7.02c SPBC216.04c SPAC3A11.10c tps1 isp4 SPCC338.06c 
SPAC1B3.20 gpx1 gld1 SPBC4F6.17c SPAC11D3.01c mug35 SPAC22F8.05 gst3 
SPCC569.05c SPAC19G12.09 SPCC1281.07c sro1 SPAC22E12.03c SPAC637.03 
SPAC23D3.05c SPCC1739.08c SPBC725.03 mug182 SPAPB1A11.03 SPAC139.05 
SPAC32A11.02c SPAC167.07c pol4 SPAC27D7.11c SPBC1271.08c plr1 SPAC11D3.13 
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Biological Process 
- GO Term 
Aspect P-
value 
Sample 
frequency 
Background 
frequency 
Genes 
SPAC5H10.02c nab3 SPCC663.08c SPAC27D7.09c SPAC22G7.11c SPAC3C7.13c 
SPAPJ691.02 SPBC947.09 SPCC965.06 chr2 SPCC1235.01 SPBC16D10.08c SPBC1289.14 
SPAC513.07 SPCC576.17c hri1 SPCC338.12 SPAC2E1P3.01 SPBC2A9.02 SPBC215.11c etr1 
SPAC11E3.14 SPBC11C11.06c mug143 SPBC16A3.02c Tf2-1 mug158 SPACUNK4.17 
SPAC513.02 SPBC23G7.10c SPAC23H3.15c SPBC8E4.05c ish1 fbp1 SPCC757.03c 
SPBC1711.12 SPBC1773.06c hsp16 SPCC191.01 grx1 SPAC22A12.17c ctt1 SPCC4G3.03 
SPAC14C4.01c SPAC2F3.05c SPBC12C2.04 isp3 SPCC338.18 ero11 SPAC4H3.08 
SPBC24C6.09c mug190 SPCC1393.12 SPAC15E1.10 SPAPB1E7.08c SPCC1281.04 
SPAC15E1.02c mug147 SPAC869.09 cdm1 SPBC725.10 gst2 tms1 SPBC119.03 zym1 
SPAC4H3.04c SPAC4H3.03c SPAC23C11.06c fus1 SPCC663.06c rhp16 obr1 lsd90 
SPAPB24D3.08c SPCC16A11.15c  
GO:0051716 
cellular response 
to stimulus  
P  8.85e-
46  
109/201 
(54.2%)  
647/5213 
(12.4%)  
SPAC513.06c SPAC4D7.02c SPBC216.04c SPAC3A11.10c tps1 isp4 SPCC338.06c 
SPAC1B3.20 gpx1 gld1 SPBC4F6.17c SPAC11D3.01c mug35 SPAC22F8.05 gst3 
SPCC569.05c SPAC19G12.09 SPCC1281.07c sro1 SPAC22E12.03c SPAC637.03 
SPAC23D3.05c SPCC1739.08c SPBC725.03 mug182 SPAPB1A11.03 SPAC139.05 
SPAC32A11.02c SPAC167.07c pol4 SPAC27D7.11c SPBC1271.08c plr1 SPAC11D3.13 
SPAC5H10.02c nab3 SPCC663.08c SPAC27D7.09c SPAC22G7.11c SPAC3C7.13c 
SPAPJ691.02 SPBC947.09 SPCC965.06 chr2 SPCC1235.01 SPBC16D10.08c SPBC1289.14 
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Biological Process 
- GO Term 
Aspect P-
value 
Sample 
frequency 
Background 
frequency 
Genes 
SPAC513.07 SPCC576.17c hri1 SPCC338.12 SPAC2E1P3.01 SPBC2A9.02 SPBC215.11c etr1 
SPAC11E3.14 SPBC11C11.06c mug143 SPBC16A3.02c Tf2-1 mug158 SPACUNK4.17 
SPAC513.02 SPBC23G7.10c SPAC23H3.15c SPBC8E4.05c ish1 fbp1 SPCC757.03c 
SPBC1711.12 SPBC1773.06c hsp16 SPCC191.01 grx1 SPAC22A12.17c ctt1 SPCC4G3.03 
SPAC14C4.01c SPAC2F3.05c SPBC12C2.04 isp3 SPCC338.18 ero11 SPAC4H3.08 
SPBC24C6.09c mug190 SPCC1393.12 SPAC15E1.10 SPAPB1E7.08c SPCC1281.04 
SPAC15E1.02c mug147 SPAC869.09 cdm1 SPBC725.10 gst2 tms1 SPBC119.03 zym1 
SPAC4H3.04c SPAC4H3.03c SPAC23C11.06c fus1 SPCC663.06c rhp16 obr1 lsd90 
SPAPB24D3.08c SPCC16A11.15c  
GO:0006950 
response to stress  
P  1.98e-
45  
110/201 
(54.7%)  
666/5213 
(12.8%)  
SPAC513.06c SPAC4D7.02c SPBC216.04c SPAC3A11.10c tps1 isp4 SPCC338.06c 
SPAC1B3.20 gpx1 gld1 SPBC4F6.17c SPAC11D3.01c mug35 SPAC22F8.05 gst3 
SPCC569.05c SPAC19G12.09 SPCC1281.07c sro1 SPAC22E12.03c SPAC637.03 
SPAC23D3.05c SPCC1739.08c SPBC725.03 mug182 SPAPB1A11.03 SPAC139.05 
SPAC32A11.02c SPAC167.07c pol4 SPAC27D7.11c SPBC1271.08c plr1 SPAC11D3.13 aif1 
SPAC5H10.02c nab3 SPCC663.08c SPAC27D7.09c SPAC22G7.11c SPAC3C7.13c 
SPAPJ691.02 SPBC947.09 SPCC965.06 chr2 SPCC1235.01 SPBC16D10.08c SPBC1289.14 
SPAC513.07 SPCC576.17c hri1 SPCC338.12 SPAC2E1P3.01 SPBC2A9.02 SPBC215.11c etr1 
SPAC11E3.14 SPBC11C11.06c mug143 SPBC16A3.02c Tf2-1 mug158 SPACUNK4.17 
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Biological Process 
- GO Term 
Aspect P-
value 
Sample 
frequency 
Background 
frequency 
Genes 
SPAC513.02 SPBC23G7.10c SPAC23H3.15c SPBC8E4.05c ish1 fbp1 SPCC757.03c 
SPBC1711.12 SPBC1773.06c hsp16 SPCC191.01 grx1 SPAC22A12.17c ctt1 SPCC4G3.03 
SPAC14C4.01c SPAC2F3.05c SPBC12C2.04 isp3 SPCC338.18 ero11 SPAC4H3.08 
SPBC24C6.09c mug190 SPCC1393.12 SPAC15E1.10 SPAPB1E7.08c SPCC1281.04 
SPAC15E1.02c mug147 SPAC869.09 cdm1 SPBC725.10 gst2 tms1 SPBC119.03 zym1 
SPAC4H3.04c SPAC4H3.03c SPAC23C11.06c fus1 SPCC663.06c rhp16 obr1 lsd90 
SPAPB24D3.08c SPCC16A11.15c  
GO:0050896 
response to 
stimulus  
P  1.33e-
42  
112/201 
(55.7%)  
738/5213 
(14.2%)  
SPAC513.06c SPAC4D7.02c SPBC216.04c SPAC3A11.10c tps1 isp4 SPCC338.06c 
SPAC1B3.20 gpx1 gld1 SPBC4F6.17c SPAC11D3.01c mug35 SPAC22F8.05 gst3 
SPCC569.05c SPAC19G12.09 SPCC1281.07c sro1 SPAC22E12.03c SPAC637.03 
SPAC23D3.05c SPCC1739.08c SPBC725.03 mug182 SPAPB1A11.03 SPAC139.05 
SPAC32A11.02c SPAC167.07c pol4 SPAC27D7.11c SPBC1271.08c plr1 SPAC11D3.13 aif1 
SPAC5H10.02c nab3 SPCC663.08c SPAC27D7.09c SPAC22G7.11c SPAC3C7.13c 
SPAPJ691.02 SPBC947.09 SPCC965.06 chr2 SPCC1235.01 SPBC16D10.08c SPBC1289.14 
SPAC513.07 SPCC576.17c hri1 SPCC338.12 SPAC2E1P3.01 SPBC2A9.02 SPBC215.11c etr1 
SPAC11E3.14 SPBC11C11.06c pmd1 mug143 SPBC16A3.02c Tf2-1 mug158 SPACUNK4.17 
SPAC513.02 SPBC23G7.10c SPAC23H3.15c SPBC8E4.05c ish1 fbp1 SPCC757.03c 
SPBC1711.12 SPBC1773.06c hsp16 SPCC191.01 grx1 SPAC22A12.17c ctt1 SPCC4G3.03 
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Biological Process 
- GO Term 
Aspect P-
value 
Sample 
frequency 
Background 
frequency 
Genes 
SPAC14C4.01c SPAC2F3.05c SPBC12C2.04 isp3 SPCC338.18 ero11 SPAC4H3.08 caf5 
SPBC24C6.09c mug190 SPCC1393.12 SPAC15E1.10 SPAPB1E7.08c SPCC1281.04 
SPAC15E1.02c mug147 SPAC869.09 cdm1 SPBC725.10 gst2 tms1 SPBC119.03 zym1 
SPAC4H3.04c SPAC4H3.03c SPAC23C11.06c fus1 SPCC663.06c rhp16 obr1 lsd90 
SPAPB24D3.08c SPCC16A11.15c  
GO:0006979 
response to 
oxidative stress  
P  4.31e-
03  
12/201 
(6.0%)  
65/5213 
(1.2%)  
SPBC216.04c gpx1 gst3 sro1 SPAPB1A11.03 aif1 SPAC5H10.02c SPBC947.09 
SPAC23H3.15c SPCC757.03c ctt1 gst2  
 
 
Back to top  
Molecular Function - GO Term Aspect P-
value 
Sample 
frequency 
Background 
frequency 
Genes 
GO:0016614 oxidoreductase activity, 
acting on CH-OH group of donors  
F  8.19e-
05  
13/201 
(6.5%)  
55/5213 (1.1%)  gld1 SPAC19G12.09 SPAPB1A11.03 plr1 SPAC3C7.13c SPAC2E1P3.01 
etr1 SPBC16A3.02c SPBC1773.06c SPAC2F3.05c SPAC4H3.08 
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Molecular Function - GO Term Aspect P-
value 
Sample 
frequency 
Background 
frequency 
Genes 
SPCC1281.04 tms1  
GO:0016616 oxidoreductase activity, 
acting on the CH-OH group of 
donors, NAD or NADP as acceptor  
F  1.33e-
04  
12/201 
(6.0%)  
48/5213 (0.9%)  gld1 SPAC19G12.09 plr1 SPAC3C7.13c SPAC2E1P3.01 etr1 
SPBC16A3.02c SPBC1773.06c SPAC2F3.05c SPAC4H3.08 SPCC1281.04 
tms1  
GO:0016491 oxidoreductase activity  F  7.29e-
04  
24/201 
(11.9%)  
206/5213 
(4.0%)  
SPBC216.04c SPCC1223.09 gpx1 gld1 gst3 SPAC19G12.09 
SPAPB1A11.03 SPAC139.05 plr1 aif1 SPAC3C7.13c zta1 SPAC2E1P3.01 
etr1 SPBC16A3.02c SPBC1773.06c grx1 ctt1 SPCC132.04c SPAC2F3.05c 
ero11 SPAC4H3.08 SPCC1281.04 tms1  
Database filter(s): GeneDB_Spombe The p-value cutoff was: 0.01 The minimum number of gene products: 2  
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APPENDIX 4 
 
Table A4.I - Genes downregulated more than 2 fold at 25°C in laz1-1 when comparing to wt: 
 
Gene ID Gene name Gene function 
 1 SPBPB2B2.09c   2-dehydropantoate 2-reductase, 0.123500004 
2 SPBC1683.09c frp1 ferric-chelate reductase Frp1, frp1 0.21200001 
3 SPAC1F8.03c str3 siderophore-iron transporter Str3, str3 0.214 
4 SPBC359.05   ABC transporter family, abc3 0.2385 
5 h4.1: hhf1.RC     0.26999998 
6 SPAC11D3.04c   SnoaL, 0.28100002 
7 SPAC19G12.06c hta2 histone H2A, hta2 0.286 
8 SPBC1289.03c fyt1;mal25-1;spi1 Ran GTPase Spi1, spi1 0.2865 
9 SPBC4F6.09 str1 siderophore-iron transporter Str1, str1 0.29299998 
10 SPCC330.03c   cytochrome b5 family, 0.2955 
11 SPBC1105.11c clo5;hht3;H3.3;h3.3 histone H3, hht3, h3.3 0.3135 
12 SPAC1834.03c ams1;H4.1;h4.1;hhf1 histone H4, hhf1, h4.1 0.32099998 
13 SPAC4A8.04 isp6;prb1 serine protease, isp6, prb1 0.3335 
14 SPBC1826.01c btaf1;mot1 TATA-binding protein (TBP)-associated factor (TAF), mot1 0.3405 
15 SPBPB7E8.01   glycoprotein, 0.3485 
16 SPAC1782.11   adenylyl-sulfate kinase, met14 0.356 
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17 SPBPB2B2.13   galactokinase, 0.3595 
18 SPBC23G7.14   sequence orphan, 0.371 
19 SPBC359.04c   glycoprotein, 0.37150002 
20 SPSNORNA.20     0.3725 
21 SPBC2G2.05 rpl13a-3;rpl16-3;rpl16c;rpl1603 60S ribosomal protein L13/L16, rpl1603, rpl16c 0.37849998 
22 SPAC1039.02   calcineurin-like phosphoesterase, 0.38099998 
23 SPAC1834.04 H3.1;hht1 histone H3, hht1 0.3915 
24 SPAC25G10.05c his1 ATP phosphoribosyltransferase, his1 0.3955 
25 SPBC11C11.07 rpl18;rpl1801;rpl18-1 60S ribosomal protein L18, rpl1801, rpl18-1, rpl18 0.39999998 
26 SPAC977.12   L-asparaginase, 0.4025 
27 SPBC8D2.03c H4.2;h4.2;hhf2;ams3 histone H4, hhf2, ams3, h4.2 0.409 
28 SPBC1105.12 h4.3;hhf3;ams4;H4.3 histone H4, hhf3, h4.3 0.4115 
29 SPAC56F8.05c   conserved yeast protein, 0.412 
30 SPAC24H6.10c   phospho-2-dehydro-3-deoxyheptonate aldolase, 0.4145 
31 h4.3: hhf3.RC     0.4165 
32 SPAC5H10.06c adh4 alcohol dehydrogenase, adh4 0.4175 
33 SPAC19G12.05   mitochondrial citrate transporter, 0.42000002 
34 SPBC8D2.04 H3.2;hht2;h3.2 histone H3, hht2, h3.2 0.42150003 
35 h3.1: hht1.RC     0.424 
36 SPBC3H7.07c   phosphoserine phosphatase, 0.428 
37 SPBC23E6.10c   methylthioribose-1-phosphate isomerase, 0.43150002 
38 SPAC23A1.03 apt1 adenine phosphoribosyltransferase (APRT), apt1 0.4325 
39 SPBC1347.02 fkbp39 peptidyl-prolyl cis-trans isomerase, fkbp39 0.4325 
40 SPAC3H5.07 rpl7-2;rpl702;rpl7-A;rpl7;rpl7- 60S ribosomal protein L7, rpl702, rpl7-2, rpl7, rpl7b 0.43699998 
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1;rpl701;rpl7b 
41 SPBC12C2.07c SPC12C2.07c spermidine synthase, 0.439 
42 SPAC1F7.07c fip1 iron permease, fip1 0.44849998 
43 SPBC21B10.10 rps402;rps4-2 40S ribosomal protein S4, rps402, rps4-2 0.44949996 
44 SPBPB10D8.02c   arylsulfatase, 0.4495 
45 SPBPB10D8.06c   malate permease, 0.4515 
46 SPBPB10D8.05c   malate permease, 0.452 
47 SPAC23H4.09 cdb4 curved DNA-binding protein Cdb4, cdb4 0.453 
48 SPAC959.07 rps4-3;rps403;rps4 40S ribosomal protein S4, rps403, rps4-3, rps4 0.4565 
49 SPBPB10D8.04c   malate permease, 0.45700002 
50 SPBC26H8.06 grx5;grx4 glutaredoxin, grx4 0.4635 
51 SPBC713.12 erg1 squalene monooxygenase Erg1, erg1 0.464 
52 SPBC13G1.04c   alkB homolog, 0.46449998 
53 SPBC428.03c pho4 thiamine-repressible acid phosphatase Pho4, pho4 0.465 
54 SPBC30D10.18c rpl1-2;rpl10a;rpl102;rpl10a-2 60S ribosomal protein L10, rpl102, rpl1-2, rpl10a-2 0.46600002 
55 SPBPB10D8.07c   malate permease, 0.46649998 
56 SPBC19F8.08 rps4-1;rps401;rps4-1B.01c;rps4 40S ribosomal protein S4, rps401, rps4-1, rps4, SPBC25H2.17c 0.467 
57 SPAC25B8.02   histone deacetylase complex subunit, 0.4685 
58 SPAC23A1.11 rpl16b;rpl16-2;rpl13a-2;rpl1602 60S ribosomal protein L13/L16, rpl1602, rpl16-2 0.4705 
59 SPAC13G6.02c rps3a-1;rps1-1;rps101 40S ribosomal protein S3a, rps101, rps1-1, rps3a-1 0.472 
60 SPBC685.06 rps0;rpsa-1;rps001;rpsA-1;rps0-1 40S ribosomal protein S0A (p40), rps001, rps0-1, rpsa-1, rps0 0.4725 
61 SPAC328.09   mitochondrial carrier, 0.47399998 
62 SPBC19F5.04   aspartate kinase, 0.4745 
63 SPAC27E2.03c   GTP binding protein, 0.4775 
 196 
 
64 SPAC17A5.03 rpl3;rpl3-1;rpl301;rpgL3-1 60S ribosomal protein L3, rpl301, rpl3-1, rpl3 0.47750002 
65 SPAC4G9.16c rpl9;rpl9-1;rpl901 60S ribosomal protein L9, rpl901, rpl9-1 0.478 
66 SPBC405.01 ade1BC3.03;min4;ade1 phosphoribosylamine-glycine ligase, ade1, min4, SPBC4C3.02c 0.48299998 
67 C19F5.04.RC     0.48299998 
68 SPBC1778.01c zuo1;mpp11 zuotin, zuo1, mpp11, SPBC30D10.01 0.4835 
69 SPBC23G7.12c let1;rpt6 19S proteasome regulatory subunit Rpt6, rpt6, let1 0.4855 
70 SPBC1711.04   methylenetetrahydrofolate reductase, 0.487 
71 SPAC1F7.13c 
rpk5a;rpl8-1;rpl2-
1;rpk5;rpl18;rpl801 
60S ribosomal protein L2A, rpl801, rpl8-1, rpl18, rpk5a, rpl2-1, 
SPAC21E11.02c 0.4895 
72 SPAC18G6.14c rps7 40S ribosomal protein S7, rps7 0.49049997 
73 SPBC20F10.01 gar1;gar1B5H2.03 snoRNP pseudouridylase complex protein Gar1, gar1, SPBC25H2.01c 0.491 
74 SPAC22A12.05 rpc11;spc11 DNA-directed RNA polymerase III complex subunit Rpc11, rpc11 0.492 
75 SPAC2E1P3.05c   conserved fungal protein, 0.4935 
76 SPBC25H2.07 tif11 translation initiation factor eIF1A, tif11 0.495 
77 atp1.RC     0.49550003 
78 SPAC144.03 min3;ade2;min10 adenylosuccinate synthetase Ade2, ade2, min10, min3 0.49550003 
79 SPCC4G3.17   HD domain, 0.49550003 
80 SPAPYUG7.05 pro3 delta-1-pyrroline-5-carboxylate reductase, 0.496 
81 SPBPB2B2.11   nucleotide-sugar 4,6-dehydratase, 0.496 
82 SPCC1672.05c   tyrosine-tRNA ligase, 0.4975 
83 SPCC1223.14   chorismate synthase, , SPCC297.01 0.498 
84 C26H8.06.RC     0.49949998 
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Table A4.II - Genes downregulated more than 2 fold at 36°C in laz1-1 when compared with wt: 
 
Gene ID Gene name Gene function 
 1 SPAC1F8.03c str3 siderophore-iron transporter Str3, str3 0.13949999 
2 SPBPB2B2.09c   2-dehydropantoate 2-reductase, 0.16800001 
3 SPBC4F6.09 str1 siderophore-iron transporter Str1, str1 0.177 
4 SPBC1683.09c frp1 ferric-chelate reductase Frp1, frp1 0.22150001 
5 SPAC4A8.04 isp6;prb1 serine protease, isp6, prb1 0.257 
6 SPBPB7E8.01   glycoprotein, 0.2905 
7 h4.1: hhf1.RC     0.299 
8 SPAC22A12.06c   serine hydrolase, 0.30150002 
9 SPAC11D3.04c   SnoaL, 0.311 
10 SPBC1289.03c fyt1;mal25-1;spi1 Ran GTPase Spi1, spi1 0.3155 
11 SPBC359.05   ABC transporter family, abc3 0.32700002 
12 SPAC1039.09 isp5 amino acid permease family, isp5 0.333 
13 SPAC19G12.06c hta2 histone H2A, hta2 0.3395 
14 SPAC1039.02   calcineurin-like phosphoesterase, 0.345 
15 SPAC1834.03c ams1;H4.1;h4.1;hhf1 histone H4, hhf1, h4.1 0.3465 
16 SPBC1105.11c clo5;hht3;H3.3;h3.3 histone H3, hht3, h3.3 0.37 
17 SPBPB2B2.13   galactokinase, 0.375 
18 SPBP8B7.05c   carbonic anhydrase, 0.4015 
19 SPBPB2B2.12c   bifunctional enzyme, 0.40649998 
20 SPAC2E1P3.05c   conserved fungal protein, 0.4205 
21 SPBC23G7.14   sequence orphan, 0.4225 
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22 SPBC2G2.05 rpl13a-3;rpl16-3;rpl16c;rpl1603 60S ribosomal protein L13/L16, rpl1603, rpl16c 0.423 
23 SPAC1786.01c   triacylglycerol lipase, , SPAC31G5.20c 0.4235 
24 SPBC1105.12 h4.3;hhf3;ams4;H4.3 histone H4, hhf3, h4.3 0.42900002 
25 SPAC1782.11   adenylyl-sulfate kinase, met14 0.435 
26 SPBC13A2.04c ptr2-a;ptr2 PTR family peptide transporter, 0.445 
27 SPAC1834.04 H3.1;hht1 histone H3, hht1 0.4505 
28 SPBC12C2.07c SPC12C2.07c spermidine synthase, 0.45999998 
29 isp5.RC     0.46 
30 SPBC359.04c   glycoprotein, 0.462 
31 SPAC513.01c eft2-1;eft201;etf2;eft2;etf201 translation elongation factor 2, eft201, eft2-1, etf2, SPAPYUK71.04c 0.465 
32 SPAC806.03c rps26;rps2601;rps26-1 40S ribosomal protein S26, rps2601, rps26-1, rps26 0.46649998 
33 SPAC1F7.07c fip1 iron permease, fip1 0.4705 
34 SPBP4H10.11c   long-chain-fatty-acid-CoA ligase, 0.47149998 
35 SPCP31B10.07 eft1;eft202 translation elongation factor 2, eft202 0.472 
36 SPBPB10D8.02c   arylsulfatase, 0.4745 
37 SPBC1826.01c btaf1;mot1 TATA-binding protein (TBP)-associated factor (TAF), mot1 0.479 
38 SPBC11C11.07 rpl18;rpl1801;rpl18-1 60S ribosomal protein L18, rpl1801, rpl18-1, rpl18 0.48000002 
39 h4.3: hhf3.RC     0.4845 
40 SPBC23E6.10c   methylthioribose-1-phosphate isomerase, 0.4935 
41 SPCC191.02c   acetyl-CoA ligase, , SPCC417.14c 0.49899998 
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Table A4.III - Genes upregulated more than 2 fold at 25°C in laz1-1 when compared with wt: 
 
Gene ID Gene name Gene function 
 1 SPAC22H10.13 zym1 metallothionein, zym1 26.6295 
2 SPBC1289.14   adducin N-terminal domain protein, , SPBC8E4.10c 25.3945 
3 SPBC16E9.16c   sequence orphan, 17.717 
4 SPAC139.05   succinate-semialdehyde dehydrogenase, 17.707 
5 SPBP4G3.03   sequence orphan, 17.622 
6 SPCC663.08c   short chain dehydrogenase, 17.4615 
7 SPCC663.06c   short chain dehydrogenase, 17.370499 
8 SPAC23H3.15c   sequence orphan, , SPAC25H1.01c 15.5315 
9 SPAC869.07c mel1 alpha-galactosidase, mel1 14.393 
10 SPCC18B5.02c     13.1665 
11 SPCC965.07c gst2;GSTII glutathione S-transferase, gst2 12.3445 
12 SPAPB1A11.03   FMN dependent dehydrogenase, 11.925 
13 SPCC757.03c   conserved fungal protein, 11.1345005 
14 SPAC15E1.02c   conserved fungal protein, 10.332 
15 SPBC215.11c   aldo/keto reductase, 9.114 
16 SPAC869.09   hypothetical protein, 8.824 
17 SPAC27D7.10c   possibly S. pombe specific, 8.547501 
18 SPAC22A12.17c   short chain dehydrogenase, 8.431999 
19 SPAC4H3.08   short chain dehydrogenase, 8.382 
20 SPNCRNA.07     8.347 
21 SPAC11D3.01c   conserved fungal protein, 8.295 
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22 SPNCRNA.29     8.0965 
23 SPCPB16A4.06c   dubious, 8.0875 
24 SPAC513.02   phosphoglycerate mutase family, 7.4160004 
25 SPAPB1A11.02   esterase/lipase, 7.353 
26 SPBC3E7.02c hsp16 heat shock protein, hsp16 7.05 
27 SPAC5H10.02c   conserved fungal protein, 6.672 
28 SPAPB24D3.08c   NADP-dependent oxidoreductase, 6.6405 
29 SPAC27D7.09c   predicted N-terminal signal sequence, 6.609 
30 SPBC24C6.09c   phosphoketolase, 6.59 
31       6.5695 
32 SPBC1289.16c   copper amine oxidase, , SPBC8E4.06 6.4545 
33 SPNCRNA.65     6.41 
34 SPCC1393.12   sequence orphan, 6.2525 
35 SPAC869.06c   cation binding protein, 6.147 
36 SPBC1773.06c   alcohol dehydrogenase, 6.1385 
37 SPAC13C5.04   glutamine amidotransferase, 6.1075 
38 SPAC22G7.11c   conserved fungal protein, , SPAC4G8.01c 5.8335 
39 SPAPJ691.02 SPAP691.02 yipee-like protein, 5.625 
40 SPAC3C7.14c uhp1;p25;obr1 ubiquitinated histone-like protein Uhp1, obr1, uhp1 5.5035 
41 SPBC16A3.13 meu7 alpha-amylase, meu7, aah4 5.4995003 
42 SPAC3G6.07   sequence orphan, 5.439 
43 SPAC4H3.03c   glucan 1,4-alpha-glucosidase, 5.349 
44 SPBC725.10   similar to peripheral-type benzodiazepine receptor, 5.2335 
45 SPBC1604.01   sulfatase modifying factor 1 related, , SPBC1677.01c 5.172 
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46 SPCC338.12   protease inhibitor, 5.172 
47 SPBC1773.05c tms1 hexitol dehydrogenase, tms1 5.1324997 
48 SPAC2E1P3.01   zinc binding dehydrogenase, 5.123 
49 SPBC337.08c ubi4 ubiquitin, ubi4 5.1064997 
50 SPAC26F1.14c aif1 apoptosis-inducing factor homolog Aif1, aif1, SPAC29A4.01c 4.8785 
51 SPAP8A3.04c hsp9;scf1 heat shock protein, hsp9, scf1 4.827 
52 SPCC757.07c cta1;ctt1 catalase, ctt1, cta1 4.827 
53 SPAC9E9.11 plr1;plr pyridoxal reductase, plr1, plr 4.686 
54 SPAC26A3.13c Tf2-4 retrotransposable element, Tf2-4 4.6245003 
55 SPAC29A4.12c ureF;ure3 sequence orphan, 4.6225 
56 SPSNRNA.01     4.588 
57 SPCC1281.04   pyridoxal reductase, 4.551 
58 SPCC1494.11c Tf2-13-pseudo   4.5195 
59 SPBC1289.17 Tf2-11;SPBC8E4.11c retrotransposable element, Tf2-11, SPBC8E4.11c 4.491 
60 SPAC4F10.17   hypothetical protein, 4.4905 
61 SPCC1020.14 Tf2-12 retrotransposable element, Tf2-12 4.484 
62 SPBC9B6.02c SPBC9B6.02;Tf2-9 retrotransposable element, Tf2-9, SPBC9B6.02 4.473 
63 SPBC1E8.04 Tf2-10-pseudo   4.4709997 
64 SPAC13D1.01c Tf2-7 retrotransposable element, Tf2-7 4.3199997 
65 SPAC27E2.08 Tf2-6 retrotransposable element, Tf2-6 4.3075 
66 SPNCRNA.113     4.294 
67 SPAC9.04 Tf2-1 retrotransposable element, Tf2-1 4.2749996 
68 SPAC19D5.09c SPAC13D1.02c;Tf2-8 retrotransposable element, Tf2-8, SPAC13D1.02c 4.266 
69 SPAC167.08 SPAC1705.01c;Tf2-2 retrotransposable element, Tf2-2, SPAC1705.01c 4.2525 
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70 SPAPB15E9.03c Tf2-5 retrotransposable element, Tf2-5 4.231 
71 SPBC2A9.02   conserved protein, 4.1555 
72 SPBC725.03   conserved yeast protein, 4.142 
73 SPAC589.02c trap240;spTrap240;srb9 mediator complex submodule, srb9, spTrap240 4.0945 
74 SPBC56F2.06   sequence orphan, 4.094 
75 SPACUNK4.17   dehydrogenase, 4.0715 
76 SPCC338.18   sequence orphan, 4.0065002 
77 SPBC8E4.05c   3-carboxy-cis,cis-muconate cycloisomerase, 4.004 
78 SPCC777.04   amino acid transporter, 4.001 
79 SPAC513.07   cinnamoyl-CoA reductase, 3.8825002 
80 SPBC1348.05   MFS family membrane transporter, , SPAC1348.05 3.872 
81 SPAC19G12.09   NADPH-dependent alpha-keto amide reductase, 3.8205 
82 SPAC186.05c   hypothetical protein, 3.8095 
83 SPNCRNA.44     3.7945 
84 SPAC23C11.06c   conserved yeast protein, 3.7415 
85 SPBC365.12c ish1 LEA domain protein, ish1 3.737 
86 SPBC16A3.02c   mitochondrial peptidase, 3.71 
87 SPAC4F10.20 grx1 glutaredoxin, grx1 3.69 
88 SPCP20C8.02c   33896 domain, 3.591 
89 SPAC26F1.04c mrf1;etr1 enoyl-[acyl-carrier protein] reductase, etr1 3.5825 
90 SPBC1271.08c   sequence orphan, 3.543 
91 SPAC13F5.03c   
glycerol dehydrogenase (Phlippen, Stevens, Wolf, Zimmermann manuscript 
in preparation), 3.467 
92 SPBPB2B2.16c   MFS family membrane transporter, 3.4175 
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93 SPBC1348.03   B44484, , SPAC1348.03 3.413 
94 SPBC119.03   S-adenosylmethionine-dependent methyltransferase, 3.381 
95 SPBC609.04 caf5 spermine transporter family, caf5 3.3595 
96 SPAC25G10.04c rec10 meiotic recombination protein Rec10, rec10, rec20 3.329 
97 SPAC2F3.05c   aldo/keto reductase, 3.309 
98 SPBC1685.12c   dubious, 3.2805 
99 SPAC3G9.11c   pyruvate decarboxylase, 3.2265 
100 SPAC977.14c   aldo/keto reductase, 3.188 
101 SPCC1739.08c   short chain dehydrogenase, 3.1555 
102 SPAC750.01     3.1515 
103 SPAC977.04     3.1345 
104 SPBC1271.05c   zinc finger protein, 3.0945 
105 SPAC869.08 pcm2 protein-L-isoaspartate O-methyltransferase, pcm2 3.074 
106 SPAC27D7.11c   possibly S. pombe specific, 3.032 
107 SPAC513.03 mfm2 M-factor precursor, mfm2 3.013 
108 SPBP4G3.02 pho1 acid phosphatase Pho1, pho1 3.0035 
109 SPCC132.04c   NAD dependent glutamate dehydrogenase, 3.0005 
110 SPAC15A10.05c   conserved protein (broad species distribution), 2.981 
111 SPBC16H5.07c ppa2 serine/threonine protein phosphatase Ppa2, ppa2 2.9805 
112 SPAC32A11.02c   sequence orphan, 2.963 
113 SPAC22A12.11 dak1 dihydroxyacetone kinase Dak1, dak1 2.9615002 
114 SPAC3C7.13c   glucose-6-phosphate 1-dehydrogenase, 2.944 
115 SPBC4F6.17c   AAA family ATPase, 2.9405 
116 SPNCRNA.26     2.933 
 204 
 
117 SPBC23G7.10c   NADH-dependent flavin oxidoreductase, 2.917 
118 SPAC27D7.03c mei2 RNA-binding protein involved in meiosis Mei2, mei2 2.914 
119 SPBC16D10.08c   heat shock protein, 2.905 
120 SPBC23G7.17c mat1;matmi_2;matmi mating-type M-specific polypeptide Mi, matmi_2, matmi, mat1 2.8944998 
121 SPBC428.07 meu6 lysine-rich protein, meu6 2.8934999 
122 SPBC1198.01   glutathione-dependent formaldehyde dehydrogenase, 2.8725 
123 NULL_matpc     2.862 
124 SPAC3H8.09c   poly(A) binding protein, 2.86 
125 SPCC16A11.15c   sequence orphan, 2.8284998 
126 SPBC1271.09   glycerophosphodiester transporter, 2.8240001 
127 SPBC1198.14c fbp1 fructose-1,6-bisphosphatase Fbp1, fbp1, SPBC660.04c 2.812 
128 SPBC947.09   conserved fungal protein, 2.7814999 
129 SPAPB24D3.07c   sequence orphan, 2.7635 
130 SPBC1347.03 meu14 meiotic expression upregulated, meu14 2.726 
131 SPAC4D7.02c   glycerophosphoryl diester phosphodiesterase, 2.7145 
132 SPAC637.03   conserved fungal protein, 2.6735 
133 SPAC20G4.03c hri1 eIF2 alpha kinase Hri1, hri1 2.6655002 
134 SPCC1682.11c   conserved fungal protein, 2.6625 
135 SPBCPT2R1.02   sequence orphan, 2.66 
136 SPSNORNA.51     2.6555 
137 SPBC1711.01c 
matmi;matM;matmi_1;matMi;mat1-Mi;mat1-Mm;mat1-
M;matMm mating-type m-specific polypeptide mi, matmi_1, matmi 2.6425 
138 SPCC24B10.22 Pol-gamma;mip1 DNA polymerase gamma catalytic subunit, , SPCPB16A4.01 2.6299999 
139 SPCC1281.07c   glutathione S-transferase, 2.6100001 
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140 SPNCRNA.128     2.609 
141 SPAC1B3.20   sequence orphan, 2.6055 
142 SPNCRNA.67     2.602 
143 SPCC338.06c   heat shock protein, 2.5955 
144 SPCC757.02c   hypothetical protein, 2.595 
145 pho1.RC     2.5825 
146 SPBC839.06 cta3 cation-transporting P-type ATPase Cta3, cta3 2.556 
147 SPSNORNA.32     2.5475001 
148 SPAC23D3.05c     2.545 
149 SPAC1006.01 psp3 serine protease, psp3 2.5325 
150 SPAC513.06c   dihydrodiol dehydrogenase, 2.526 
151 SPAC20G4.02c fus1 formin Fus1, fus1 2.508 
152 SPCC330.01c rhp16;rad16 DEAD/DEAH box helicase, rhp16, SPCC613.13c, rad16 2.5045 
153 SPAPB1E7.08c   membrane transporter, 2.504 
154 SPAC24C9.15c mde9;meu28;spn5 septin, spn5, mde9, meu28 2.5025 
155 SPCC1442.16c   quinone oxidoreductase, , SPCC285.01c 2.4935 
156 SPAC4H3.04c   UPF0103 family, 2.473 
157 SPAC167.07c   ubiquitin-protein ligase (E3), , SPAC57A7.03c 2.4555001 
158 SPBC1347.14c     2.452 
159 SPCC1235.01   glycoprotein, , SPCC320.02c 2.447 
160 SPCC736.13   short chain dehydrogenase, 2.4425 
161 SPAC31G5.21   conserved eukaryotic protein, 2.434 
162 SPNCRNA.32     2.428 
163 SPCC191.01   sequence orphan, , SPCC417.13 2.411 
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164 SPAC688.03c   conserved protein (broad species distribution), 2.395 
165 SPNCRNA.17     2.379 
166 SPCC794.04c   MFS family membrane transporter, 2.356 
167 SPBC1347.11   sequence orphan, 2.3545 
168 SPBPB2B2.01   amino acid permease family, 2.345 
169 SPAC977.15   dienelactone hydrolase family, 2.3355 
170 SPAC1F8.05 meu4;isp3 meiotic expression upregulated, isp3, meu4 2.333 
171 SPAC24C9.06c   aconitate hydratase, 2.3295 
172 SPNCRNA.21     2.327 
173 SPCC569.05c   spermidine family transporter, 2.322 
174 SPAC22H12.01c   sequence orphan, , SPAC23G3.13c 2.313 
175 SPAC328.03 tps1;ggs1 alpha,alpha-trehalose-phosphate synthase [UDP-forming], tps1 2.3109999 
176 C1952.16.RC     2.3105001 
177 SPCC576.17c   MFS family membrane transporter, 2.304 
178 SPBC12C2.04   dehydrogenase, 2.295 
179 SPCC188.12 spn6 septin, spn6, SPCC584.09 2.2925 
180 SPAC167.06c   sequence orphan, , SPAC57A7.02c 2.2884998 
181 SPCC965.06   aldo/keto reductase, 2.2835 
182 SPAC17C9.16c   spermine transporter family, , SPAC9E9.16 2.28 
183 SPSNORNA.40     2.278 
184 SPAPB8E5.10   sequence orphan, 2.27 
185 SPAC22E12.03c   THIJ/PFPI family protein, 2.2635 
186 SPBC2D10.19c   sequence orphan, 2.2625 
187 SPAC458.06   WD repeat protein, 2.2549999 
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188 SPNCRNA.58     2.254 
189 SPAC5H10.05c   NADHdh_2 domain protein, 2.248 
190 SPBC1711.12   dipeptidyl peptidase, 2.2424998 
191 SPCC417.15     2.239 
192 SPAC30D11.01c   alpha-glucosidase, , SPAC56F8.01 2.2125 
193 SPBC1289.15   glycoprotein, , SPBC8E4.07c 2.211 
194 Tf-fragment4     2.2094998 
195 SPAC24C9.08   vacuolar carboxypeptidase, 2.208 
196 SPAC1556.06b meu2 meiotic expression upregulated, 2.2 
197 SPCC622.06c   dubious, 2.194 
198 SPBC29B5.02c isp4 OPT oligopeptide transporter family, isp4 2.1729999 
199 SPBC27.03 meu25 sequence orphan, meu25 2.1655002 
200 SPAC1610.03c crp79;meu5 poly(A) binding protein Crp79, crp79, meu5 2.162 
201 SPCC1223.09   uricase, 2.16 
202 SPBC12D12.02c cdm1 DNA polymerase delta subunit Cdm1, cdm1 2.1560001 
203 SPBC11C11.06c   sequence orphan, 2.155 
204 SPAC20G4.05c   conserved protein (mainly fungal and bacterial), 2.1545 
205 SPBC1271.01c pof13 F-box protein, pof13 2.1374998 
206 SPCC569.03   B13958 domain, 2.1335 
207 SPAC2F7.06c pol4;Pol-mu DNA polymerase X family, pol4 2.128 
208 SPCP31B10.06   C2 domain, 2.1275 
209 SPAC1002.16c   nicotinic acid plasma membrane transporter, 2.1245 
210 SPCC285.07c wtf5;wtf18 wtf element, wtf18 2.1225 
211 I2_ubc4     2.113 
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212 SPAC11D3.13   ThiJ domain, 2.1125 
213 SPAC688.04c gst3;GSTIII glutathione S-transferase, gst3 2.1035 
214 SPAC15E1.10   conserved fungal family, , SPAP7G5.01 2.0970001 
215 SPBC4F6.16c ero11 ER oxidoreductin Ero1a, ero11 2.0965 
216 SPCC306.10 wtf8   2.094 
217 SPAPB1E7.04c   chitinase, 2.0895 
218       2.0865002 
219 SPNCRNA.39     2.082 
220 SPAC11E3.14   conserved fungal protein, 2.0735002 
221 SPCC663.03 pmd1 ABC transporter family, pmd1 2.072 
222 SPBC609.01   ribonuclease II (RNB) family, 2.07 
223 SPBC32F12.03c gpx1 glutathione peroxidase Gpx1, gpx1 2.0625 
224 SPCC663.07c     2.061 
225 SPBC19C7.02 ubr1 ubiquitin-protein ligase (E3), ubr1, SPBC32F12.14 2.0575 
226 C3A11.09.RC     2.0500002 
227 SPAC14C4.01c   conserved fungal protein, , SPAC19D5.08c 2.0455 
228 SPAC22F8.05   alpha,alpha-trehalose-phosphate synthase, 2.0435 
229 SPBC216.04c   methionine sulfoxide, 2.043 
230 SPAC5H10.04   NADPH dehydrogenase, 2.0425 
231 SPCC4G3.03   WD repeat protein, 2.0419998 
232 SPBC18H10.05   WD repeat protein, 2.0384998 
233 SPAC31G5.18c   ubiquitin family protein, 2.0355 
234 SPNCRNA.41     2.035 
235 SPAC3A11.10c   membrane dipeptidase, 2.0345001 
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236 SPBC800.02 whi5 cell cycle transcriptional repressor Whi5, whi5 2.0325 
237 SPAC11E3.13c   GPI anchored protein, 2.0245 
238 SPCC126.07c   zinc finger protein, 2.0205002 
239 SPCC1259.14c B8647-6;meu27 meiotic expression upregulated, meu27 2.02 
240 SPNCRNA.101     2.0195 
241 SPNCRNA.16     2.017 
242 SPSNORNA.35     2.0095 
243 SPCC417.05c chr2;cfh2 chitin synthase regulatory factor Chr2, chr2, cfh2 2.003 
244 SPAC9E9.17c   sequence orphan, 2.002 
 
Table A4-IV - Genes upregulated more than 2 fold at 36°C in laz1-1 when compared with wt: 
 
Gene ID Gene name Gene function 
 1 SPBC1289.14   adducin N-terminal domain protein, , SPBC8E4.10c 36.022 
2 SPBC3E7.02c hsp16 heat shock protein, hsp16 21.140999 
3 SPCC663.08c   short chain dehydrogenase, 17.6485 
4 SPCC663.06c   short chain dehydrogenase, 17.6125 
5 SPCC18B5.02c     15.2295 
6 SPAC22H10.13 zym1 metallothionein, zym1 14.944 
7 SPCC965.07c gst2;GSTII glutathione S-transferase, gst2 13.7785 
8 SPAPB1A11.03   FMN dependent dehydrogenase, 13.320499 
9 SPBP4G3.03   sequence orphan, 11.289499 
10 SPAC3C7.14c uhp1;p25;obr1 ubiquitinated histone-like protein Uhp1, obr1, uhp1 11.272 
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11 SPAC11D3.01c   conserved fungal protein, 9.273 
12 SPAC869.09   hypothetical protein, 8.592 
13 SPNCRNA.07     6.9255 
14 SPAC1F8.05 meu4;isp3 meiotic expression upregulated, isp3, meu4 6.7645 
15 SPAC869.07c mel1 alpha-galactosidase, mel1 6.6905003 
16 SPAC513.07   cinnamoyl-CoA reductase, 6.501 
17 SPAPB24D3.07c   sequence orphan, 6.3485003 
18 SPAC3H8.09c   poly(A) binding protein, 6.0550003 
19 SPAPB24D3.08c   NADP-dependent oxidoreductase, 5.91 
20 SPBC1685.12c   dubious, 5.7595 
21 SPBC29A10.15 orp1;cdc30;orc1 origin recognition complex subunit Orc1, orc1, orp1, cdc30 5.7535 
22 SPAC167.08 SPAC1705.01c;Tf2-2 retrotransposable element, Tf2-2, SPAC1705.01c 5.689 
23 SPAC750.01     5.6885 
24 SPBC119.03   S-adenosylmethionine-dependent methyltransferase, 5.6615 
25 SPAC26A3.13c Tf2-4 retrotransposable element, Tf2-4 5.545 
26 SPAPB15E9.03c Tf2-5 retrotransposable element, Tf2-5 5.538 
27 SPAC977.14c   aldo/keto reductase, 5.5145 
28 SPAC9E9.11 plr1;plr pyridoxal reductase, plr1, plr 5.4985 
29 SPAC27E2.08 Tf2-6 retrotransposable element, Tf2-6 5.4975004 
30 SPAC19D5.09c SPAC13D1.02c;Tf2-8 retrotransposable element, Tf2-8, SPAC13D1.02c 5.4960003 
31 SPBC1773.06c   alcohol dehydrogenase, 5.4175 
32 SPBC1E8.04 Tf2-10-pseudo   5.4145 
33 SPAC13D1.01c Tf2-7 retrotransposable element, Tf2-7 5.4040003 
34 SPCC1020.14 Tf2-12 retrotransposable element, Tf2-12 5.3995 
Appendix 4 
211 
 
35 SPNCRNA.29     5.373 
36 SPAC23H3.15c   sequence orphan, , SPAC25H1.01c 5.3245 
37 SPCC1494.11c Tf2-13-pseudo   5.278 
38 SPBC16E9.16c   sequence orphan, 5.2775 
39 SPAC9.04 Tf2-1 retrotransposable element, Tf2-1 5.262 
40 SPBC1289.17 Tf2-11;SPBC8E4.11c retrotransposable element, Tf2-11, SPBC8E4.11c 5.2555 
41 SPBC9B6.02c SPBC9B6.02;Tf2-9 retrotransposable element, Tf2-9, SPBC9B6.02 5.218 
42 SPCC338.12   protease inhibitor, 5.193 
43 SPBC4F6.17c   AAA family ATPase, 4.985 
44 SPBC215.11c   aldo/keto reductase, 4.9845 
45 SPCC757.07c cta1;ctt1 catalase, ctt1, cta1 4.9835 
46 SPAC26F1.04c mrf1;etr1 enoyl-[acyl-carrier protein] reductase, etr1 4.9020004 
47 SPAC22A12.17c   short chain dehydrogenase, 4.7605 
48 SPAC139.05   succinate-semialdehyde dehydrogenase, 4.7130003 
49 meu8.RC     4.684 
50 SPAC11D3.13   ThiJ domain, 4.6705 
51 SPBC16A3.13 meu7 alpha-amylase, meu7, aah4 4.66 
52 SPCC1281.04   pyridoxal reductase, 4.637 
53 SPAC186.05c   hypothetical protein, 4.5885 
54 SPAC27D7.10c   possibly S. pombe specific, 4.582 
55 SPBC16D10.08c   heat shock protein, 4.3365 
56 SPAPB1A10.14   F-box protein, 4.3185 
57 SPBC21C3.19   conserved fungal protein, 4.3145 
58 SPBC19C7.04c   conserved yeast protein, 4.308 
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59 SPBPB2B2.16c   MFS family membrane transporter, 4.255 
60 SPBC8E4.02c   sequence orphan, 4.1975 
61 SPBC1105.13c   sequence orphan, 4.182 
62 SPBC609.04 caf5 spermine transporter family, caf5 4.159 
63 C1347.12.RC     4.087 
64 SPBC839.06 cta3 cation-transporting P-type ATPase Cta3, cta3 4.0299997 
65 SPAPB1A11.02   esterase/lipase, 4.007 
66 SPAC1002.16c   nicotinic acid plasma membrane transporter, 3.9845 
67 SPCPB16A4.06c   dubious, 3.881 
68 SPBP4G3.02 pho1 acid phosphatase Pho1, pho1 3.8720002 
69 SPBC16A3.02c   mitochondrial peptidase, 3.8140001 
70 SPAC4H3.08   short chain dehydrogenase, 3.758 
71 SPAC19G12.09   NADPH-dependent alpha-keto amide reductase, 3.737 
72 SPAC4F10.17   hypothetical protein, 3.7255 
73 SPAPB1A11.01   MFS family membrane transporter, , SPAPB24D3.11 3.6469998 
74 SPCC569.05c   spermidine family transporter, 3.646 
75 SPAC27D7.09c   predicted N-terminal signal sequence, 3.541 
76 pho1.RC     3.5395 
77 SPAC3G9.11c   pyruvate decarboxylase, 3.536 
78 SPBC725.03   conserved yeast protein, 3.4695 
79 SPAP8A3.04c hsp9;scf1 heat shock protein, hsp9, scf1 3.4325 
80 SPBC725.10   similar to peripheral-type benzodiazepine receptor, 3.3965 
81 SPBPB2B2.14c   DUF999, 3.392 
82 SPBC2A9.02   conserved protein, 3.3675 
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83 SPBC24C6.09c   phosphoketolase, 3.3635 
84 SPBC337.08c ubi4 ubiquitin, ubi4 3.3579998 
85 SPCC757.03c   conserved fungal protein, 3.3475 
86 SPCC830.07c psi;psi1 DNAJ domain protein, psi1, psi 3.26 
87 SPCC777.04   amino acid transporter, 3.255 
88 SPAC9E9.17c   sequence orphan, 3.242 
89 SPAC869.03c   urea transporter, 3.2245 
90 SPAC13C5.04   glutamine amidotransferase, 3.217 
91 SPAPJ691.02 SPAP691.02 yipee-like protein, 3.209 
92 SPAC13F5.03c   
glycerol dehydrogenase (Phlippen, Stevens, Wolf, Zimmermann manuscript 
in preparation), 3.1805 
93 Tf-fragment4     3.1775 
94 SPSNORNA.47     3.1635 
95 SPBC365.12c ish1 LEA domain protein, ish1 3.147 
96 SPAC977.05c   conserved fungal protein, 3.126 
97 SPCC576.03c tpx1 thioredoxin peroxidase Tpx1, tpx1 3.1015 
98 SPBC1348.03   B44484, , SPAC1348.03 3.065 
99 SPBC3B9.01   Hsp70 nucleotide exchange factor, 3.0595 
100 SPAC15E1.02c   conserved fungal protein, 3.0454998 
101 SPAC328.03 tps1;ggs1 alpha,alpha-trehalose-phosphate synthase [UDP-forming], tps1 3.0149999 
102 SPBC1773.05c tms1 hexitol dehydrogenase, tms1 3.0054998 
103 SPAC22H12.01c   sequence orphan, , SPAC23G3.13c 3.001 
104 SPAC750.07c   66294 domain, 2.9465 
105 SPCC576.17c   MFS family membrane transporter, 2.942 
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106 SPNCRNA.32     2.926 
107 SPAC977.04     2.911 
108 SPAC27D7.03c mei2 RNA-binding protein involved in meiosis Mei2, mei2 2.8920002 
109 SPCC417.15     2.8685 
110 SPAC212.08c   66294 domain, 2.857 
111 SPAC2E1P3.01   zinc binding dehydrogenase, 2.852 
112 I24_rpt4     2.837 
113 SPBPB21E7.04c   S-adenosylmethionine-dependent methyltransferase, , SPAPB21E7.04c 2.8000002 
114 SPCC338.06c   heat shock protein, 2.7754998 
115 SPCC4G3.10c rhp4b;rhp42 DNA repair protein Rhp42, rhp42, rhp4b 2.77 
116 SPAC4H3.03c   glucan 1,4-alpha-glucosidase, 2.7615 
117 SPSNORNA.51     2.756 
118 SPAC589.02c trap240;spTrap240;srb9 mediator complex submodule, srb9, spTrap240 2.7035 
119 SPAC9E9.12c abc1 ABC transporter family, ybt1, abc1 2.6845 
120 SPNCRNA.67     2.6785 
121 SPAC869.02c   nitric oxide dioxygenase, 2.674 
122 SPAC869.08 pcm2 protein-L-isoaspartate O-methyltransferase, pcm2 2.662 
123 SPAC5H10.04   NADPH dehydrogenase, 2.6615 
124 SPBC27.03 meu25 sequence orphan, meu25 2.6529999 
125 SPAC513.02   phosphoglycerate mutase family, 2.652 
126 SPSNORNA.32     2.6495 
127 SPNCRNA.14     2.6420002 
128 SPCC1235.01   glycoprotein, , SPCC320.02c 2.6399999 
129 SPBC11C11.06c   sequence orphan, 2.6225 
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130 SPAC1610.03c crp79;meu5 poly(A) binding protein Crp79, crp79, meu5 2.618 
131 SPBC119.04 mei3 meiosis inducing protein Mei3, mei3 2.607 
132 SPCC24B10.22 Pol-gamma;mip1 DNA polymerase gamma catalytic subunit, , SPCPB16A4.01 2.5925 
133 SPACUNK4.16c   alpha,alpha-trehalose-phosphate synthase, 2.592 
134 SPAC22E12.03c   THIJ/PFPI family protein, 2.5895 
135 SPSNRNA.01     2.566 
136 SPBC428.07 meu6 lysine-rich protein, meu6 2.5435 
137 SPBC1711.15c   dubious, 2.5105 
138 SPCC18B5.07c nup61 nucleoporin, nup61 2.505 
139 SPBP8B7.15c   zinc finger protein, 2.496 
140 SPAC17G6.13 slt1 sequence orphan, 2.4724998 
141 SPBC12C2.04   dehydrogenase, 2.4645 
142 SPBPB21E7.02c     2.453 
143 SPCC1281.07c   glutathione S-transferase, 2.4394999 
144 SPBPB8B6.02c   urea transporter, , SPAPB8B6.02c 2.428 
145 SPNCRNA.17     2.42 
146 SPAC25G10.04c rec10 meiotic recombination protein Rec10, rec10, rec20 2.417 
147 NULL_matpc     2.412 
148 SPCC188.12 spn6 septin, spn6, SPCC584.09 2.4060001 
149 SPBC1348.04   sterol methyltransferase, , SPAC1348.04 2.404 
150 SPCC1393.12   sequence orphan, 2.4039998 
151 SPAC26F1.07   2-methylbutyraldehyde reductase, 2.3715 
152 SPBC23G7.17c mat1;matmi_2;matmi mating-type M-specific polypeptide Mi, matmi_2, matmi, mat1 2.3685 
153 SPCC1442.16c   quinone oxidoreductase, , SPCC285.01c 2.3665 
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154 SPNCRNA.44     2.3504999 
155 SPBC1711.01c 
matmi;matM;matmi_1;matMi;mat1-Mi;mat1-Mm;mat1-
M;matMm mating-type m-specific polypeptide mi, matmi_1, matmi 2.349 
156 SPBC409.08   spermine transporter family, 2.3485 
157 SPCC132.04c   NAD dependent glutamate dehydrogenase, 2.3395 
158 SPBC354.12 gpd3 glyceraldehyde 3-phosphate dehydrogenase Gpd3, gpd3 2.336 
159 SPBC2G2.17c   beta-glucosidase, 2.3245 
160 SPBC56F2.06   sequence orphan, 2.3185 
161 SPAC4F10.20 grx1 glutaredoxin, grx1 2.3179998 
162 SPAC29A4.12c ureF;ure3 sequence orphan, 2.312 
163 SPBC83.17   multiprotein bridging factor, 2.3115 
164 SPNCRNA.65     2.31 
165 SPCC16A11.15c   sequence orphan, 2.2919998 
166 SPBC1289.16c   copper amine oxidase, , SPBC8E4.06 2.2775002 
167 SPBC106.11c   1-alkyl-2-acetylglycerophosphocholine esterase, plg7 2.275 
168 SPCC645.14c sti1 TPR repeat protein, sti1 2.2645001 
169 SPBC1348.06c   conserved fungal protein, , SPAC1348.06c 2.2605 
170 SPCC777.03c   nifs homolog, 2.2595 
171 SPAC22F3.02 atf31 transcriptuion factor Atf31, atf31 2.2554998 
172 SPAC16A10.01   conserved protein (mainly fungal and bacterial), 2.2554998 
173 SPCC18.03   shuttle craft like transcriptional regulator, 2.2465 
174 SPAC23D3.05c     2.2395 
175 SPAC513.06c   dihydrodiol dehydrogenase, 2.2280002 
176 SPACUNK4.17   dehydrogenase, 2.217 
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177 SPAC186.09   pyruvate decarboxylase, 2.217 
178 I2_ubc4     2.204 
179 SPNCRNA.02     2.202 
180       2.19 
181 SPCC757.02c   hypothetical protein, 2.188 
182 I5_C550.11     2.1865 
183 SPBC660.07 ntp1 alpha,alpha-trehalase Ntp1, ntp1 2.1859999 
184 SPCC338.18   sequence orphan, 2.182 
185 SPCC737.04   UPF0300 family, 2.1755 
186 SPAC110.04c ssp1;pss1 heat shock protein 70 family, pss1, ssp1, SPAP14E8.01c 2.1729999 
187 SPBC19C7.02 ubr1 ubiquitin-protein ligase (E3), ubr1, SPBC32F12.14 2.171 
188 SPAC1F5.11c   phosphatidylinositol kinase, 2.1694999 
189 SPBC30D10.14   dienelactone hydrolase family, 2.1625 
190 SPAC1093.06c dhc1 dynein heavy chain, dhc1, SPAC30C2.01c 2.1625 
191 SPCC31H12.06   sequence orphan, 2.1605 
192 SPAC1F3.05   VHS domain, 2.153 
193 SPAC17A2.15   dubious, 2.147 
194 SPBC16H5.07c ppa2 serine/threonine protein phosphatase Ppa2, ppa2 2.137 
195 SPCC622.06c   dubious, 2.1345 
196 SPAC26F1.14c aif1 apoptosis-inducing factor homolog Aif1, aif1, SPAC29A4.01c 2.1234999 
197 SPAC4D7.02c   glycerophosphoryl diester phosphodiesterase, 2.112 
198 SPBC1604.01   sulfatase modifying factor 1 related, , SPBC1677.01c 2.0974998 
199 SPAC1486.01 sod2 manganese superoxide dismutase (AF069292), 2.096 
200 SPAC24C9.06c   aconitate hydratase, 2.0939999 
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201       2.089 
202 C18A7.01.RC     2.0885 
203 SPBC8E4.05c   3-carboxy-cis,cis-muconate cycloisomerase, 2.0875 
204 SPAC29E6.07   sequence orphan, , SPAC30.11 2.0865002 
205 SPBC1861.01c cnp3 CENP-C, cnp3, SPBC56F2.13 2.0640001 
206 SPAC5H10.05c   NADHdh_2 domain protein, 2.0625 
207 SPBC725.06c ppk31 serine/threonine protein kinase, ppk31 2.062 
208 SPAC6F6.03c   GTP binding protein associated, 2.0555 
209 SPAC1A6.08c mcp2 sequence orphan, 2.049 
210 SPAC11E3.06 map1 MADS-box transcription factor Map1, map1 2.047 
211 SPCC18B5.01c hba2;bfr1 ABC transporter family, bfr1, hba2, SPCPJ732.04c 2.0415 
212 SPAC15A10.05c   conserved protein (broad species distribution), 2.0410001 
213 SPSNORNA.34     2.0314999 
214 SPAC23C11.06c   conserved yeast protein, 2.0265 
215 SPBC29A10.08   GPI anchored protein, 2.0245 
216 SPAC1F8.04c   hydrolase, 2.024 
217 C1753.05.RC     2.0225 
218 SPAC2F7.06c pol4;Pol-mu DNA polymerase X family, pol4 2.016 
219 SPAC17C9.16c   spermine transporter family, , SPAC9E9.16 2.0125 
220 SPBC106.02c srx1 sulphiredoxin, srx1 2.0095 
221 SPAC1B3.06c   UbiE family methyltransferase, 2.007 
222 C3A11.09.RC     2.005 
223 SPBC1198.01   glutathione-dependent formaldehyde dehydrogenase, 2 
224 SPSNORNA.40     2 
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